International Drug Price Indicator Guide 2012

Publication date: 2012

INTERNATIONAL DRUG PRICE INDICATOR GUIDE GUIA INTERNACIONAL DE INDICADORES DE PRECIOS DE MEDICAMENTOS INDICATEUR DE PRIX INTERNATIONAUX DES MEDICAMENTS 2012 Edited by Julie E. Frye Copyright © 2013 Management Sciences for Health, Inc. Management Sciences for Health Phone: 617.250.9500 784 Memorial Drive Fax: 617.250.9090 Cambridge, MA 02139-4613 USA URL: www.msh.org Center for Pharmaceutical Management Phone: 703.524.6575 Management Sciences for Health Fax: 703.524.7898 4301 N. Fairfax Drive, Suite 400 E-mail: cpm@msh.org Arlington, VA 22203 USA Cover design by Joe Meiring This publication was developed by Management Sciences for Health’s Center for Pharmaceutical Management, Arlington, Virginia. The Guide is updated annually. The explanatory notes are in English, French, and Spanish and the products and prices are in English. Comments and questions should be e-mailed to cpm@msh.org. Note: All rights reserved. Published by Management Sciences for Health (MSH) on its own behalf and for the World Health Organization (WHO). MSH and WHO have made every effort to ensure the accuracy of price, supplier, procurement agency and other information presented in this publication. However, the reader’s attention is drawn to the introduction, which describes the specific sources and limitations of information provided in this publication. The reader’s attention is also drawn to the importance of quality assurance for pharmaceutical products. Licensing authorities in the respective countries of manufacture are responsible for the review and approval of the detailed composition and formulation when authorizing a pharmaceutical product to be marketed, including the specifica- tions of its ingredients, as submitted by the manufacturer of the dosage form, and to oversee compliance with Good Manufacturing Practice requirements as recommended by WHO. MSH and WHO do not warrant that the products mentioned are in accordance with the national laws and regula- tions of any country, including but not limited to patent laws. It is recommended that readers intending to use this publication familiarize themselves with issues such as quality, safety and efficacy as well as quantification, patents, financial stability and standing of the supplier, ability to supply the required quantities, delivery time, and other related aspects. This publication does not constitute an endorsement or warranty of the fitness of any product for a particular purpose. This publication is not based on an active assessment of, and does not therefore constitute an acceptance or recommendation in regard to, any product’s quality, safety, or efficacy. This list may not be used by manufacturers and suppliers for commercial or promotional purposes. The mention of specific companies and certain of their products does not imply that they are recommended by MSH and WHO in preference to others of a similar nature that are not mentioned. Errors or omissions excepted, the names of propriety products are distinguished by initial capital letters. Bearing in mind that the data and information provided for a product depend largely on the supplier or procure- ment agency, these data and information are being provided as is, and MSH and WHO make no representations or warranties, either express or implied, as to their accuracy, completeness, or fitness for a particular purpose. MSH and WHO accept no responsibility or liability for the reliance on, or use of, such data and information. Nota: Todos los derechos reservados. Publicado por Management Sciences for Health (MSH) por cuenta propia y para la Organización Mundial de la Salud (OMS). MSH y la OMS han realizado todos los esfuerzos necesarios para asegurar la exactitud de los precios, proveedores, agencias de adquisiciones y otra información presentada en esta publicación. Sin embargo, se llama la atención del lector a la introducción que describe las fuentes específicas y las limitaciones de la información proporcionada en esta publicación. También se llama la atención del lector a la importancia del aseguramiento de la calidad para los productos farmacéuticos. Las autoridades responsables de otorgar licencias en los respectivos países de fabricación son responsables de la revisión y aprobación de la composición y formulación detallada al autorizar un producto farmacéutico para su comercialización, incluyendo las especificaciones de los ingredientes, de acuerdo con la información suministrada por el fabricante, así como de supervisar el cumplimiento con los requisitos de las Buenas Prácticas de Fabricación recomendadas por la OMS. MSH y la OMS no garantizan que los productos mencionados están de acuerdo con las leyes y regulaciones nacionales de ningún país, incluyendo pero no limitándose a las leyes de patentes. Se recomienda que los lectores que tengan la intención de utilizar esta publicación se familiaricen con los aspectos relativos a la calidad, seguridad y eficacia así como la cuantificación, los patentes, la estabilidad financiera y la situación del proveedor, su habilidad para suministrar las cantidades requeridas, el tiempo de entrega y otros aspectos relacionados. Esta publicación no constituye un respaldo o garantía con respecto a la idoneidad de cualquier producto para un fin en particular. Esta publicación no está basada en una evaluación activa y por lo tanto no constituye una aceptación o recomendación con respecto a la calidad, seguridad o eficacia de cualquier producto. Esta lista no puede ser utilizada por los fabricantes y proveedores para fines comerciales o promocionales. La mención de empresas específicas así como ciertos de sus productos no implica que estos están recomendados por MSH y la OMS con preferencia sobre otros productos de naturaleza similar que no hubieran sido mencionados. Salvo por errores u omisiones, los nombres de los productos comerciales se distinguen con una letra mayúscula inicial. Teniendo en mente que los datos y la información dados para un producto dependen en gran medida del proveedor o de la agencia de adquisiciones, estos datos e información se suministran tal cuál están, y MSH y la OMS no realizan ninguna declación o garantía, ya sea expresa o implícita con respecto a la exactitud, integridad o idoneidad para un propósito en particular. MSH y la OMS no aceptan responsabilidad alguna por la confianza depositada o el uso de dichos datos e información. Note:Note:Note:Note:Note: Tous droits réservés. Publié par Management Sciences for Health (MSH) pour son propre compte et pour l’Organisation mondiale de la Santé (OMS). MSH et l’OMS ont cherché dans la mesure du possible à vérifier l’exactitude des données sur les prix, les fournisseurs, les organismes d’achat et des autres informations présentées dans cette publication. Le lecteur n’en est pas moins prié de se rapporter à l’introduction qui décrit les sources spécifiques et les limitations de l’information donnée dans cette publication. Le lecteur doit également prêter attention à l’importance de l’assurance de qualité pour les produits pharmaceutiques. Les organismes chargés de la délivrance des autorisations dans les pays respectifs des fabricants sont responsables de l’examen et de l’approbation de la composition et formulation détaillées avant d’autoriser la mise sur le marché d’un produit donnée, notamment des spécifications des composants, tel qu’indiqué par le fabricant dans la présentation et doivent par ailleurs s’assurer que sont observées les Bonnes pratiques de fabrication recommandées par l’OMS. MSH et l’OMS ne garantissent pas que les produits mentionnés soient conformes aux lois et réglementations nationales d’un pays donné, notamment les lois relatives aux brevets. On recommande au lecteur qui souhaite utiliser cette publication de se mettre au courant des divers aspects tels que la qualité, l’innocuité et l’efficacité ainsi que la quantifications, brevets, situation financière et réputation du fournisseur ainsi que sa capacité à fournir les quantités demandées dans les bons délais. La présente publication ne constitue pas une approbation ou recommandation de l’efficacité d’un produit dans un but précis. Cette publication ne se fonde pas sur une évaluation active et ne constitue donc pas une acceptation ou recommandation de la qualité, innocuité ou efficacité d’un produit. Cette liste ne peut pas être utilisée par des fabricants ou fournisseurs à des fins commerciales ou promotionnelles. Si certaines sociétés ou certains produits sont mentionnés, cela ne veut nullement dire qu’ils sont recommandés par MSH et l’OMS de préférence à d’autres de nature analogue qui ne sont pas recommandés. Sauf erreur ou omission, les marques déposées sont indiquées par des initiales en majuscule. Sachant que les données et informations fournies sur un produit dépendent largement du fournisseur ou de l’organisme chargé des achats, lesdites informations sont donc données telles quelles, sans que MSH et l’OMS ne fassent aucune recommandation ou garantie, explicite ou implicite, quant à leur exactitude, intégralité ou adéquation dans tel but donné. MSH et l’OMS n’acceptent aucune responsabilité concernant la fiabilité ou l’utilisation des dites données et informations. Editor Julie E. Frye, Management Sciences for Health Consulting Editor Keith Johnson, Management Sciences for Health Contributors We thank MSH and WHO staff for their assistance with the International Drug Price Indicator Guide. We also very much appreciate the information and cooperation we receive from the suppliers included in the Guide. Finally, the tender data provided by government agencies around the world greatly enhances the usefulness of the International Drug Price Indicator Guide, and we thank the staff of the following organizations for their time and effort. • Botswana Public Procurement and Asset Disposal Board • La División Médica, la Gerencia de Operaciones y el Departamento de Farmacoterapia de la Caja Costarricense de Seguro Social (“Costa Rica Social Security”) • Dominican Republic PROMESE/CAL (“Central Support Unit for the Essential Medicines Program”) • Ghana MOH Procurement Unit • Mission for Essential Medical Supplies (MEMS), Tanzania • Namibia Ministry of Health and Social Services • Organisation of Eastern Caribbean States Pharmaceutical Procurement Service, St. Lucia • Ministerio de Salud del Perú (“Ministry of Health, Peru”) • El Sistema de Integración Centroamericana (SICA) ("System of Central American Integra- tion") • South Africa Department of Health • Sudan National Health Insurance Fund Contents/Contenido/Table des Matières vii Contents ACRONYMS/ABREVIATURAS/SIGLES . ix PREFACE . E-3 Prólogo . S-3 Préface .F-3 HOW TO USE THE GUIDE . E-5 Cómo Usar la Guía .S-5 Comment Utiliser le Guide . F-5 INFORMATION YOU SHOULD KNOW . E-6 Información que Usted Debe Saber . S-6 Information que Vous Devriez Connaître . F-6 LIST OF PRICE SOURCES . E-9 Fuentes de las Listas de Precios . S-10 Liste des Sources des Prix .F-9 CONTACT INFORMATION. E-15 Información del Contacto . S-17 Information de Contact . F-15 FORMAT OF THE PRICE LISTS . E-21 Formato de las Listas de Precios . S-23 Format des Listes de Prix . F-21 HOW TO ANALYZE AND COMPARE YOUR PRICES . E-31 Cómo Analizar y Comparar sus Precios . S-35 Comment Analyser et Comparer vos Prix . F-33 PLEASE NOTE: Explanatory notes are presented in three languages, each displayed with its own pagination: English - E-1 Spanish - S-1 French - F-1 FAVOR DE NOTAR: Notas explicativas están presenta- das en tres idiomas, cada uno con su propia paginación: Inglés - E-1 Español - S-1 Francés - F-1 NOTE: Le texte explicatif est disponible en trois langues, chacune avec une numérotation différente : Anglais - E-1 Espagnol - S-1 Français - F-1 viii International Drug Price Indicator Guide 2012 LIST I: PRODUCTS SORTED ALPHABETICALLY . A-1 Lista I: Productos Clasificados por Orden Alfabético Liste I : Produits Pharmaceutiques Classés par Ordre Alphabétique LIST II: PRODUCTS SORTED BY THERAPEUTIC CATEGORY . T-1 Lista II: Productos Clasificados por Categoría Terapéutica Liste II : Produits Pharmaceutiques Classés par Classe Thérapeutique LIST III: PRICE COMPARISON FORM (SUPPLIER PRICES ONLY) . SP-1 Lista III: Formulario para la Comparación de Precios (Precios de Proveedores Solamente) Liste III : Formulaire pour la Comparaison des Prix (Prix des Fournisseurs Seulement) LIST III: PRICE COMPARISON FORM (BUYER PRICES ONLY) . BP-1 Lista III: Formulario para la Comparación de Precios (Precios de Compradores Solamente) Liste III : Formulaire pour la Comparaison des Prix (Prix des Acheteurs Seulement) ANNEXES List of Synonyms WHO Essential Medicines List Therapeutic Categories OMS Lista Modelo de Medicamentos Esenciales Categorías Terapéuticas OMS Liste Modèle des Médicaments Essentiels Catégories Thérapeutiques ABOUT MANAGEMENT SCIENCES FOR HEALTH ABOUT THE MSH CENTER FOR PHARMACEUTICAL MANAGEMENT Acronyms/Abreviaturas/Sigles ix Acronyms/Abreviaturas/Sigles AIDS acquired immunodeficiency syndrome ARV antiretroviral ATC anatomical therapeutic chemical anatómica terapéutica química anatomique thérapeutique chimique BP British Pharmacopoeia Farmacopea Británica Pharmacopée britannique BPF Bonnes Pratiques de Fabrication CIF cost, insurance, and freight [Incoterm] costo, seguro y flete coût, assurance et fret CIP carriage and insurance paid [Incoterm] transporte y seguro pagados port payé assurance comprise CPM Center for Pharmaceutical Management Centro de Gestión Farmacéutica Centre pour la Gestion des Médicaments DAP delivered at place [Incoterm] entregado en el lugar est délivrée à DDD defined daily dose dosis diaria definida dose journalière définie DDP delivered duty paid [Incoterm] entregada derechos pagados délivré dédouané DMP Drug Management Program [part of Management Sciences for Health] DOTS directly observed treatment, short-course tratamiento directamente observado, a corto plazo stratégie de traitement sous surveillance directe DURG Drug Utilization Research Group Grupo de Investigación sobre la Utilización de Medicamentos Groupe de Recherche de l’Utilisation des Médicaments ECDS Eastern Caribbean Drug Service Servicio de Medicamentos del Caribe Oriental Service pharmaceutique de Etats de la Caraïbe de l’Est EEUU estadounidense EML Essential Medicines List [WHO] EP European Pharmacopoeia Farmacopea Europea Pharmacopée européenne x International Drug Price Indicator Guide 2012 EXW ex-works [Incoterm] franco en almacén sin transporte départ usine FCA free carrier [Incoterm] franco transportista [Incoterm] franco transporteur [Incoterm] FNUAP Fonds des Nations Unies pour la Population FOB free on board [Incoterm] franco a bordo franco à bord GDF Global TB Drug Facility GLC Green Light Committee Comité de Luz Verde GMP good manufacturing practices buenas prácticas de manufactura HIV human immunodeficiency virus IC international (narcotics) control control internacional de narcóticos contrôle international (narcotiques) IDA International Dispensary Association INN international nonproprietary name denominación común internacional dénomination internationale LME Lista de Medicamentos Esenciales [OMS] Liste de Médicaments essentiels [OMS] MDR-TB multidrug-resistant tuberculosis tuberculosis con farmacorresistencia multiple la tuberculose polychimiorésistante MOH Ministry of Health MS ministère de la santé MSF Doctors without Borders Médicos sin Fronteras Médecins sans Frontières MSH Management Sciences for Health MSP ministerios de salud pública N/D no disponible NGO nongovernmental organization OECS Organisation of Eastern Caribbean States Organización de Estados del Caribe Oriental Organisation des Etats de la Caraïbe de l’Est OMS Organización Mundial de la Salud Organisation mondiale de la Santé ONG organizaciones no gubernamentales organisations nongouvernementales ONUSIDA Programa Conjunto de las Naciones Unidas sobre el VIH/SIDA Programme Commun des Nations Unies sur le VIH/SIDA Acronyms/Abreviaturas/Sigles xi OPB organisations bénévoles privées OVP organizaciones voluntarias privadas P/D pas disponible PPS Pharmaceutical Procurement Service Servicio de Abastecimiento Farmacéutico Service d’Approvisionnement pharmaceutique PSI Population Services International PVO private voluntary organization RBM Roll Back Malaria SIDA síndrome de inmunodeficiencia adquirida syndrome d’immunodéficience acquise TB tuberculosis tuberculosis tuberculose TU thousand units miles de unidades mille unités UNAIDS Joint United Nations Programme on HIV/AIDS UNFPA United Nations Population Fund Fonds des Nations Unies pour la Population UNICEF United Nations Children’s Fund Fondo de las Naciones Unidas para la Infancia Fonds des Nations Unies pour l’Enfance USAID United States Agency for International Development USP United States Pharmacopeia Farmacopea de los Estados Unidos Pharmacopée des Etats Unis VIH virus de la inmunodeficiencia humana virus d’immunodéficience humaine WHO World Health Organization INTERNATIONAL DRUG PRICE INDICATOR GUIDE Preface E-3 Preface The International Drug Price Indicator Guide provides what the name implies—an indication of drug prices on the international market. This Guide has been published by MSH since 1986, and in collaboration with WHO since 2000. It provides a spectrum of prices from nonprofit drug suppliers and commercial procurement agencies, based on their current catalogs or price lists. It also contains prices obtained from international development agencies and from government agencies. MSH, in collaboration with WHO, is working with partners to make existing drug price infor- mation more widely available in order to improve procurement of medicines of assured quality for the lowest possible price. This will contribute to equitable access to health services and commodities, including essential medicines, that are necessary for the prevention and treatment of prevalent diseases. Because the potential cost of providing a full range of treatments for common diseases is high, prices and financing are inescapable factors in determining access to essential medicines. Lower prices can be obtained through bulk purchasing, competition, skillful negotiation, and sound supply management. Comparative price information is important for getting the best price. Such information helps in price negotiations, in locating new supply sources, and in assessing the efficiency of local procurement systems. The International Drug Price Indicator Guide helps supply officers determine the probable cost of pharmaceutical products for their programs. It can be used as a reference list to compare current prices paid to prices for products available on the international market; it can also be used to assess the potential financial impact of changes to a drug list. The database of prices is maintained by the Center for Pharmaceutical Management of Manage- ment Sciences for Health, a nonprofit organization, as a contribution towards making essential medicines available to all the world’s citizens. The Guide may be copied for in-service educa- tion or other nonprofit use. Additional information on international drug prices can be found on the Web at: • “Medicines Price Information” (http://www.who.int/medicines/areas/access/ecofin/ en/index.html), a page maintained by WHO. It includes prices of international price information services on starting materials, finished products, and selected HIV-related medicines. In addition, it reports on disease-specific price information and individual country price information services. Please note that an electronic version of the International Drug Price Indicator Guide can be found on MSH’s Electronic Resource Center at http://erc.msh.org. For more information or to provide comments or suggestions on the format or the contents of this publication, please contact us at: E-4 International Drug Price Indicator Guide 2012 Center for Pharmaceutical Management Medicines Policy and Standards Management Sciences for Health World Health Organization 4301 North Fairfax Drive, Suite 400 Avenue Appia 20 Arlington, VA 22203-1627 USA CH-1211 Geneva 27 Telephone: 1.703.524.6575 Switzerland Fax: 1.703.524.7898 Fax: 41.22.791.4167 E-mail: cpm@msh.org E-mail: psminfo@who.int How to Use the Guide E-5 How to Use the Guide The Guide begins with “Information You Should Know” to better understand the data pre- sented here. A list of the suppliers and buyers in this edition follows that section and includes details on shipping terms and restrictions. Supplier and buyer addresses appear next. After that, the Guide explains the format of the comparative price information reports, as well as the terms used on the price listings and the codes and abbreviations used. The price data are provided in three formats in this Guide. Each format includes supplier prices and buyer prices. The buyer prices are usually government agency international competitive bidding (or tender) prices. • List I: The products are in alphabetical order by generic name, and the list includes the price details for each supplier and buyer. This format is intended for procurement refer- ence and allows a quick search for a particular medicine. • List II: The products are in alphabetical order within the WHO Essential Medicines List (EML) classification system. This format assists with, for example, formulary develop- ment and allows a convenient comparison of medicines within classes. Items in a class cannot necessarily directly substitute for each other. • List III: The products are in alphabetical order with only the median price for an item displayed. This format is meant to facilitate comparison of a user’s prices with Guide prices. The supplier and buyer prices appear on separate lists. If you need information on how to use these prices for comparison purposes, please see the section called “How to Analyze and Compare Your Prices.” A list of synonyms and the WHO therapeutic class categories are included in the Annexes for reference. This Guide is intended as a comparative reference only; it is not suitable for actually ordering products. To place orders, the vendor must be contacted directly. No guarantees are implied as to availability of prices listed, quality of products, or specific sales conditions. The vendors included are not intended to be a comprehensive list of potential suppliers. Prices from buyers are listed for comparison purposes only. E-6 International Drug Price Indicator Guide 2012 Information You Should Know Products Included The International Drug Price Indicator Guide primarily focuses on essential medicines, but includes other products as well. Medicines from the WHO Essential Medicines Lists are always included, as are medicines and products important for the treatment or prevention of tuberculo- sis, malaria, and HIV/AIDS. Vaccines, immunologic agents, disinfectants, fluids and electro- lytes, and diagnostic tests and agents are also typically covered. Increasingly, medicines re- quired for cancer treatment and chronic disease care, and strengths and dosage forms required for pediatric care are being added to the database. New products are added to the Guide each year, as the information reported to us changes. Price Conversion Prices in the International Drug Price Indicator Guide are listed in ascending order according to unit price. All prices for the organizations listed below have been converted to U.S. dollars (USD). The exchange rates used are for 1 July 2012 (http://www.oanda.com). Other catalogue prices were listed originally in U.S. dollars and were not converted. Currency (Organization Code) Exchange Rate (to USD) British pound (DURBIN) 1.5700 Dominican Republic pesos (DOMREPUB) 0.0253 Euro (IDA, MEDEOR/EU) 1.2660 Kenya shilling (MEDS) 0.0117 Namibian dollar (NAMIBIA) 0.1195 Peruvian nuevo sol (PERU) 0.3690 Sudanese pound (SUDANNHIF) 0.3708 Tanzanian shilling (MEDEOR/TZ, MEMS) 0.0006 Ugandan shilling (JMS) 0.0004 Changes in exchange rates can cause costs to vary widely. The most current rate at the time of your analysis should always be used when calculating drug costs. Price Terms The supplier prices and buyer prices in this Guide are based on different price terms, and so must not be directly compared. The following incoterms are used to define the price types: • CIF (cost, insurance, and freight): includes insurance and transport charges up to the port of destination (sea shipments only) • CIP (carriage and insurance paid): The seller delivers the goods to the carrier at an agreed place and pays the costs of carriage necessary to bring the goods there. The seller also contracts for insurance cover against the buyer’s risk of loss or damage during carriage. Information You Should Know E-7 • DAP (delivered at place): seller pays for carriage to the named place, except for costs related to import clearance, and assumes all risks prior to the point that the goods are ready for unloading by the buyer • DDP (delivered duty paid): includes delivery and import duties and unloading costs • DDU (delivered duty unpaid): includes delivery, but not import duties or unloading costs • EXW (ex works): does not include loading, insurance, or freight • FCA (free carrier): includes transport and insurance until the goods are delivered to the carrier • FOB (free on board): the price of goods at the point of shipment, but does not include the cost of insurance and freight (transportation) Some suppliers and agencies charge a standard handling fee. The handling fees shown in the List of Price Sources have been added to the prices listed in this Guide. Calculating Prices When calculating and projecting real costs, it is important to consider factors such as financing, delivery times, modes of transportation (air/sea/inland), and handling charges. An analysis of these factors is beyond the scope and intent of this Guide. However, it is reasonable, for estima- tion purposes, to add 10% for shipping costs to the listed price for suppliers in this Guide. The buyer (government agency tender) prices listed generally do not require adjustment for ship- ping charges. Quality Assurance We require all suppliers included in the International Drug Price Indicator Guide to complete a quality assurance questionnaire. The purpose of the mandatory questionnaire is to help ensure that the prices listed in this Guide are from reputable suppliers with established quality assur- ance processes in place. The 28 questions address issues including inspection, testing, quality assurance, licensing, recalls, quality control procedures, standards, and documentation. Al- though this requirement provides some assurance of quality control processes, it does not necessarily guarantee the quality of the products listed. Copies of the questionnaire can be obtained from MSH on request. The price sources included in the Guide have been screened only through the completeness of the documents they have provided. This screening in no way constitutes an in-depth review of product quality. Inclusion in the Guide does not constitute pre-qualification or approval of any sort by MSH and WHO. E-8 International Drug Price Indicator Guide 2012 Product Quality The suppliers and agencies selected for this Guide are not manufacturers, but they offer prod- ucts that are stated to be in compliance with international quality standards specified by organi- zations such as the United States Pharmacopeia (USP), the British Pharmacopoeia (BP), and the European Pharmacopoeia (EP). All suppliers in this guide state that the manufacturing plants with which they work maintain high quality standards by having in place on-site quality assur- ance systems in order to ensure that all products are complying with WHO Good Manufactur- ing Practices (GMP) and with government regulations. Quality certificates in line with the WHO Certification Scheme on the Quality of Pharmaceutical Products Moving in International Commerce should be available from all of these suppliers on request. Suppliers and agencies listed in the Guide maintain their own independent quality assurance programs. Contact them directly for these details. ATC/DDD System1 Drug utilization data have a central role in the quality of care cycle and are essential to the management of policy related to drug supply, pricing, cost, and use. The anatomical therapeutic chemical (ATC) and defined daily dose (DDD) methodologies for classification and measure- ment can be helpful in following and comparing cost trends, but need to be used with caution. Basing detailed reimbursement, therapeutic group reference pricing, and other specific pricing decisions on the ATC and DDD assignments is a misuse of the system. The purpose of the ATC/DDD system is to serve as a tool for drug utilization research in order to improve drug use practices. One component of this is the presentation and comparison of drug consumption statistics at international and other levels. A major aim of the WHO Collaborating Centre for Drug Statistics Methodology and Working Group is to maintain stable ATC codes and DDDs over time to allow trends in drug consump- tion to be studied without the complication of frequent changes to the system. There is a strong reluctance to make changes to classifications or DDDs when such changes are requested for reasons not directly related to drug consumption studies. For this reason the ATC/DDD system by itself is not suitable for guiding decisions about reimbursement, pricing, and therapeutic substitution. The classification of a substance in the ATC/DDD system is not a recommendation for use, nor does it imply any judgments about efficacy or relative efficacy of drugs and groups of drugs. 1Text in this section is adapted from the WHO Collaborating Centre for Drug Statistics Methodology website (http:// www.whocc.no/atcddd/). List of Price Sources E-9 Li st o f P ri ce S ou rc es T hr ee p ri m ar y ty pe s of s up pl ie rs a nd b uy er s ar e in cl ud ed in th e G ui de . 1. S up pl ie rs w ho m ai nt ai n a w ar eh ou se a nd s up pl y it em s d ir ec tl y to c us to m er s. A ll of th es e su pp lie rs p ro vi d e a w id er r an ge o f pr od uc ts th an s ho w n in th is G ui de . F or a c om pl et e lis t o f p ro d uc ts , c on ta ct th e ve nd or d ir ec tl y. T he fo llo w in g su pp lie rs a re in cl ud ed in th e G ui de : S u p p li er C o d e D at e o f L is t H an d li n g F ee P ri ce T yp e D et ai ls A ct io n M ed eo r M ED EO R / EU 20 12 1% EX W T ön is vo rs t Pr ic es a re e ffe ct iv e un til p ub lic at io n of r ev is ed p ri ce li st . T ra ns po rt c os ts ar e ch ar ge d in di vi du al ly a cc or di ng t o ex pe ns es . S pe ci al p ac ka gi ng in c as es co st s Eu ro 2 6 pe r ca se . M in im um h an dl in g fe e is E ur o 50 . O nl y se rv es n on - pr of it or ga ni za tio ns . A ct io n M ed eo r In te rn at io na l H ea lth ar e M ED EO R / T Z M ar ch 2 01 2 0% EX W A ct io n M ed eo r In te rn at io na l H ea lth ca re is a n ot -fo r pr of it pr oc ur em en t ag en cy fo un de d in 2 00 4 an d ow ne d by A ct io n M ed eo r. It s up pl ie s th e no t- fo r- pr of it m ar ke t (p ri m ar ily in T an za ni a) a nd d oe s no t su pp ly t o in di vi du al s or c om m er ci al p ha rm ac ie s. A 3 .5 % s er vi ce c ha rg e ap pl ie s fo r al l n on - T an za ni an c us to m er s to c ov er b an k ch ar ge s an d cu rr en cy lo ss . N o m in im um q ua nt iti es a re r eq ui re d. D ur bi n PL C D U R BI N 20 11 -2 01 2 0% EX W U ni te d K in gd om D ur bi n su pp lie s ph ar m ac eu tic al s an d m ed ic al s up pl ie s to d oc to rs , ph ar m ac ie s, h os pi ta ls , p ha rm ac eu tic al w ho le sa le rs a nd t ra de rs , m ili ta ry a nd go ve rn m en t ag en ci es , c ha ri tie s an d ot he r re lie f o rg an is at io ns w or ld w id e. M in im um o rd er U K £ 50 0. ID A F ou nd at io n ID A N ov em be r 20 12 1. 5% EX W A m st er da m Si nc e 19 72 , t he ID A F ou nd at io n ha s be en c om m itt ed t o im pr ov in g ac ce ss to a nd d el iv er in g hi gh -q ua lit y es se nt ia l m ed ic in es a nd m ed ic al s up pl ie s to lo w - an d m ed iu m -in co m e co un tr ie s. A s an in de pe nd en t an d se lf- su pp or tin g fo un da tio n, ID A d is tr ib ut es m or e th an 3 ,0 00 p ro du ct s to o ve r 10 0 co un tr ie s w or ld w id e. M in im um o rd er o f U S$ 50 00 . O rd er s un de r Eu ro 5, 00 0 ar e ch ar ge d a ha nd lin g fe e of 3 % . O rd er s ov er E ur o 5, 00 0 ar e ch ar ge d a ha nd lin g fe e of 1 .5 % . P ri ce s ar e in di ca tiv e an d m ay c ha ng e. E-10 International Drug Price Indicator Guide 2012 S u p p li er C o d e D at e o f L is t H an d li n g F ee P ri ce T yp e D et ai ls Jo in t M ed ic al S to re s JM S A ug us t 20 12 0% EX W K am pa la JM S su pp lie s ph ar m ac eu tic al s an d m ed ic al s up pl ie s to m is si on h ea lth u ni ts an d ot he r N G O s in U ga nd a an d do es n ot e xp or t pr od uc ts . J M S op er at es on a n ot -fo r- pr of it ba si s, a nd p ri ce t er m s ar e ca sh -a nd -c ar ry o nl y. P ri ce s ar e in di ca tiv e. M ed ic al E xp or t G ro up M EG D ec em be r 20 12 0% FC A G or in ch em , T he N et he rl an ds Pr ic es a re g iv en a s an in di ca tio n on ly . T he re a re n o m in im um o rd er s re qu ir ed o r se rv ic e ch ar ge s. M is si on fo r Es se nt ia l D ru gs a nd S up pl ie s M ED S Ju ly 2 01 2 0% FO B N ai ro bi M ED S su pp lie s dr ug s an d m ed ic al s up pl ie s to n on pr of it he al th c ar e pr ov id er s. F re ig ht c ha rg es a re a dd ed fo r de liv er ie s ou ts id e of K en ya . M is si on ph ar m a M IS SI O N D ec em be r 20 12 0% EX W L yn ge Pr ic es a re g iv en a s an in di ca tio n on ly . T he re a re n o m in im um o rd er s re qu ir ed o r se rv ic e ch ar ge s. List of Price Sources E-11 2. In te rn at io na l d ev el o pm en t o rg an iz at io ns th at p ro vi d e co m m od it ie s to c ou nt ry p ro gr am s th ey a nd o th er s su pp or t. T he o rg an i- za ti on s lis te d in th e G ui de a re : In te rn at io n al D ev el o p m en t O rg an iz at io n C o d e D at e o f L is t H an d li n g F ee P ri ce T yp e D et ai ls G lo ba l T B D ru g Fa ci lit y G D F N ov em be r 20 12 0% EX W S up pl ie r Fa ct or y Su pp ly C ha in M an ag em en t Sy st em SC M S N ov em be r 20 12 5% EX W ( SC M S re gi on al di st ri bu tio n ce nt er o r di re ct ly fr om t he su pp lie r) T he S up pl y C ha in M an ag em en t Sy st em p ro je ct d el iv er s es se nt ia l l ife sa vi ng m ed ic in es t o H IV /A ID S pr og ra m s ar ou nd t he w or ld . T he p ro je ct h el ps st re ng th en e xi st in g su pp ly c ha in s or e st ab lis he s ne w o ne s to e ns ur e a sa fe , se cu re , r el ia bl e an d su st ai na bl e su pp ly c ha in m an ag em en t sy st em t o pr oc ur e ph ar m ac eu tic al s an d ot he r pr od uc ts fo r pe op le w ith H IV /A ID S an d re la te d in fe ct io ns . S C M S is fu nd ed b y th e U S go ve rn m en t as p ar t of t he Pr es id en t's E m er ge nc y Pl an fo r A ID S R el ie f ( PE PF A R ). T he S C M S pr oj ec t ca n w or k an yw he re in t he w or ld , b ut is in iti al ly fo cu se d on t he 1 5 PE PF A R fo cu s co un tr ie s. In a dd iti on t o se rv in g an y pr oj ec t or im pl em en tin g pa rt ne r su pp or te d by P EP FA R , S C M S ca n al so s up pl y pr oj ec ts s up po rt ed b y na tio na l g ov er nm en ts a nd o th er d on or s, s ub je ct t o in di vi du al ar ra ng em en ts . T he G lo ba l D ru g Fa ci lit y (G D F) is a m ec ha ni sm t o ex pa nd a cc es s to , a nd av ai la bi lit y of , h ig h- qu al ity a nt i-T B dr ug s to f ac ili ta te g lo ba l e xp an si on a nd m ai nt en an ce o f D O T S, t he in te rn at io na lly r ec om m en de d st ra te gy t o co nt ro l t ub er cu lo si s. D ru gs a re s up pl ie d th ro ug h fr ee g ra nt s, b ut a re a ls o av ai la bl e fo r pu rc ha se b y go ve rn m en ts a nd o rg an iz at io ns w is hi ng to t ak e ad va nt ag e of th e qu al ity , p ri ce s, a nd te ch ni ca l s up po rt o ffe re d th ro ug h th e G D F D ir ec t Pr oc ur em en t Se rv ic e. G D F pe rf or m s co m pu ls or y in de pe nd en t te st in g of e ac h ba tc h of d ru gs it s up pl ie s an d pr e- sh ip m en t in sp ec tio n of ea ch o rd er it d el iv er s to c on fir m h ig h qu al ity . T o fa ci lit at e th e ef fic ie nt d el iv er y of p ro du ct s, G D F us es p ro cu re m en t ag en ts . P ri ce s in cl ud e th e co st o f th e pr od uc t as w el l as q ua lit y co nt ro l co st s an d a G D F pr oc ur em en t ag en t f ee . C os ts f or p re -s hi pm en t in sp ec tio n, tr an sp or t (a ir fr ei gh t or s ea fr ei gh t) a nd in su ra nc e, a re n ot in cl ud ed in th e lis te d pr od uc t p ri ce s. G D F se nd s a te am o f T B an d dr ug m an ag em en t e xp er ts t o th e co un tr y fo ur m on th s af te r dr ug s ar ri ve , t o as se ss d ru g us ag e an d pr ov id e an y ne ed ed t ec hn ic al a ss is ta nc e. G D F do es no t c ha rg e fo r its t ec hn ic al a ss is ta nc e to c ou nt ri es . E-12 International Drug Price Indicator Guide 2012 In te rn at io n al D ev el o p m en t O rg an iz at io n C o d e D at e o f L is t H an d li n g F ee P ri ce T yp e D et ai ls U N P op ul at io n Fu nd U N FP A 20 12 0% FO B U N FP A c on du ct s an nu al t en de rs t o pu rc ha se g oo ds fo r th ei r fie ld o ffi ce s an d on b eh al f o f e xt er na l c lie nt s in m or e th an 1 68 c ou nt ri es , m ai nl y in t he de ve lo pi ng w or ld . U N FP A s er ve s on ly g ov er nm en ts a nd n on pr of it or ga ni za tio ns . U N FP A c ha rg es a 5 % a dm in is tr at io n fe e an d a 0. 13 2% in su ra nc e fe e to n on -U N FP A b uy er s. T he re is a m in im um o rd er re qu ir em en t of U S$ 5, 00 0 pe r ite m . U .S . A ge nc y fo r In te rn at io na l D ev el op m en t C en tr al C on tr ac ep tiv e Pr oc ur em en t Pr oj ec t U SA ID /C C P 20 12 5. 5% EX W T he U SA ID | C C P Pr oj ec t, es ta bl is he d in 1 99 0, s er ve s as t he c en tr al pr oc ur em en t m ec ha ni sm fo r U SA ID M is si on s to p ur ch as e hi gh q ua lit y co nt ra ce pt iv es , c on do m s, a nd o th er e ss en tia l p ub lic h ea lth s up pl ie s. T he U SA ID | C C P Pr oj ec t (C en tr al C on tr ac ep tiv e Pr oc ur em en t) a ls o ad m in is te rs t he C om m od ity F un d, w hi ch s er ve s to in cr ea se c on do m av ai la bi lit y an d us e by m ak in g co nd om s fo r H IV p re ve nt io n fr ee o f c ha rg e to n on fo cu s pr og ra m s. S in ce 2 00 6, C C P al so h as p ro vi de d ot he r es se nt ia l pu bl ic h ea lth p ha rm ac eu tic al s, d ia gn os tic s, a nd m ed ic al e qu ip m en t at t he re qu es t of U SA ID M is si on s. A h an dl in g fe e is a pp lie d to e ac h or de r an d th is is b as ed o n th e ty pe o f c om m od ity p ro cu re d. In a dd iti on t o pr oc ur em en t se rv ic es , t he U SA ID | C om m od iti es S ec ur ity a nd L og is tic s D iv is io n al so p ro vi de s te ch ni ca l a ss is ta nc e to U SA ID M is si on s an d ho st co un tr y or ga ni za tio ns t o im pr ov e th e pe rf or m an ce o f l oc al s up pl y ch ai ns , to s tr en gt he n lo ca l s ys te m s an d in st itu tio ns , a nd t o in cr ea se t he a va ila bi lit y of e ss en tia l p ub lic h ea lth s up pl ie s. List of Price Sources E-13 3. B uy er s (u su al ly p ub lic -s ec to r ag en ci es ) t ha t p ro cu re c om m od it ie s th ro ug h in te rn at io na l c om pe ti ti ve b id d in g, o r te nd er s. T he se ar e ac tu al p ri ce s ob ta in ed b y th e or ga ni za ti on s lis te d a nd a re in cl ud ed fo r co m pa ri so n pu rp os es . I t i s no t p os si bl e fo r a re ad er to pl ac e an o rd er w it h an y of th es e or ga ni za ti on s. B u ye r C o d e D at e o f L is t P ri ce T yp e A p p ro x. V al u e o f T en d er (U S D ) D et ai ls Bo ts w an a Pu bl ic P ro cu re m en t an d A ss et D is po sa l B oa rd BO T SW A N A 20 12 N /A N /A T he P ub lic P ro cu re m en t an d A ss et D is po sa l B oa rd o f Bo ts w an a co nd uc ts o pe n an d cl os ed d om es tic a nd in te rn at io na l t en de rs o n a re gu la r ba si s. C aj a C os ta rr ic en se d e Se gu ro S oc ia l C R SS 20 12 D D U 82 .4 m ill io n C os ta R ic a So ci al S ec ur ity c on du ct s an a nn ua l, op en , in te rn at io na l t en de r an d ne go tia te s co nt ra ct s fo r dr ug s an d m ed ic al s up pl ie s fo r its o w n fa ci lit ie s. R ep úb lic a D om in ic an a C en tr al d e A po yo L og ís tic o Pr og ra m a de M ed ic am en to s Es en ci al es (P R O M ES E/ C A L) D O M R EP U B A ug us t 20 12 D D P 30 .4 m ill io n T he D om in ic an R ep ub lic E ss en tia l M ed ic in e Pr og ra m C en tr al L og is tic s Su pp or t co nd uc ts a n an nu al o pe n, do m es tic t en de r fo r ph ar m ac eu tic al s an d m ed ic al s up pl ie s. G ha na M in is tr y of H ea lth P ro cu re m en t U ni t G H A N A A R V s: M ar . 20 12 . Es se nt ia l m ed s: M ay 20 12 . A nt im al ar - ia ls : J ul y 20 12 C IF , D D P, C IP A R V s: 18 .4 m ill io n E ss en tia l m ed i- ci ne s: 12 .8 m ill io n A nt im al ar - ia ls : 2 .1 m ill io n T he G ha na M in is tr y of H ea lth P ro cu re m en t U ni t co nd uc ts an in te rn at io na l, op en ( cl os ed fo r ps yc ho th er ap eu tic s) te nd er fo r es se nt ia l m ed ic in es e ve ry t w o ye ar s. T he y co nd uc t an nu al , i nt er na tio na l, op en t en de rs fo r an tir et ro vi ra ls a nd a nt im al ar ia ls . M is si on fo r Es se nt ia l M ed ic al S up pl ie s (M EM S) , T an za ni a M EM S Ju ly 2 01 2 N /A 0. 2 m ill io n M EM S aw ar ds a n an nu al d ru g an d m ed ic al s up pl y co nt ra ct to a p ri m e ve nd or , a fte r an o pe n do m es tic p re -q ua lif ic at io n pr oc es s an d a cl os ed t en de r pr oc es s. E-14 International Drug Price Indicator Guide 2012 B u ye r C o d e D at e o f L is t P ri ce T yp e A p p ro x. V al u e o f T en d er (U S D ) D et ai ls N am ib ia C en tr al M ed ic al S to re s N A M IB IA 20 12 D D P N /A T he N am ib ia C en tr al M ed ic al S to re s co nd uc ts a n op en , in te rn at io na l t en de r ev er y tw o ye ar s fo r ph ar m ac eu tic al s an d m ed ic al s up pl ie s an d on ce a y ea r fo r an ti- re tr ov ir al s. O rg an is at io n of E as te rn C ar ib be an St at es P ha rm ac eu tic al P ro cu re m en t Se rv ic e (O EC S/ PP S) O EC S/ PP S 20 12 -2 01 4 C IF 12 .9 m ill io n T he O EC S/ PP S pr ov id es it s se rv ic es t o m em be r co un tr ie s of th e O rg an is at io n of E as te rn C ar ib be an S ta te s on ly . F or t he se ni ne c ou nt ri es , O EC S/ PP S ne go tia te s co nt ra ct s an d pu rc ha se s th ro ug h a cl os ed , i nt er na tio na l t en de r ev er y 18 m on th s. Pe rú M in is te ri o de S al ud PE R U 20 12 D D P 68 m ill io n T he P er u M in is tr y of H ea lth ( M IN SA ) co nd uc ts a n an nu al , do m es tic , o pe n te nd er fo r ph ar m ac eu tic al s an d m ed ic al su pp lie s. El S is te m a de In te gr ac ió n C en tr oa m er ic an a (S IC A ) SI C A M ay 2 01 2 C IF 38 .9 m ill io n T he S ys te m o f C en tr al A m er ic an In te gr at io n (S IC A ) co nd uc ts a n op en , i nt er na tio na l t en de r ev er y tw o ye ar s fo r 66 p ha rm ac eu tic al s. So ut h A fr ic a D ep ar tm en t of H ea lth SA FR IC A 20 11 -2 01 2 D D P 1. 7 bi lli on T he S ou th A fr ic a D ep ar tm en t of H ea lth c on du ct s tw o- ye ar do m es tic , o pe n te nd er s on a r ol lin g ba si s fo r ph ar m ac eu tic al s an d m ed ic al s up pl ie s. Su da n N at io na l H ea lth In su ra nc e Fu nd SU D A N - N H IF Ju ly 2 01 2 D A P 10 .2 m ill io n T he N at io na l H ea lth In su ra nc e Fu nd o f S ud an c on du ct s an nu al , o pe n, d om es tic t en de rs fo r ph ar m ac eu tic al s an d m ed ic al s up pl ie s. Contact Information E-15 Contact Information Action Medeor Deutsches Medikamenten-Hilfswerk St. Töniser Strasse 21 D-47918 Tönisvorst GERMANY Telephone: 49.21.56.97.88.0 Fax: 49.21.56.97.88.88 E-mail: info@medeor.org URL: http://www.medeor.org Action Medeor International Healthcare Deutsches Medikamenten-Hilfswerk St. Töniser Strasse 21 D-47918 Tönisvorst GERMANY and P.O. Box 72305 Dar es Salaam TANZANIA Telephone: 49.21.56.97.88.0 Fax: 49.21.56.97.88.88 E-mail: medeortz@bol.co.tz URL: http://www.medeor.org Botswana Public Procurement and Asset Disposal Board Plot 8913 Maakgadigau Way, Gaborone West Industrial Gaborone Private Bag 0058 BOTSWANA Telephone: 267 360 2000 Fax: 267 390 6822 E-mail: sbpac@ppadb.co.bw URL: http://www.ppadb.co.bw E-16 International Drug Price Indicator Guide 2012 Caja Costarricense de Seguro Social—CCSS (“Costa Rica Social Security—CRSS”) Pharmacotherapy Department Apartado 10105 San José 1000 COSTA RICA Telephone: 506.222.1878 Fax: 506.257.7004 E-mail: farmaco@ccss.sa.cr URL: http://www.info.ccss.sa.cr/ Dominican Republic PROMESE/CAL Calle “H” No. 15 Zona Industrial de Herrera Santo Domingo DOMINICAN REPUBLIC Telephone: 809.518.1313 E-mail: promesecal@promesecal.gov.do URL: http://www.promesecal.gov.do/ Durbin PLC 180 Northolt Road South Harrow Middlesex HA2 0LT UNITED KINGDOM Telephone: 44.20.8660.2220 Fax: 44.20.8668.0751 E-mail: cataloguesales@durbin.co.uk URL: http://www.durbin.co.uk Global TB Drug Facility (GDF) Stop TB Partnership Secretariat c/o World Health Organization 20, avenue Appia 1211 Geneva, 27 SWITZERLAND Telephone: 41.22.791.3647 Fax: 41.22.791.4886 E-mail: gdf@who.int URL: http://www.globaldrugfacility.org or http://www.stoptb.org/GDF Contact Information E-17 Ghana MOH Procurement Unit MOH Ghana P.O. Box MB44 Accra GHANA Telephone: 233.21.66.8782 Fax: 233.21.66.4032 E-mail: mohpu@ghana.com IDA Foundation P.O. Box 37098 1030 AB Amsterdam THE NETHERLANDS Telephone: 31.20.40.33.051 Fax: 31.20.40.31.854 E-mail: info@idafoundation.org URL: http://www.idafoundation.org Joint Medical Store P.O. Box 4501 Kampala UGANDA Telephone: 256.41.510096 Fax: 256.41.510098 Email: store@jms.co.ug URL: http://www.jms.co.ug/ Medical Export Group, BV Papland 16 P.O. Box 598 4200 AN Gorinchem THE NETHERLANDS Telephone: 31.183.356.100 Fax: 31.183.356.122 E-mail: sales@meg.nl URL: http://www.meg.nl E-18 International Drug Price Indicator Guide 2012 Mission for Essential Medical Supplies (MEMS) P.O. Box 10810 Arusha TANZANIA Telephone: 255.27.250.9366 Fax: 255.27.254.4908 E-mail: info@mems.or.tz Mission for Essential Drugs and Supplies (MEDS) MEDS Centre P.O. Box 78040-00507 Viwandani Nairobi, 00507 KENYA Telephone: 254.020.3920.404 Fax: 254.020.3920.600 E-mail: customerservice@meds.or.ke URL: http://www.meds.or.ke Missionpharma A/S Vassingeroedvej 9 DK-3540 Lynge DENMARK Telephone: 45.48.16.32.00 Fax: 45.48.16.32.48 E-mail: info@missionpharma.com URL: http://www.missionpharma.com Namibia Central Medical Stores P.O. Box 5552 Windhoek NAMIBIA Phone: 264.61.233151 Fax: 264.61.238746 Contact Information E-19 Organisation of Eastern Caribbean States Pharmaceutical Procurement Service OECS The Morne, P.O. Box 3093 Castries ST. LUCIA, WEST INDIES Telephone: 758.452.5895 Fax: 758.453.0227 E-mail: pps@oecs.org URL: http://www.oecs.org/pps/ Perú Ministerio de Salud (MINSA) (“Peru Ministry of Health”) Av. Salaverry 801 Jesús Maria Lima PERU Telephone: 51.14.315.6600 E-mail: webmaster@minsa.gob.pe URL: http://www.minsa.gob.pe/portada/ South Africa Department of Health Private Bag X828 Pretoria, 0001 SOUTH AFRICA Telephone: 27.12.312.0000 Fax: 27.12.326.4395 URL: http://www.doh.gov.za Sudan National Health Insurance Fund Pharmaceutical Services Department Baladya Street P.O. Box: 13267 Khartoum SUDAN Telephone: 249 1 837 47618 Fax: 249 1 837 47619 E-mail: info@nhif.gov.sd URL: http://www.nhif.gov.sd E-20 International Drug Price Indicator Guide 2012 Supply Chain Management System (SCMS) 1616 Fort Myer Drive 12th Floor Arlington, VA 22209-3100 USA Telephone: 1.571.227.8600 Fax: 1.571.227.8601 URL: http://www.pfscm.org System of Central American Integration (SICA) Boulevard Orden de Malta No. 470 Urbanización Santa Elena Antiguo Cuscatlán Department of La Libertad EL SALVADOR Telephone: 503 2248-8800 Fax: 503 2248-8899 E-mail: info.sgsica@sica.int URL: http://www.sica.int/ United Nations Population Fund (UNFPA) Midtermolen 3 P.O. Box 2530 Copenhagen DENMARK Telephone: 45.3546.7000 Fax: 45.3546.7018 E-mail: accessrh@unfpa.org URL: http://www.unfpa.org/public/supplies United States Agency for International Development (USAID)/CCP Project GH/PRH/CSL 1300 Pennsylvania Ave., NW Third Floor, Ronald Reagan Building Washington, DC 20523-3601 USA Telephone: 1.202.712.4539 Fax: 1.202.216.3404 URL: http://www.usaid.gov/what-we-do/global-health/family-planning Format of the Price Lists E-21 Format of the Price Lists The pharmaceutical products are presented in three separate lists, with different formats and features, but certain elements are common to all. • List I: Products Sorted Alphabetically • List II: Products Sorted by Therapeutic Category • List III: Price Comparison Form A detailed description of the information included in each list follows. E-22 International Drug Price Indicator Guide 2012 List I - Products Sorted Alphabetically List I is intended for procurement reference and lists drugs in alphabetical order by generic name to allow a quick search for a particular drug. This list shows the pack size(s) available from each source and the pack price in U.S. dollars, including the source’s standard service charges where applicable. Item Description The item description includes the generic name, strength, dosage form, and the route of admin- istration. If the product has two widely used names (for example, vitamin C and ascorbic acid), one name will appear in brackets. See the List of Synonyms in the Annex. IC Products under international narcotics control are identified with (IC) next to the de- scription. Nomenclature International nonproprietary names (INNs) have been used for the list of drugs in this Guide. If an INN has not been assigned, the most common generic name has been used. Drug dosage forms listed are generally those included in the World Health Organization’s 17th Model List of Essential Medicines (revised March 2011), found at http://www.who.int/medicines. Route of Administration Routes of administration are coded as follows: Item Type Code Condoms COND Diagnostic Strips and Tests and Lab Supplies DIAG Ear Preparations OTIC Eye Preparations OPHT Injectable Medicines INJ Intrauterine Device (IUD) IUD Intravenous Solutions IV Medicines for Inhalation INH Medicines for Nasal and Throat Use N/T Subcutaneous Medicines S/C Sublingual Tablets SL Suppositories/Enemas/Rectal Ointment RECT Tablets/Capsules/Oral Liquids PO Topical Medicines (liquids, powders, creams, ointments) TOP Vaginal Preparations VAG Not Applicable N/A Format of the Price Lists E-23 Source The list of price sources can be found on page E-9. Package Package sizes are provided by the suppliers and buyers. Package Price (US$) Package prices are provided by the suppliers and buyers and have been converted to U.S. dollars at the exchange rates listed on page E-6 to facilitate comparison. If a supplier charges a standard handling fee percentage, that percentage has been added to the package price listed. Unit Price (US$) The unit price is calculated by dividing the package price by the package size. This format facilitates the price comparison of different vendor pack sizes. The unit used to compare prices varies with the type of pharmaceutical preparation as follows: Pharmaceutical Dosage Form Comparison Unit (Code) Ampoule or Vial Milliliter (ML) Cartridge Milliliter (ML) Condom, Intrauterine Device (IUD), Net, Test Each (EACH) Ear, Nose, and Throat Preparation Milliliter (ML) Enema Milliliter (ML) Gas Cubic Meter (CUBMETER) Granules Gram (G) Inhaler Dose (DOSE) Oral Liquid Milliliter (ML) Pack Pack (PACK) Pessary Pessary (PESS) Suppository Suppository (SUPP) Syringe Syringe (SYRINGE) Tablet or Capsule Tablet or Capsule (TAB-CAP) Topical Liquid Milliliter (ML) Topical Solid Gram (G) Treatment Treatment (TREATMEN) Vaccine Dose (DOSE) Vial (single strength) Vial (VIAL) DDD The DDD is the assumed average maintenance dose per day for a drug used for its main indica- tion in adults. The defined daily dose is a unit of measurement and does not necessarily reflect the recommended or prescribed daily dose. Doses for individual patients and patient groups will often differ from the DDD and will necessarily be based on individual characteristics (e.g., E-24 International Drug Price Indicator Guide 2012 age and weight) and pharmacokinetic considerations. Drug consumption data presented in DDDs give only a rough estimate of consumption and not an exact picture of actual use. DDDs provide a fixed unit of measurement independent of price and formulation, enabling the researcher to assess trends in drug consumption and to perform comparisons between population groups. The defined daily doses are from the WHO Collaborating Centre for Drug Statistics Methodol- ogy. They are illustrative defined daily doses, as recommended by the World Health Organization’s Drug Utilization Research Group (DURG). Not all drugs listed in this price comparison guide have defined daily doses assigned by this method. A DDD will only be assigned for drugs that already have an ATC code. The main use of the DDD is for estimating drug consumption, based on inventory/distribution data. This estimate can be combined with price information for budgeting purposes. Note: The defined daily dose should not be used for dosing or therapeutic determinations. Refer to prescribing information for dosing schedules for specific indications. WHO EML The “WHO EML” column indicates whether the product is included on the 2011 WHO Model List of Essential Medicines. We identify five categories in the International Drug Price Indicator Guide: E = On the WHO core list in the same dosage form and strength C = On the WHO complementary list in the same dosage form and strength P = On the WHO list, but in a different presentation (different dosage form and/or strength) T = Not on the WHO list, but can be an alternative for an item listed as a therapeutic group example N = Not on the WHO model list ATC Code The ATC code is the anatomical therapeutic chemical classification code assigned by the WHO Collaborating Centre for Drug Statistics Methodology. The purpose of the ATC/DDD system is to serve as a tool for drug utilization research in order to improve drug use practices. One component of this is the presentation and comparison of drug consumption statistics at interna- tional and other levels. In the ATC classification system, the drugs are divided into different groups according to the organ or system on which they act and their chemical, pharmacological, and therapeutic proper- ties. Drugs are classified in groups at five different levels. The drugs are divided into 14 main groups (1st level), with one pharmacological/therapeutic subgroup (2nd level). The 3rd and 4th levels are chemical/pharmacological/therapeutic subgroups, and the 5th level is the chemical substance.2 2 Adapted from the WHO Collaborating Centre for Drug Statistics Methodology website at http://www.whocc.no/ atcddd/. Format of the Price Lists E-25 Median Price When using the Guide for comparison with local prices, or for estimating the total value of a proposed procurement list, an average price can be helpful. There are basically two kinds of average prices that could be used: the mean price and the median price. The mean price is the simple average of all prices shown for a drug; the values are added up and divided by the number of values. However, there is a problem when one or two prices are much higher or lower than the rest for a certain drug. These “outliers” skew the mean and make it less representative. For example, in a series of seven values such as $1, $2, $2, $3, $5, $16, $20, the total of all the values is $49, and dividing by seven gives a mean value of $7. For comparison or estimation purposes, it is likely that this average is too high, due to the two prices that are much higher than others in the series. To avoid this risk, we use the median price. The median price is a type of average; it is the value that splits a series of values in half when the series is put in ascending order. This is likely to be a more valuable approach for estimating actual future prices (or for comparing with local prices) when there is a skewed distribution. If there is an odd number of values in the series, as in the example above, the median value is the middle value in the series ($3 in the example). When there is an even number of values in a series, such as the series $1, $3, $4, $6, $14, $20, the median is calculated by averaging the two middle values. In this example, the median is the average of $4 and $6, which is $5. Again, this is likely to be closer to reality for comparison or estimation than the arithmetic mean of $8 ($48 divided by 6).3 High/Low Ratio The high/low ratio compares the highest unit price with the lowest unit price. For example, a high/low ratio of 3 means that the highest unit price is three times greater than the lowest unit price. 3 For further discussion, see Statistics without Tears—A Primer for Non-Mathematicians, by Derek Rowntree (New York: Charles Scribner’s Sons, 1981), pp. 41–45. E-26 International Drug Price Indicator Guide 2012 List II - Products Sorted by Therapeutic Category For List II, the pharmaceuticals are listed in alphabetical order within each therapeutic class based on the WHO Essential Medicines List classification system. For products not included on the latest WHO EML (i.e., those products with an “N” in the “WHO EML” column in this Guide), we have assigned a therapeutic class based on the WHO EML classification system. This is done when a non-EML product clearly falls within an EML therapeutic category, as determined by MSH staff. This assignment does not reflect a decision by WHO Essential Drugs and Medicines Policy or MSH staff that the non-EML product is appropriate for inclusion in the WHO Model List of Essential Medicines. If an unambiguous assignment of an EML therapeutic category was not possible, we placed the product in the category of “UA – Agents Unclassified in WHO EML.” Items in a class cannot necessarily directly substitute for each other. All prices on this list are unit prices. For each item in this list, the following data are shown: Item Description The item description includes the generic name, strength, dosage form, and the route of admin- istration. If the product has two widely used names (for example, vitamin C and ascorbic acid), one name will appear in brackets. See the List of Synonyms in the Annex. IC Products under international narcotics control are identified with (IC) next to the de- scription. Nomenclature International nonproprietary names have been used for the list of drugs in this Guide. If an INN has not been assigned, the most common generic name has been used. Drug dosage forms listed are generally those included in the World Health Organization’s 17th Model List of Essential Medicines (revised March 2011), found at http://www.who.int/ medicines. Route of Administration Routes of administration are coded as follows: Item Type Code Condoms COND Diagnostic Strips and Tests and Lab Supplies DIAG Ear Preparations OTIC Eye Preparations OPHT Injectable Medicines INJ Intrauterine Device (IUD) IUD Intravenous Solutions IV Medicines for Inhalation INH Format of the Price Lists E-27 Medicines for Nasal and Throat Use N/T Subcutaneous Medicines S/C Sublingual Tablets SL Suppositories/Enemas/Rectal Ointment RECT Tablets/Capsules/Oral Liquids PO Topical Medicines (liquids, powders, creams, ointments) TOP Vaginal Preparations VAG Not Applicable N/A WHO EML The “WHO EML” column indicates whether the product is included on the 2011 WHO Model List of Essential Medicines. We identify five categories in the International Drug Price Indicator Guide: E = On the WHO core list in the same dosage form and strength C = On the WHO complementary list in the same dosage form and strength P = On the WHO list, but in a different presentation (different dosage form and/or strength) T = Not on the WHO list, but can be an alternative for an item listed as a therapeutic group example N = Not on the WHO model list Number of Suppliers/Buyers The number of suppliers or buyers offering this product. Median Price When using the Guide for comparison with local prices, or for estimating the total value of a proposed procurement list, an average price can be helpful. There are basically two kinds of average prices that could be used: the mean price and the median price. The mean price is the simple average of all prices shown for a drug; the values are added up and divided by the number of values. However, there is a problem when one or two prices are much higher or lower than the rest for a certain drug. These “outliers” skew the mean and make it less representative. For example, in a series of seven values such as $1, $2, $2, $3, $5, $16, $20, the total of all the values is $49, and dividing by seven gives a mean value of $7. For comparison or estimation purposes, it is likely that this average is too high, due to the two prices that are much higher than others in the series. To avoid this risk, we use the median price. The median price is a type of average; it is the value that splits a series of values in half when the series is put in ascending order. This is likely to be a more valuable approach for estimating actual future prices (or for comparing with local prices) when there is a skewed distribution. If there is an odd number of values in the series, as in the example above, the median value is the middle value in the series ($3 in the example). When there is an even number of values in a E-28 International Drug Price Indicator Guide 2012 series, such as the series $1, $3, $4, $6, $14, $20, the median is calculated by averaging the two middle values. In this example, the median is the average of $4 and $6, which is $5. Again, this is likely to be closer to reality for comparison or estimation than the arithmetic mean of $8 ($48 divided by 6).4 Highest Price The highest price from listed suppliers and buyers. Lowest Price The lowest price from listed suppliers and buyers. High/Low Ratio The high/low ratio compares the highest unit price with the lowest unit price. For example, a high/low ratio of 3 means that the highest unit price is three times greater than the lowest unit price. DDD The DDD is the assumed average maintenance dose per day for a drug used for its main indica- tion in adults. The defined daily dose is a unit of measurement and does not necessarily reflect the recommended or prescribed daily dose. Doses for individual patients and patient groups will often differ from the DDD and will necessarily be based on individual characteristics (e.g., age and weight) and pharmacokinetic considerations. Drug consumption data presented in DDDs give only a rough estimate of consumption and not an exact picture of actual use. DDDs provide a fixed unit of measurement independent of price and formulation, enabling the researcher to assess trends in drug consumption and to perform comparisons between population groups. The defined daily doses are from the WHO Collaborating Centre for Drug Statistics Methodol- ogy. They are illustrative defined daily doses, as recommended by the World Health Organization’s Drug Utilization Research Group (DURG). Not all drugs listed in this price comparison guide have defined daily doses assigned by this method. A DDD will only be assigned for drugs that already have an ATC code. The main use of the DDD is for estimating drug consumption, based on inventory/distribution data. This estimate can be combined with price information for budgeting purposes. Note: The defined daily dose should not be used for dosing or therapeutic determinations. Refer to prescribing information for dosing schedules for specific indications. 4 For further discussion, see Statistics without Tears—A Primer for Non-Mathematicians, by Derek Rowntree (New York: Charles Scribner’s Sons, 1981), pp. 41–45. Format of the Price Lists E-29 List III - Price Comparison Form The purpose of this list is to help the user compare his or her prices with the prices in the Guide. Only the median price is displayed here, and a shortened description of the item is used. Item Description The item description includes the generic name, strength, dosage form, and the route of admin- istration. If the product has two widely used names (for example, vitamin C and ascorbic acid), one name will appear in brackets. See the List of Synonyms in the Annex. IC Products under international narcotics control are identified with (IC) next to the de- scription. Nomenclature International nonproprietary names have been used as the basis for the list of drugs in this Guide. If an INN has not been assigned, the most common generic name has been used. Drug dosage forms listed are generally those included in the World Health Organization’s 17th Model List of Essential Medicines (revised March 2011), found at http://www.who.int/medicines. WHO EML The “WHO EML” column indicates whether the product is included on the 2011 WHO Model List of Essential Medicines. We identify five categories in the International Drug Price Indicator Guide: E = On the WHO core list in the same dosage form and strength C = On the WHO complementary list in the same dosage form and strength P = On the WHO list but in a different presentation (different dosage form and/or strength) T = Not on the WHO list, but can be an alternative for an item listed as a therapeutic group example N = Not on the WHO model list Pack Size The blank here is for the user to enter his or her purchase pack size. Pack Price This blank is for the user to enter the price for the purchase pack entered in the previous blank. E-30 International Drug Price Indicator Guide 2012 Unit Price The user should calculate his or her unit price by dividing the pack price by the pack size. The comparison units used in the Guide are listed for each item to help ensure that prices are being compared on an equivalent basis. Median Int. Supplier/Buyer Unit Price (US$) The unit price is calculated by dividing the package price by the package size. This format facilitates the price comparison of different vendor pack sizes. The unit used to compare prices varies with the type of pharmaceutical preparation as follows: Pharmaceutical Dosage Form Comparison Unit Ampoule or Vial Milliliter (ML) Cartridge Milliliter (ML) Condom, Intrauterine Device (IUD), Net, Test Each (EACH) Ear, Nose, and Throat Preparation Milliliter (ML) Enema Milliliter (ML) Gas Cubic Meter (CUBMETER) Granules Gram (G) Inhaler Dose (DOSE) Oral Liquid Milliliter (ML) Pack Pack (PACK) Pessary Pessary (PESS) Suppository Suppository (SUPP) Syringe Syringe (SYRINGE) Tablet or Capsule Tablet or Capsule (TAB-CAP) Topical Liquid Milliliter (ML) Topical Solid Gram (G) Treatment Treatment (TREATMEN) Vaccine Dose (DOSE) Vial (single strength) Vial (VIAL) The median price is a type of average; it is whatever value splits a series of values in half when the series is put in ascending order. If there is an odd number of values in the series, the median value is the middle value in the series. This is likely to be more valuable for estimating actual future prices (or comparing with local prices), when there is a skewed distribution. When there is an even number of values in a series, such as the series $1, $3, $4, $6, $14, $20, the median is calculated by averaging the two middle values. In this example, the median is the average of $4 and $6, which is $5. Again, this is likely to be closer to reality for comparison or estimation than the arithmetic mean of $8 ($48 divided by 6).5 5 For further discussion, see Statistics without Tears—A Primer for Non-Mathematicians, by Derek Rowntree (New York: Charles Scribner’s Sons, 1981), pp. 41–45. How to Analyze and Compare Your Prices E-31 How to Analyze and Compare Your Prices Comparison of prices that you have paid with international prices is one of the most fundamen- tal indicators for assessing procurement efficiency. Other key indicators of procurement effi- ciency are the accuracy of needs estimation, timeliness of deliveries, and quality of products procured. With the assistance of this Guide, it is possible for procurement personnel to compare the prices they pay with international reference prices (refer to the Price Comparison Form, SP-1 and BP- 1). The method below presents one approach to making such comparisons. You may wish to visit the electronic version of the International Drug Price Indicator Guide in the Electronic Resource Center at http://erc.msh.org/priceguide. It contains features to help you compare your prices to those in the Guide and plan a budget or tender. 1. Make a list of products that you routinely procure in large volumes or that represent a high percentage of the budget. 2. For each product, list the vendor pack size used and the most recent price for this vendor pack size. Be sure to note whether the price is CIF (cost, insurance, and freight); FOB (free on board: transportation as far as the port of departure); EXW (ex-works: no transportation included); or another type of price. Prices may need to be adjusted so that they can be compared accurately. 3. Choose one of the two price comparison forms included in the Guide, based on the type of prices you are comparing. The buyer prices include shipping costs, and may be most appro- priate if they represent a region of the world and tender value similar to yours. The supplier prices are FOB and EXW and must be adjusted to reflect the usual shipping, handling, and insurance charges for your situation. 4. On one of the price comparison forms, select the product in this Guide that corresponds most closely to your product. If the prices you are using locally are CIF prices and you have selected the buyer comparison form, no adjustment should be needed for either set of prices. If the prices you are using locally are CIF prices and you have selected the supplier compari- son form, we suggest that the prices on the supplier list be adjusted upward to reflect the difference between CIF and EXW/FOB. When prices on this list are FOB or EXW, it is rea- sonable to add 10% to the list price for freight and insurance, depending on the distance and the mode of transport. Any standard percentage charged for handling has already been added to the prices on this list. When significant fluctuations in exchange rates occur, price adjustments must be made to reflect these changes. 5. Once the pack prices have been adjusted to reflect freight, insurance, and other additional costs, divide the pack price by the number of comparison units contained in the vendor pack (for example, divide the pack price by 1,000 if that pack is a bottle of 1,000 tablets, or by 100 if the pack is a vial of 100 ml). Make sure that the comparison unit used is the same as the comparison unit on the Guide list. The median international unit price is listed on both price comparison forms for your convenience. E-32 International Drug Price Indicator Guide 2012 Because packaging can add considerably to the cost of a product, caution is needed when comparing unit prices between different packages. For example, the unit price with strip packaging is usually much higher than the unit price for tablets packaged in a bottle of 1,000. Prices in the Guide do not cover specialty packaging, except where noted. An analysis of this type includes many assumptions that affect its outcome. International price comparisons identify extreme price differences, both high and low. An extremely high ratio between locally available prices and the prices in this Guide may indicate that a less expensive source is available. If the locally available prices are much lower than the prices in this Guide, it might reflect effective procurement, but it could also be the result of a compromise of quality control, differences in packaging, or other factors that might reduce product quality. These comparisons are only indicators, and should be viewed as pointers for further investigation. List I: Products Sorted Alphabetically Lista I: Productos Clasificados por Orden Alfabético Liste I : Produits Pharmaceutiques Classés par Ordre Alphabétique List I: Products Sorted Alphabetically ITEM DESCRIPTION PACKAGE UNIT DEFINED WHO ATC SOURCE PACKAGE PRICE (US$) PRICE (US$) COMMENTS DAILY DOSE* EML CODE ABACAVIR (ABC) 20 mg/ml solution (PO) Price/ml 0.6 g E J05AF06 Supplier IDA 1 BOTT (240 ml) 11.93 0.0497 Supplier SCMS 1 BOTT (240 ml) 12.68 0.0529 Supplier Median Price/ml=0.0513 High/Low Ratio=1.06 Buyer SAFRICA 1 BOTT (240 ml) 5.69 0.0237 Buyer NAMIBIA 1 BOTT (240 ml) 9.19 0.0383 Buyer GHANA 1 BOTT (240 ml) 12.62 0.0526 Buyer Median Price/ml=0.0383 High/Low Ratio=2.22 ABACAVIR (ABC) 300 mg tab-cap (PO) Price/tab-cap 0.6 g E J05AF06 Supplier SCMS 60 TAB-CAP 13.46 0.2244 AS SULFATE, TABLETS Supplier IDA 60 TAB-CAP 15.23 0.2538 TABLETS Supplier MEG 60 TAB-CAP 29.00 0.4833 TABLETS Supplier Median Price/tab-cap=0.2538 High/Low Ratio=2.15 Buyer PERU 100 TAB-CAP 19.99 0.1999 TABLETS, ILLUSTRATIVE PACK SIZE Buyer SAFRICA 60 TAB-CAP 12.47 0.2078 TABLETS Buyer NAMIBIA 60 TAB-CAP 13.93 0.2322 TABLETS Buyer CRSS 100 TAB-CAP 192.24 1.9224 TABLETS Buyer Median Price/tab-cap=0.2200 High/Low Ratio=9.62 ABACAVIR SULFATE 60 mg tab-cap (PO) Price/tab-cap 0.6 g P J05AF06 Supplier IDA 60 TAB-CAP 5.58 0.0930 TABLETS ABACAVIR+LAMIVUDINE (ABC/3TC) 600 mg+300mg tab-cap (PO) Price/tab-cap 1 tab P J05AR02 Supplier SCMS 30 TAB-CAP 16.89 0.5632 TABLETS ACETAZOLAMIDE 250 mg tab-cap (PO) Price/tab-cap 0.75 g E S01EC01 Supplier JMS 1000 TAB-CAP 25.83 0.0258 TABLETS Supplier IDA 1000 TAB-CAP 30.00 0.0300 TABLETS Supplier DURBIN 1000 TAB-CAP 32.89 0.0330 TABLETS Supplier MISSION 1000 TAB-CAP 34.31 0.0343 TABLETS Supplier MEDEOR/TZ 100 TAB-CAP 4.76 0.0476 TABLETS Supplier Median Price/tab-cap=0.0330 High/Low Ratio=1.84 Buyer PERU 100 TAB-CAP 2.75 0.0274 TABLETS, ILLUSTRATIVE PACK SIZE Buyer OECS/PPS 500 TAB-CAP 13.90 0.0278 TABLETS Buyer SAFRICA 100 TAB-CAP 2.96 0.0296 TABLETS Buyer MEMS 100 TAB-CAP 4.06 0.0406 TABLETS Buyer NAMIBIA 100 TAB-CAP 4.81 0.0481 TABLETS Buyer Median Price/tab-cap=0.0296 High/Low Ratio=1.75 ACETYLSALICYLIC ACID 100 mg tab-cap (PO) Price/tab-cap 3 g E B01AC06 Supplier IDA 1000 TAB-CAP 1.93 0.0019 TABLETS Supplier MISSION 1000 TAB-CAP 2.47 0.0025 TABLETS Supplier MEG 1000 TAB-CAP 2.65 0.0027 TABLETS Supplier MEDEOR/EU 3500 TAB-CAP 15.86 0.0045 TABLETS Supplier Median Price/tab-cap=0.0026 High/Low Ratio=2.38 Buyer PERU 100 TAB-CAP 0.44 0.0044 TABLETS, ILLUSTRATIVE PACK SIZE ACETYLSALICYLIC ACID 300 mg tab-cap (PO) Price/tab-cap 3 g E N02BA01 Supplier MEDEOR/TZ 1000 TAB-CAP 2.20 0.0022 TABLETS Supplier UNFPA 1000 TAB-CAP 2.60 0.0026 TABLETS Supplier JMS 1000 TAB-CAP 2.61 0.0026 TABLETS Supplier IDA 1000 TAB-CAP 3.15 0.0031 TABLETS Supplier MEDS 1000 TAB-CAP 3.21 0.0032 TABLETS Supplier MEG 1000 TAB-CAP 3.50 0.0035 TABLETS Supplier MISSION 1000 TAB-CAP 3.86 0.0039 TABLETS Supplier DURBIN 1000 TAB-CAP 4.95 0.0049 TABLETS Supplier Median Price/tab-cap=0.0032 High/Low Ratio=2.23 Buyer MEMS 1000 TAB-CAP 2.40 0.0024 TABLETS Buyer NAMIBIA 1000 TAB-CAP 3.43 0.0034 TABLETS Buyer OECS/PPS 100 TAB-CAP 1.91 0.0191 325 MG, E.C. TABLETS Buyer Median Price/tab-cap=0.0034 High/Low Ratio=7.96 ACETYLSALICYLIC ACID 500 mg tab-cap (PO) Price/tab-cap 3 g E N02BA01 Supplier UNFPA 1000 TAB-CAP 3.50 0.0035 TABLETS Supplier IDA 1000 TAB-CAP 3.98 0.0040 TABLETS Supplier MEG 1000 TAB-CAP 4.25 0.0043 TABLETS Supplier DURBIN 1000 TAB-CAP 4.63 0.0046 TABLETS Supplier MISSION 1000 TAB-CAP 5.25 0.0053 TABLETS WHO EML = <E>ssential, <C>omplementary, <P>resentation, <T>herapeutic group alternative, <N>ot on list *The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. DDDs have not been established for pediatric use. A-1 International Drug Price Indicator Guide, 2012 List I: Products Sorted Alphabetically ITEM DESCRIPTION PACKAGE UNIT DEFINED WHO ATC SOURCE PACKAGE PRICE (US$) PRICE (US$) COMMENTS DAILY DOSE* EML CODE ACETYLSALICYLIC ACID 500 mg tab-cap (PO) Price/tab-cap 3 g E N02BA01 Supplier MEDEOR/EU 1000 TAB-CAP 11.76 0.0118 TABLETS Supplier Median Price/tab-cap=0.0045 High/Low Ratio=3.37 ACETYLSALICYLIC ACID 75 mg tab-cap (PO) Price/tab-cap 3 g P B01AC06 Supplier DURBIN 1000 TAB-CAP 4.71 0.0047 DISPERSIBLE TABLETS Supplier MEDS 28 TAB-CAP 0.48 0.0171 ENTERIC-COATED TABLETS Supplier JMS 140 TAB-CAP 3.08 0.0220 ENTERIC-COATED TABLETS Supplier MEDEOR/TZ 30 TAB-CAP 1.38 0.0460 TABLETS Supplier Median Price/tab-cap=0.0196 High/Low Ratio=9.79 Buyer GHANA 100 TAB-CAP 0.82 0.0082 10 X 10 BLISTER PACK DISPERSIBLE TABLETS Buyer OECS/PPS 120 TAB-CAP 1.40 0.0117 81 MG, E.C. TABLETS Buyer Median Price/tab-cap=0.0100 High/Low Ratio=1.43 ACICLOVIR 200 mg tab-cap (PO) Price/tab-cap 4 g E J05AB01 Supplier JMS 100 TAB-CAP 1.66 0.0166 TABLETS Supplier UNFPA 100 TAB-CAP 3.00 0.0300 TABLETS Supplier MEDS 30 TAB-CAP 0.91 0.0304 TABLETS Supplier MEDEOR/EU 1000 TAB-CAP 42.84 0.0428 BLISTER PACK TABLETS, 40 X 25 Supplier MISSION 100 TAB-CAP 4.94 0.0494 TABLETS Supplier MEDEOR/TZ 25 TAB-CAP 1.60 0.0640 TABLETS Supplier DURBIN 30 TAB-CAP 2.12 0.0707 TABLETS Supplier Median Price/tab-cap=0.0428 High/Low Ratio=4.26 Buyer PERU 100 TAB-CAP 1.68 0.0168 TABLETS, ILLUSTRATIVE PACK SIZE Buyer MEMS 30 TAB-CAP 1.87 0.0624 TABLETS Buyer GHANA 100 TAB-CAP 27.01 0.2701 10 X 10 BLISTER PACK TABLETS Buyer Median Price/tab-cap=0.0624 High/Low Ratio=16.08 ACICLOVIR 200 mg/5 ml suspen (PO) Price/ml 4 g P J05AB01 Buyer OECS/PPS 1 BOTT (100 ml) 24.70 0.2470 Buyer SAFRICA 1 BOTT (125 ml) 43.02 0.3442 Buyer Median Price/ml=0.2956 High/Low Ratio=1.39 ACICLOVIR 3% opht oint (OPHT) Price/g N S01AD03 Supplier MISSION 1 TUBE (4.50 g) 2.91 0.6471 Supplier MEDS 1 TUBE (4.50 g) 9.92 2.2048 Supplier DURBIN 1 TUBE (4.50 g) 20.33 4.5181 Supplier Median Price/g=2.2048 High/Low Ratio=6.98 Buyer NAMIBIA 1 TUBE (4.50 g) 5.48 1.2186 Buyer SAFRICA 1 TUBE (4.50 g) 25.72 5.7156 Buyer Median Price/g=3.4671 High/Low Ratio=4.69 ACICLOVIR 400 mg tab-cap (PO) Price/tab-cap 4 g P J05AB01 Supplier MISSION 100 TAB-CAP 5.95 0.0595 TABLETS Supplier MEDS 10 TAB-CAP 0.96 0.0959 TABLETS Supplier MEDEOR/TZ 25 TAB-CAP 2.96 0.1183 TABLETS Supplier Median Price/tab-cap=0.0959 High/Low Ratio=1.99 Buyer PERU 100 TAB-CAP 2.91 0.0291 TABLETS, ILLUSTRATIVE PACK SIZE Buyer DOMREPUB 1 TAB-CAP 0.03 0.0304 BLISTER PACK TABLETS Buyer OECS/PPS 100 TAB-CAP 8.50 0.0850 TABLETS Buyer Median Price/tab-cap=0.0304 High/Low Ratio=2.92 ACICLOVIR 5% cream (TOP) Price/g N D06BB03 Supplier UNFPA 1 TUBE (5 g) 0.35 0.0700 Supplier MEDEOR/TZ 1 TUBE (5 g) 0.64 0.1284 Supplier DURBIN 2 TUBE (5 g) 1.73 0.1727 Supplier IDA 1 TUBE (2 g) 1.22 0.6104 Supplier Median Price/g=0.1506 High/Low Ratio=8.72 Buyer DOMREPUB 1 TUBE (5 g) 0.14 0.0271 Buyer SAFRICA 1 TUBE (10 g) 1.34 0.1340 Buyer GHANA 10 TUBE (5 g) 41.13 0.8226 Buyer Median Price/g=0.1340 High/Low Ratio=30.35 ACICLOVIR 800 mg tab-cap (PO) Price/tab-cap 4 g P J05AB01 Buyer NAMIBIA 35 TAB-CAP 4.49 0.1284 TABLETS ACICLOVIR (DISPERSIBLE) 200 MG tab-cap (PO) Price/tab-cap 4 G EP J05AB01 Supplier IDA 500 TAB-CAP 21.40 0.0428 TABLETS Supplier MEG 100 TAB-CAP 5.77 0.0577 TABLETS Supplier Median Price/tab-cap=0.0502 High/Low Ratio=1.35 Buyer SAFRICA 25 TAB-CAP 1.20 0.0480 TABLETS ACICLOVIR (POWDER) 250 mg vial (INJ) Price/vial 4 g E J05AB01 Buyer CRSS 1 VIAL 5.20 5.2000 WHO EML = <E>ssential, <C>omplementary, <P>resentation, <T>herapeutic group alternative, <N>ot on list *The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. DDDs have not been established for pediatric use. A-2 International Drug Price Indicator Guide, 2012 List I: Products Sorted Alphabetically ITEM DESCRIPTION PACKAGE UNIT DEFINED WHO ATC SOURCE PACKAGE PRICE (US$) PRICE (US$) COMMENTS DAILY DOSE* EML CODE ACICLOVIR (POWDER) 250 mg vial (INJ) Price/vial 4 g E J05AB01 Buyer SAFRICA 1 VIAL 6.65 6.6500 Buyer Median Price/vial=5.9250 High/Low Ratio=1.28 ADENOSINE 3 mg/ml ampoule (INJ) Price/ml 15 mg N C01EB10 Buyer PERU 1 AMP (2 ml) 2.79 1.3930 Buyer OECS/PPS 6 AMP (2 ml) 17.95 1.4958 Buyer SAFRICA 1 AMP (2 ml) 8.79 4.3950 Buyer Median Price/ml=1.4958 High/Low Ratio=3.16 ALBENDAZOLE 100 mg/5 ml suspen (PO) Price/ml 0.4 g P P02CA03 Buyer PERU 1 BOTT (20 ml) 0.27 0.0133 Buyer MEMS 1 BOTT (20 ml) 0.27 0.0135 Buyer NAMIBIA 1 BOTT (20 ml) 0.91 0.0454 Buyer OECS/PPS 1 BOTT (20 ml) 0.98 0.0490 Buyer SAFRICA 1 BOTT (20 ml) 1.20 0.0600 Buyer Median Price/ml=0.0454 High/Low Ratio=4.51 ALBENDAZOLE 200 mg tab-cap (PO) Price/tab-cap 0.4 g P P02CA03 Supplier IDA 1000 TAB-CAP 11.63 0.0116 TABLETS Supplier DURBIN 1000 TAB-CAP 22.77 0.0228 TABLETS Supplier MEDEOR/TZ 1500 TAB-CAP 51.08 0.0341 TABLETS Supplier MEDS 100 TAB-CAP 3.51 0.0351 TABLETS Supplier Median Price/tab-cap=0.0285 High/Low Ratio=3.03 Buyer OECS/PPS 1000 TAB-CAP 14.23 0.0142 TABLETS Buyer NAMIBIA 100 TAB-CAP 3.87 0.0387 TABLETS Buyer MEMS 2 TAB-CAP 1.92 0.9600 TABLET Buyer Median Price/tab-cap=0.0387 High/Low Ratio=67.61 ALBENDAZOLE 200 mg/5 ml suspen (PO) Price/ml 0.4 g P P02CA03 Supplier MEDEOR/TZ 1 BOTT (10 ml) 0.34 0.0336 Supplier IDA 30 BOTT (10 ml) 10.67 0.0356 Supplier MISSION 1 BOTT (10 ml) 0.51 0.0506 SYRUP Supplier Median Price/ml=0.0356 High/Low Ratio=1.51 Buyer DOMREPUB 1 BOTT (10 ml) 0.08 0.0078 Buyer GHANA 1 BOTT (10 ml) 0.70 0.0700 Buyer Median Price/ml=0.0389 High/Low Ratio=8.97 ALBENDAZOLE 400 mg tab-cap (PO) Price/tab-cap 0.4 g P P02CA03 Supplier DURBIN 500 TAB-CAP 22.77 0.0455 TABLETS Supplier JMS 1 TAB-CAP 0.14 0.1368 TABLETS Supplier Median Price/tab-cap=0.0912 High/Low Ratio=3.01 Buyer DOMREPUB 1 TAB-CAP 0.02 0.0230 BLISTER PACK TABLETS Buyer SAFRICA 1 TAB-CAP 0.32 0.3200 TABLET Buyer Median Price/tab-cap=0.1715 High/Low Ratio=13.91 ALBENDAZOLE (CHEWABLE) 200 mg tab-cap (PO) Price/tab-cap 0.4 g P P02CA03 Supplier MISSION 1000 TAB-CAP 13.36 0.0134 TABLETS Supplier MEDEOR/EU 1500 TAB-CAP 31.58 0.0211 TABLETS Supplier Median Price/tab-cap=0.0172 High/Low Ratio=1.57 Buyer GHANA 10 TAB-CAP 0.26 0.0260 BLISTER PACK TABLETS ALBENDAZOLE (CHEWABLE) 400 mg tab-cap (PO) Price/tab-cap 0.4 g E P02CA03 Supplier UNFPA 1000 TAB-CAP 11.80 0.0118 TABLETS Supplier MEG 1000 TAB-CAP 13.21 0.0132 TABLETS Supplier IDA 1000 TAB-CAP 18.76 0.0188 TABLETS Supplier MISSION 1000 TAB-CAP 23.42 0.0234 TABLETS Supplier MEDS 100 TAB-CAP 3.72 0.0372 TABLETS Supplier Median Price/tab-cap=0.0188 High/Low Ratio=3.15 Buyer GHANA 100 TAB-CAP 30.32 0.3032 10 X 10 BLISTER PACK TABLETS ALBUMIN, HUMAN NORMAL 20-25% vial (INJ) Price/ml N B05AA01 Supplier UNFPA 1 VIAL (50 ml) 37.50 0.7500 20% Buyer SICA 1 VIAL (50 ml) 26.60 0.5320 20% Buyer SAFRICA 1 VIAL (50 ml) 35.53 0.7106 20% Buyer Median Price/ml=0.6213 High/Low Ratio=1.34 ALCOHOL (ETHANOL) 95-96% solution (TOP) Price/ml N V07AV Supplier MEDEOR/TZ 1 BOTT (2500 ml) 33.48 0.0134 ANALYTIC GRADE Buyer CRSS 1 BOTT (1000 ml) 1.43 0.0014 95% Buyer SAFRICA 20 LITER (1000 ml) 46.74 0.0023 96%, PLASTIC CONTAINER WHO EML = <E>ssential, <C>omplementary, <P>resentation, <T>herapeutic group alternative, <N>ot on list *The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. DDDs have not been established for pediatric use. A-3 International Drug Price Indicator Guide, 2012 List I: Products Sorted Alphabetically ITEM DESCRIPTION PACKAGE UNIT DEFINED WHO ATC SOURCE PACKAGE PRICE (US$) PRICE (US$) COMMENTS DAILY DOSE* EML CODE ALCOHOL (ETHANOL) 95-96% solution (TOP) Price/ml N V07AV Buyer MEMS 1 BOTT (2500 ml) 20.10 0.0080 ETHANOL, 96% Buyer Median Price/ml=0.0023 High/Low Ratio=5.71 ALCOHOL, DENATURED 70% bott (TOP) Price/ml N Supplier UNFPA 1 BOTT (1000 ml) 3.95 0.0040 ETHYL ALCOHOL Supplier IDA 1 BOTT (1000 ml) 7.77 0.0078 Supplier MISSION 1 BOTT (1000 ml) 7.98 0.0080 ETHANOL, METHYLATED Supplier Median Price/ml=0.0078 High/Low Ratio=2.00 ALCOHOL, DENATURED 95-96% bott (TOP) Price/ml N Supplier IDA 1 BOTT (1000 ml) 7.45 0.0075 Supplier MISSION 1 BOTT (1000 ml) 9.24 0.0092 ETHANOL 96%, METHYLATED Supplier Median Price/ml=0.0084 High/Low Ratio=1.23 Buyer SAFRICA 20 LITER (1000 ml) 83.37 0.0042 96% ALCOHOL, ISOPROPYL 70% solution (TOP) Price/ml N V07AV Buyer DOMREPUB 1 BOTT (1000 ml) 1.76 0.0018 ALENDRONATE 10 mg tab-cap (PO) Price/tab-cap N M05BA04 Buyer SAFRICA 30 TAB-CAP 3.45 0.1150 TABLETS ALLOPURINOL 100 mg tab-cap (PO) Price/tab-cap 0.4 g E M04AA01 Supplier IDA 28 TAB-CAP 0.77 0.0275 7 X 4 BLISTER PACK TABLETS Supplier MISSION 100 TAB-CAP 2.79 0.0279 TABLETS Supplier DURBIN 28 TAB-CAP 1.49 0.0532 TABLETS Supplier MEDEOR/TZ 50 TAB-CAP 5.21 0.1042 TABLETS Supplier Median Price/tab-cap=0.0406 High/Low Ratio=3.79 Buyer PERU 100 TAB-CAP 1.07 0.0107 TABLETS, ILLUSTRATIVE PACK SIZE Buyer GHANA 100 TAB-CAP 1.10 0.0110 BLISTER PACK 10 X 10 TABLETS Buyer OECS/PPS 28 TAB-CAP 0.50 0.0179 TABLETS Buyer SAFRICA 500 TAB-CAP 12.48 0.0250 TABLETS Buyer MEMS 50 TAB-CAP 3.48 0.0696 TABLETS Buyer Median Price/tab-cap=0.0179 High/Low Ratio=6.50 ALLOPURINOL 300 mg tab-cap (PO) Price/tab-cap 0.4 g C M04AA01 Supplier JMS 28 TAB-CAP 4.02 0.1436 TABLETS Buyer GHANA 100 TAB-CAP 2.20 0.0220 BLISTER PACK 10 X 10 TABLETS Buyer OECS/PPS 28 TAB-CAP 0.90 0.0321 TABLETS Buyer SAFRICA 28 TAB-CAP 1.33 0.0475 TABLETS IN A PATIENT-READY PACK Buyer NAMIBIA 30 TAB-CAP 2.02 0.0673 TABLETS Buyer Median Price/tab-cap=0.0398 High/Low Ratio=3.06 ALPRAZOLAM 0.5 mg tab-cap (PO) Price/tab-cap 1 mg T N05BA12 Buyer PERU 100 TAB-CAP 0.48 0.0048 TABLETS, ILLUSTRATIVE PACK SIZE Buyer SAFRICA 30 TAB-CAP 0.90 0.0300 TABLETS Buyer DOMREPUB 1 TAB-CAP 0.12 0.1184 TABLETS Buyer Median Price/tab-cap=0.0300 High/Low Ratio=24.67 ALUMINIUM HYDROXIDE 500 mg tab-cap (PO) Price/tab-cap 3 g N A02AB01 Supplier UNFPA 1000 TAB-CAP 4.00 0.0040 MINT-FLAVORED TABLETS Supplier MEG 1000 TAB-CAP 5.55 0.0056 TABLETS Supplier DURBIN 1000 TAB-CAP 5.89 0.0060 TABLETS Supplier IDA 1000 TAB-CAP 6.10 0.0061 BLISTER PACK TABLETS Supplier MISSION 1000 TAB-CAP 6.84 0.0068 CHEWABLE TABLETS Supplier Median Price/tab-cap=0.0060 High/Low Ratio=1.70 Buyer GHANA 1000 TAB-CAP 8.27 0.0083 BLISTER PACK 10 X 100 TABLETS ALUMINIUM HYDROXIDE (CHEWABLE) 500 mg tab-cap (PO) Price/tab-cap 3 g N A02AB01 Supplier MEDEOR/EU 1000 TAB-CAP 11.19 0.0112 TABLETS AMIDOTRIZOATE 76% ampoule (INJ) Price/ml P V08AA01 Supplier IDA 1 AMP (20 ml) 5.08 0.2538 AMIKACIN SULFATE 250 mg/ml vial (INJ) Price/ml 1 g P J01GB06 Supplier GDF 10 VIAL (2 ml) 9.66 0.4830 Buyer PERU 1 AMP (2 ml) 0.21 0.1052 Buyer DOMREPUB 1 VIAL (2 ml) 0.24 0.1221 WHO EML = <E>ssential, <C>omplementary, <P>resentation, <T>herapeutic group alternative, <N>ot on list *The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. DDDs have not been established for pediatric use. A-4 International Drug Price Indicator Guide, 2012 List I: Products Sorted Alphabetically ITEM DESCRIPTION PACKAGE UNIT DEFINED WHO ATC SOURCE PACKAGE PRICE (US$) PRICE (US$) COMMENTS DAILY DOSE* EML CODE AMIKACIN SULFATE 250 mg/ml vial (INJ) Price/ml 1 g P J01GB06 Buyer OECS/PPS 1 AMP (2 ml) 0.40 0.2000 Buyer SAFRICA 1 VIAL (2 ml) 0.65 0.3250 Buyer SAFRICA 1 VIAL (4 ml) 2.80 0.7000 Buyer Median Price/ml=0.2000 High/Low Ratio=6.65 AMIKACIN SULFATE 50 mg/ml ampoule (INJ) Price/ml 1 g P J01GB06 Buyer SAFRICA 1 VIAL (2 ml) 0.81 0.4050 AMINOPHYLLINE 100 mg tab-cap (PO) Price/tab-cap 0.6 g N R03DA05 Supplier MEDS 1000 TAB-CAP 3.10 0.0031 TABLETS Supplier MEDEOR/TZ 1000 TAB-CAP 4.02 0.0040 TABLETS Supplier MISSION 1000 TAB-CAP 5.25 0.0053 TABLETS Supplier IDA 1000 TAB-CAP 5.72 0.0057 TABLETS Supplier DURBIN 1000 TAB-CAP 6.04 0.0061 TABLETS Supplier MEG 1000 TAB-CAP 7.20 0.0072 TABLETS Supplier JMS 500 TAB-CAP 3.70 0.0074 TABLETS Supplier MEDEOR/EU 1900 TAB-CAP 16.37 0.0086 TABLETS Supplier Median Price/tab-cap=0.0059 High/Low Ratio=2.78 Buyer MEMS 1000 TAB-CAP 3.87 0.0039 TABLETS AMINOPHYLLINE 25 mg/ml ampoule (INJ) Price/ml 0.6 g N R03DA05 Supplier JMS 10 AMP (10 ml) 0.77 0.0077 Supplier DURBIN 100 AMP (10 ml) 12.56 0.0126 Supplier IDA 100 AMP (10 ml) 42.34 0.0423 Supplier MEG 100 AMP (10 ml) 49.50 0.0495 Supplier MISSION 100 AMP (10 ml) 53.55 0.0536 Supplier MEDEOR/TZ 50 AMP (10 ml) 31.00 0.0620 Supplier MEDS 1 AMP (10 ml) 0.77 0.0772 Supplier Median Price/ml=0.0495 High/Low Ratio=10.03 Buyer GHANA 100 AMP (10 ml) 5.25 0.0053 Buyer NAMIBIA 10 AMP (10 ml) 2.15 0.0215 Buyer MEMS 10 AMP (10 ml) 3.48 0.0348 Buyer SAFRICA 1 AMP (10 ml) 0.53 0.0530 Buyer Median Price/ml=0.0282 High/Low Ratio=10.00 AMIODARONE 200 mg tab-cap (PO) Price/tab-cap 0.2 g C C01BD01 Buyer PERU 100 TAB-CAP 4.36 0.0436 TABLETS, ILLUSTRATIVE PACK SIZE Buyer DOMREPUB 1 TAB-CAP 0.07 0.0665 BLISTER PACK TABLETS Buyer SAFRICA 30 TAB-CAP 2.71 0.0903 TABLETS Buyer Median Price/tab-cap=0.0665 High/Low Ratio=2.07 AMIODARONE 50 mg/ml vial (INJ) Price/ml 0.2 g C C01BD01 Supplier UNFPA 10 AMP (3 ml) 30.00 1.0000 Buyer SAFRICA 1 AMP (3 ml) 4.13 1.3767 AMITRIPTYLINE 10 mg tab-cap (PO) Price/tab-cap 75 mg P N06AA09 Buyer SAFRICA 100 TAB-CAP 2.94 0.0294 TABLETS AMITRIPTYLINE 25 mg tab-cap (PO) Price/tab-cap 75 mg E N06AA09 Supplier MEDS 1000 TAB-CAP 3.63 0.0036 TABLETS Supplier MEG 1000 TAB-CAP 4.65 0.0047 TABLETS Supplier JMS 1000 TAB-CAP 6.34 0.0063 TABLETS Supplier IDA 1000 TAB-CAP 6.94 0.0069 COATED TABLETS Supplier MISSION 1000 TAB-CAP 7.09 0.0071 TABLETS, HCL Supplier DURBIN 500 TAB-CAP 8.63 0.0173 TABLETS Supplier MEDEOR/TZ 1000 TAB-CAP 19.05 0.0191 TABLETS Supplier MEDEOR/EU 1000 TAB-CAP 23.91 0.0239 TABLETS Supplier Median Price/tab-cap=0.0070 High/Low Ratio=6.59 Buyer NAMIBIA 500 TAB-CAP 3.66 0.0073 TABLETS Buyer SAFRICA 500 TAB-CAP 4.13 0.0083 TABLETS Buyer OECS/PPS 1000 TAB-CAP 10.00 0.0100 TABLETS Buyer MEMS 500 TAB-CAP 6.00 0.0120 TABLET Buyer PERU 100 TAB-CAP 2.63 0.0263 TABLETS, ILLUSTRATIVE PACK SIZE Buyer DOMREPUB 1 TAB-CAP 0.07 0.0691 BLISTER PACK TABLETS Buyer Median Price/tab-cap=0.0110 High/Low Ratio=9.47 AMITRIPTYLINE 50 mg tab-cap (PO) Price/tab-cap 75 mg P N06AA09 Buyer OECS/PPS 100 TAB-CAP 2.15 0.0215 TABLETS AMLODIPINE 10 mg tab-cap (PO) Price/tab-cap 5 mg N C08CA01 Supplier MEDEOR/TZ 28 TAB-CAP 3.96 0.1414 TABLETS WHO EML = <E>ssential, <C>omplementary, <P>resentation, <T>herapeutic group alternative, <N>ot on list *The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. DDDs have not been established for pediatric use. A-5 International Drug Price Indicator Guide, 2012 List I: Products Sorted Alphabetically ITEM DESCRIPTION PACKAGE UNIT DEFINED WHO ATC SOURCE PACKAGE PRICE (US$) PRICE (US$) COMMENTS DAILY DOSE* EML CODE AMLODIPINE 10 mg tab-cap (PO) Price/tab-cap 5 mg N C08CA01 Buyer DOMREPUB 1 TAB-CAP 0.00 0.0033 BLISTER PACK TABLETS Buyer PERU 100 TAB-CAP 0.69 0.0069 TABLETS, ILLUSTRATIVE PACK SIZE Buyer OECS/PPS 500 TAB-CAP 6.45 0.0129 CAPSULES Buyer SAFRICA 28 TAB-CAP 0.41 0.0146 TABLETS IN A PATIENT-READY PACK Buyer GHANA 100 TAB-CAP 3.00 0.0300 BILSTER PACK 10 X 10 TABLETS Buyer Median Price/tab-cap=0.0129 High/Low Ratio=9.09 AMLODIPINE 5 mg tab-cap (PO) Price/tab-cap 5 mg T C08CA01 Supplier MEDS 20 TAB-CAP 0.27 0.0135 TABLETS Supplier IDA 100 TAB-CAP 3.21 0.0321 TABLETS Supplier JMS 28 TAB-CAP 2.27 0.0809 TABLETS Supplier Median Price/tab-cap=0.0321 High/Low Ratio=6.01 Buyer DOMREPUB 1 TAB-CAP 0.01 0.0053 BLISTER PACK TABLETS Buyer SAFRICA 28 TAB-CAP 0.30 0.0107 TABLETS IN A PATIENT-READY PACK Buyer OECS/PPS 500 TAB-CAP 5.40 0.0108 CAPSULES Buyer GHANA 100 TAB-CAP 2.16 0.0216 BLISTER PACK 10 X 10 TABLETS Buyer Median Price/tab-cap=0.0108 High/Low Ratio=4.08 AMODIAQUINE 150-200 mg tab-cap (PO) Price/tab-cap 0.5 g E P01BA06 Supplier MEDEOR/TZ 1000 TAB-CAP 11.00 0.0110 200 MG TABLETS Supplier DURBIN 1000 TAB-CAP 15.46 0.0154 200 MG TABLETS Supplier Median Price/tab-cap=0.0132 High/Low Ratio=1.40 Buyer MEMS 75 TAB-CAP 1.80 0.0240 200 MG TABLETS AMODIAQUINE 50 mg/5 ml suspen (PO) Price/ml 0.5 g P P01BA06 Buyer MEMS 1 BOTT (60 ml) 0.39 0.0065 AMOXICILLIN 125 mg/5 ml suspen (PO) Price/ml 1 g E J01CA04 Supplier MEDS 1 BOTT (100 ml) 0.35 0.0035 POWDER FOR SYRUP Supplier MEDS 1 BOTT (60 ml) 0.25 0.0041 POWDER Supplier UNFPA 10 BOTT (100 ml) 4.24 0.0042 POWDER Supplier MEG 10 BOTT (100 ml) 4.45 0.0045 POWDER Supplier JMS 1 BOTT (100 ml) 0.48 0.0048 POWDER Supplier MEDEOR/TZ 1 BOTT (100 ml) 0.50 0.0050 POWDER Supplier IDA 40 BOTT (100 ml) 20.37 0.0051 Supplier MISSION 1 BOTT (100 ml) 0.57 0.0057 Supplier DURBIN 1 BOTT (100 ml) 0.60 0.0060 POWDER FOR SYRUP Supplier MEDEOR/EU 25 BOTT (100 ml) 24.17 0.0097 Supplier Median Price/ml=0.0049 High/Low Ratio=2.75 Buyer MEMS 1 BOTT (100 ml) 0.42 0.0042 Buyer GHANA 1 BOTT (100 ml) 0.46 0.0046 Buyer NAMIBIA 1 BOTT (100 ml) 0.47 0.0047 Buyer SAFRICA 1 BOTT (100 ml) 0.48 0.0048 GRANULES Buyer OECS/PPS 40 BOTT (100 ml) 34.08 0.0085 Buyer Median Price/ml=0.0047 High/Low Ratio=2.02 AMOXICILLIN 250 mg tab-cap (PO) Price/tab-cap 1 g E J01CA04 Supplier MEDEOR/TZ 100 TAB-CAP 1.49 0.0149 CAPSULES Supplier IDA 1000 TAB-CAP 15.16 0.0152 TABLETS Supplier MEG 1000 TAB-CAP 15.50 0.0155 TABLETS Supplier UNFPA 1000 TAB-CAP 16.10 0.0161 CAPSULES Supplier MEDS 1000 TAB-CAP 17.78 0.0178 CAPSULES Supplier DURBIN 1000 TAB-CAP 18.84 0.0188 CAPSULES, ANHYDROUS Supplier MEDEOR/EU 1000 TAB-CAP 22.44 0.0224 TABLETS Supplier MISSION 1000 TAB-CAP 22.91 0.0229 TABLETS Supplier IDA 1000 TAB-CAP 26.98 0.0270 CAPSULES Supplier Median Price/tab-cap=0.0178 High/Low Ratio=1.81 Buyer SAFRICA 500 TAB-CAP 7.56 0.0151 CAPSULES Buyer MEMS 1000 TAB-CAP 16.20 0.0162 CAPSULE Buyer OECS/PPS 1000 TAB-CAP 18.81 0.0188 CAPSULES Buyer NAMIBIA 500 TAB-CAP 10.78 0.0216 CAPSULES Buyer PERU 100 TAB-CAP 2.23 0.0223 TABLETS, ILLUSTRATIVE PACK SIZE Buyer Median Price/tab-cap=0.0188 High/Low Ratio=1.47 AMOXICILLIN 250 mg/5 ml suspen (PO) Price/ml 1 g P J01CA04 Supplier UNFPA 10 BOTT (100 ml) 5.61 0.0056 POWDER Supplier MEG 10 BOTT (100 ml) 6.30 0.0063 POWDER Supplier MISSION 1 BOTT (100 ml) 0.75 0.0075 Supplier MEDS 1 BOTT (100 ml) 1.29 0.0129 POWDER Supplier Median Price/ml=0.0069 High/Low Ratio=2.30 Buyer DOMREPUB 1 BOTT (120 ml) 0.45 0.0037 Buyer SAFRICA 1 BOTT (100 ml) 0.59 0.0059 GRANULES WHO EML = <E>ssential, <C>omplementary, <P>resentation, <T>herapeutic group alternative, <N>ot on list *The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. DDDs have not been established for pediatric use. A-6 International Drug Price Indicator Guide, 2012 List I: Products Sorted Alphabetically ITEM DESCRIPTION PACKAGE UNIT DEFINED WHO ATC SOURCE PACKAGE PRICE (US$) PRICE (US$) COMMENTS DAILY DOSE* EML CODE AMOXICILLIN 250 mg/5 ml suspen (PO) Price/ml 1 g P J01CA04 Buyer PERU 1 BOTT (60 ml) 0.46 0.0076 POWDER Buyer OECS/PPS 40 BOTT (100 ml) 34.68 0.0087 POWDER Buyer Median Price/ml=0.0068 High/Low Ratio=2.35 AMOXICILLIN 500 mg tab-cap (PO) Price/tab-cap 1 g E J01CA04 Supplier UNFPA 500 TAB-CAP 14.33 0.0287 CAPSULES Supplier MEDS 500 TAB-CAP 15.44 0.0309 CAPSULES Supplier IDA 1000 TAB-CAP 31.16 0.0312 TABLETS Supplier MEG 1000 TAB-CAP 31.32 0.0313 CAPSULES Supplier MISSION 1000 TAB-CAP 34.31 0.0343 TABLETS Supplier DURBIN 1000 TAB-CAP 37.60 0.0377 CAPSULES, ANHYDROUS Supplier MEDEOR/EU 1000 TAB-CAP 44.82 0.0448 TABLETS Supplier Median Price/tab-cap=0.0313 High/Low Ratio=1.56 Buyer DOMREPUB 1 TAB-CAP 0.02 0.0228 BLISTER PACK CAPSULES Buyer SAFRICA 100 TAB-CAP 2.92 0.0292 CAPSULES Buyer OECS/PPS 1000 TAB-CAP 30.47 0.0305 CAPSULES Buyer CRSS 100 TAB-CAP 3.14 0.0314 Buyer PERU 100 TAB-CAP 3.21 0.0321 TABLETS, ILLUSTRATIVE PACK SIZE Buyer Median Price/tab-cap=0.0305 High/Low Ratio=1.41 AMOXICILLIN+CLAVULANIC ACID 1000+200 mg vial (INJ) Price/vial 1 g P J01CR02 Supplier IDA 10 VIAL 8.99 0.8995 Supplier MEDS 1 VIAL 1.61 1.6146 Supplier Median Price/vial=1.2571 High/Low Ratio=1.79 Buyer SAFRICA 1 VIAL 1.79 1.7900 POWDER Buyer OECS/PPS 25 VIAL 47.00 1.8800 Buyer GHANA 10 VIAL 23.40 2.3400 POWDER Buyer Median Price/vial=1.8800 High/Low Ratio=1.31 AMOXICILLIN+CLAVULANIC ACID 250mg+125mg tab-cap (PO) Price/tab-cap 1 g P J01CR02 Supplier MEDS 20 TAB-CAP 2.64 0.1322 TABLETS Supplier DURBIN 20 TAB-CAP 5.50 0.2748 TABLETS Supplier Median Price/tab-cap=0.2035 High/Low Ratio=2.08 Buyer SAFRICA 100 TAB-CAP 13.79 0.1379 TABLETS Buyer SUDANNHIF 1 TAB-CAP 0.27 0.2744 TABLETS Buyer Median Price/tab-cap=0.2062 High/Low Ratio=1.99 AMOXICILLIN+CLAVULANIC ACID 500mg+100mg vial (INJ) Price/vial 1 g P J01CR02 Buyer SAFRICA 1 VIAL 1.02 1.0200 POWDER AMOXICILLIN+CLAVULANIC ACID 500mg+125mg tab-cap (PO) Price/tab-cap 1 g E J01CR02 Supplier MEDS 14 TAB-CAP 2.55 0.1822 TABLETS Supplier MEG 50 TAB-CAP 9.55 0.1910 10 X 5 TABLETS, BLISTER PACK Supplier IDA 50 TAB-CAP 9.70 0.1940 10 X 5 BLISTER PACK TABLETS Supplier MEDEOR/EU 60 TAB-CAP 11.76 0.1961 BLISTER PACK TABLETS Supplier MISSION 50 TAB-CAP 11.27 0.2253 TABLETS, 5 X 10 ALUMINUM STRIP Supplier MEDEOR/TZ 15 TAB-CAP 4.71 0.3142 TABLETS Supplier DURBIN 20 TAB-CAP 7.85 0.3925 TABLETS Supplier Median Price/tab-cap=0.1961 High/Low Ratio=2.15 Buyer DOMREPUB 1 TAB-CAP 0.13 0.1262 BLISTER PACK Buyer OECS/PPS 20 TAB-CAP 2.57 0.1285 CAPSULES Buyer PERU 100 TAB-CAP 15.37 0.1537 TABLETS, ILLUSTRATIVE PACK SIZE Buyer SAFRICA 15 TAB-CAP 2.48 0.1653 TABLETS Buyer GHANA 14 TAB-CAP 2.78 0.1986 7 X 2 BLISTER PACK TABLETS Buyer SUDANNHIF 1 TAB-CAP 0.33 0.3300 TABLETS Buyer Median Price/tab-cap=0.1595 High/Low Ratio=2.61 AMOXICILLIN+CLAVULANIC ACID 875mg+125mg tab-cap (PO) Price/tab-cap 1 g P J01CR02 Supplier GDF 14 TAB-CAP 4.40 0.3143 FILM-COATED, BLISTER PACK TABLETS Buyer SAFRICA 10 TAB-CAP 1.93 0.1930 TABLETS AMOXICILLIN+CLAVULANIC ACID (125+31.25 MG/5ML) Price/ml 1 g P J01CR02 125+31mg/5ml suspen (PO) Supplier MEDS 1 BOTT (100 ml) 1.64 0.0164 POWDER FOR SYRUP Supplier IDA 1 BOTT (100 ml) 2.51 0.0251 Supplier MEG 1 BOTT (100 ml) 3.10 0.0310 Supplier Median Price/ml=0.0251 High/Low Ratio=1.89 Buyer SAFRICA 1 BOTT (100 ml) 1.47 0.0147 GRANULES AMOXICILLIN+CLAVULANIC ACID (250+62.5 MG/5ML) suspen (PO) Price/ml 1 g P J01CR02 Supplier MEG 1 BOTT (100 ml) 3.25 0.0325 WHO EML = <E>ssential, <C>omplementary, <P>resentation, <T>herapeutic group alternative, <N>ot on list *The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. DDDs have not been established for pediatric use. A-7 International Drug Price Indicator Guide, 2012 List I: Products Sorted Alphabetically ITEM DESCRIPTION PACKAGE UNIT DEFINED WHO ATC SOURCE PACKAGE PRICE (US$) PRICE (US$) COMMENTS DAILY DOSE* EML CODE AMOXICILLIN+CLAVULANIC ACID (250+62.5 MG/5ML) suspen (PO) Price/ml 1 g P J01CR02 Supplier IDA 1 BOTT (100 ml) 3.79 0.0379 Supplier JMS 1 BOTT (100 ml) 3.99 0.0399 POWDER Supplier Median Price/ml=0.0379 High/Low Ratio=1.23 Buyer SAFRICA 1 BOTT (100 ml) 1.90 0.0190 GRANULES Buyer DOMREPUB 1 BOTT (60 ml) 1.39 0.0232 Buyer OECS/PPS 1 BOTT (100 ml) 2.88 0.0288 Buyer PERU 1 BOTT (60 ml) 1.82 0.0303 Buyer Median Price/ml=0.0260 High/Low Ratio=1.59 AMPHOTERICIN B 50 mg vial (INJ) Price/vial 35 mg E J02AA01 Supplier MEDS 1 VIAL 5.57 5.5692 IV USE ONLY Supplier IDA 1 VIAL 8.03 8.0312 Supplier MISSION 1 VIAL 9.62 9.6216 Supplier JMS 1 VIAL 12.10 12.1032 Supplier Median Price/vial=8.8264 High/Low Ratio=2.17 Buyer GHANA 1 VIAL 4.20 4.2000 POWDER Buyer NAMIBIA 1 VIAL 6.35 6.3490 Buyer Median Price/vial=5.2745 High/Low Ratio=1.51 AMPICILLIN 1 g vial (INJ) Price/vial 2 g E J01CA01 Supplier MEG 50 VIAL 7.20 0.1440 Supplier UNFPA 50 VIAL 7.53 0.1506 POWDER Supplier DURBIN 50 VIAL 8.63 0.1727 POWDER, SODIUM SALT Supplier MISSION 50 VIAL 10.38 0.2076 AS SODIUM Supplier IDA 50 VIAL 10.92 0.2184 Supplier Median Price/vial=0.1727 High/Low Ratio=1.52 Buyer DOMREPUB 1 VIAL 0.11 0.1052 Buyer MEMS 1 VIAL 0.84 0.8400 Buyer Median Price/vial=0.4726 High/Low Ratio=7.98 AMPICILLIN 10 mcg disc (N/A) Price/each N V07AR Supplier UNFPA 250 DISC (1 EACH) 12.50 0.0500 5 X 50 DISCS Supplier JMS 100 DISC (1 EACH) 5.74 0.0574 Supplier Median Price/each=0.0537 High/Low Ratio=1.15 AMPICILLIN 125 mg/5 ml suspen (PO) Price/ml 2 g P J01CA01 Supplier DURBIN 1 BOTT (100 ml) 0.71 0.0071 POWDER FOR SYRUP AMPICILLIN 250 mg tab-cap (PO) Price/tab-cap 2 g P J01CA01 Supplier UNFPA 1000 TAB-CAP 16.58 0.0166 CAPSULES Supplier DURBIN 1000 TAB-CAP 18.45 0.0185 CAPSULES Supplier MEG 1000 TAB-CAP 18.85 0.0189 CAPSULES Supplier IDA 1000 TAB-CAP 19.53 0.0195 CAPSULES Supplier Median Price/tab-cap=0.0187 High/Low Ratio=1.17 AMPICILLIN 250 mg vial (INJ) Price/vial 2 g P J01CA01 Buyer SAFRICA 1 VIAL 0.17 0.1700 POWDER Buyer NAMIBIA 50 VIAL 10.52 0.2105 SODIUM Buyer Median Price/vial=0.1903 High/Low Ratio=1.24 AMPICILLIN 500 mg tab-cap (PO) Price/tab-cap 2 g P J01CA01 Supplier UNFPA 1000 TAB-CAP 34.00 0.0340 CAPSULES Supplier MISSION 1000 TAB-CAP 37.35 0.0373 CAPSULES Supplier MEDEOR/EU 1000 TAB-CAP 52.30 0.0523 TABLETS/CAPSULES Supplier Median Price/tab-cap=0.0373 High/Low Ratio=1.54 Buyer DOMREPUB 1 TAB-CAP 0.02 0.0225 BLISTER PACK CAPSULES AMPICILLIN 500 mg vial (INJ) Price/vial 2 g E J01CA01 Supplier UNFPA 50 VIAL 4.74 0.0948 POWDER Supplier DURBIN 50 VIAL 5.18 0.1036 POWDER, SODIUM SALT Supplier MEG 50 VIAL 5.25 0.1050 Supplier IDA 50 VIAL 7.45 0.1491 Supplier MISSION 50 VIAL 9.24 0.1848 AS SODIUM Supplier MEDEOR/EU 50 VIAL 18.67 0.3734 SODIUM Supplier MEDEOR/TZ 1 VIAL 0.38 0.3780 POWDER Supplier Median Price/vial=0.1491 High/Low Ratio=3.99 Buyer OECS/PPS 100 AMP (1 VIAL) 8.58 0.0858 Buyer GHANA 10 VIAL 1.03 0.1030 POWDER Buyer SAFRICA 1 VIAL 0.19 0.1900 POWDER Buyer NAMIBIA 50 VIAL 12.41 0.2482 SODIUM WHO EML = <E>ssential, <C>omplementary, <P>resentation, <T>herapeutic group alternative, <N>ot on list *The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. DDDs have not been established for pediatric use. A-8 International Drug Price Indicator Guide, 2012 List I: Products Sorted Alphabetically ITEM DESCRIPTION PACKAGE UNIT DEFINED WHO ATC SOURCE PACKAGE PRICE (US$) PRICE (US$) COMMENTS DAILY DOSE* EML CODE AMPICILLIN 500 mg vial (INJ) Price/vial 2 g E J01CA01 Buyer MEMS 1 VIAL 0.54 0.5400 POWDER Buyer Median Price/vial=0.1900 High/Low Ratio=6.29 ANASTROZOLE 1 mg tab-cap (PO) Price/tab-cap 1 mg N L02BG03 Buyer SAFRICA 30 TAB-CAP 10.59 0.3530 TABLETS Buyer CRSS 100 TAB-CAP 126.82 1.2682 COATED TABLETS Buyer Median Price/tab-cap=0.8106 High/Low Ratio=3.59 ANTI-RABIES IMMUNOGLOBULIN, HUMAN 150 IU/ml ampoule (INJ) Price/ml E J06BB05 Buyer SAFRICA 1 AMP (2 ml) 71.73 35.8650 ANTIHAEMORRHOIDAL ointment (RECT) Price/g E C05A Supplier DURBIN 50 TUBE (30 g) 53.38 0.0356 BENZOCAINE 2%+BUTAMBEN 2%+TANNIC ACID 10% Supplier MISSION 1 TUBE (30 g) 1.58 0.0528 Supplier JMS 1 TUBE (20 g) 1.10 0.0550 Supplier MEDEOR/TZ 1 TUBE (30 g) 2.16 0.0720 Supplier MEDS 1 TUBE (15 g) 1.37 0.0913 CREAM/OINTMENT Supplier Median Price/g=0.0550 High/Low Ratio=2.56 Buyer MEMS 1 TUBE (30 g) 3.00 0.1000 CREAM, WITH STEROID ANTIHAEMORRHOIDAL suppos (RECT) Price/supp E C05A Supplier MEG 100 SUPP 12.50 0.1250 Supplier IDA 100 SUPP 14.58 0.1458 Supplier DURBIN 100 SUPP 14.84 0.1484 BISMUTH SUBGALL. 100 MG+ZINC OXIDE 100 MG+LIDOCAINE 60 MG Supplier MISSION 100 SUPP 17.22 0.1722 Supplier JMS 6 SUPP 1.10 0.1833 Supplier MEDS 10 SUPP 5.93 0.5932 Supplier Median Price/supp=0.1603 High/Low Ratio=4.75 Buyer OECS/PPS 12 SUPP 1.98 0.1650 HYDROCORTISONE Buyer NAMIBIA 12 SUPP 3.28 0.2732 WITH STEROID AND LOCAL ANESTHETIC Buyer MEMS 10 SUPP 3.72 0.3720 Buyer Median Price/supp=0.2732 High/Low Ratio=2.25 ANTIVENOM SERUM vial (INJ) Price/vial E J06AA03 Supplier JMS 1 VIAL 20.29 20.2944 10 ML, INCL. COBRA Supplier MEDS 1 VIAL 44.58 44.5770 10 ML Supplier IDA 10 AMP (1 VIAL) 1810.55 181.0551 Supplier Median Price/vial=44.5770 High/Low Ratio=8.92 Buyer CRSS 1 VIAL 20.31 20.3100 10 ML, CORAL SNAKE Buyer NAMIBIA 1 VIAL 151.02 151.0169 SCORPION, 5 ML Buyer NAMIBIA 1 VIAL 151.02 151.0169 SNAKE, POLYVALENT, 10 ML Buyer NAMIBIA 1 VIAL 151.02 151.0169 SPIDER, 5 ML Buyer Median Price/vial=151.0169 High/Low Ratio=7.44 ARTEMETHER 20 mg/ml ampoule (INJ) Price/ml 120 mg P P01BE02 Supplier IDA 30 AMP (1 ml) 10.60 0.3534 Supplier JMS 10 AMP (1 ml) 5.30 0.5295 Supplier MEG 10 AMP (1 ml) 6.70 0.6700 Supplier MISSION 10 AMP (1 ml) 7.55 0.7545 Supplier MEDEOR/EU 100 AMP (1 ml) 81.19 0.8119 Supplier Median Price/ml=0.6700 High/Low Ratio=2.30 ARTEMETHER 80 mg/ml ampoule (INJ) Price/ml 120 mg C P01BE02 Supplier IDA 50 AMP (1 ml) 21.97 0.4395 Supplier JMS 5 AMP (1 ml) 3.99 0.7973 Supplier MISSION 5 AMP (1 ml) 4.30 0.8609 Supplier MEG 5 AMP (1 ml) 4.50 0.9000 Supplier MEDEOR/EU 50 AMP (1 ml) 65.53 1.3106 Supplier MEDEOR/TZ 6 AMP (1 ml) 8.56 1.4260 Supplier MEDEOR/TZ 6 AMP (0.50 ml) 5.58 1.8600 Supplier Median Price/ml=0.9000 High/Low Ratio=4.23 ARTEMETHER+LUMEFANTRINE 20 mg+120 mg tab-cap (PO) Price/tab-cap E P01BE52 Supplier JMS 24 TAB-CAP 0.19 0.0078 TABLETS Supplier MEDEOR/TZ 18 TAB-CAP 0.22 0.0120 TABLETS Supplier DURBIN 16 TAB-CAP 6.28 0.3925 TABLETS Supplier Median Price/tab-cap=0.0120 High/Low Ratio=50.32 Buyer GHANA 720 TAB-CAP 49.50 0.0688 30 X 24 TABLETS Buyer GHANA 540 TAB-CAP 39.30 0.0728 30 X 18 TABLETS Buyer NAMIBIA 24 TAB-CAP 1.93 0.0803 BLISTER PACK TABLETS, TEARING LINE AFTER EACH 6 TABLETS Buyer SAFRICA 24 TAB-CAP 4.83 0.2013 TABLETS Buyer Median Price/tab-cap=0.0766 High/Low Ratio=2.93 WHO EML = <E>ssential, <C>omplementary, <P>resentation, <T>herapeutic group alternative, <N>ot on list *The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. DDDs have not been established for pediatric use. A-9 International Drug Price Indicator Guide, 2012 List I: Products Sorted Alphabetically ITEM DESCRIPTION PACKAGE UNIT DEFINED WHO ATC SOURCE PACKAGE PRICE (US$) PRICE (US$) COMMENTS DAILY DOSE* EML CODE ARTEMETHER+LUMEFANTRINE (6 X 1 TABLETS CO-PACK) 20 mg+120 Price/pack E P01BE52 mg tab-cap (PO) Supplier MEDEOR/EU 30 PACK 11.96 0.3985 BLISTER PACK DISPERSIBLE TABLETS Supplier MISSION 30 PACK 19.37 0.6457 Supplier Median Price/pack=0.5221 High/Low Ratio=1.62 Buyer GHANA 30 PACK 16.99 0.5663 DISPERSIBLE TABLETS ARTEMETHER+LUMEFANTRINE (6 X 2 TABLETS CO-PACK) 20 mg+120 Price/pack E P01BE52 mg tab-cap (PO) Supplier MEDEOR/EU 30 PACK 23.97 0.7992 BLISTER PACK DISPERSIBLE TABLETS Supplier MISSION 30 PACK 39.12 1.3040 Supplier Median Price/pack=1.0516 High/Low Ratio=1.63 Buyer GHANA 30 PACK 26.96 0.8987 DISPERSIBLE TABLETS ARTEMETHER+LUMEFANTRINE (6 X 3 TABLETS CO-PACK) 20 mg+120 Price/pack E P01BE52 mg tab-cap (PO) Supplier MEDEOR/EU 30 PACK 34.40 1.1465 BLISTER PACK TABLETS Supplier IDA 30 PACK 51.34 1.7112 TABLETS Supplier MISSION 30 PACK 56.97 1.8990 Supplier Median Price/pack=1.7112 High/Low Ratio=1.66 ARTEMETHER+LUMEFANTRINE (6 X 4 TABLETS CO-PACK) 20 mg+120 Price/pack E P01BE52 mg tab-cap (PO) Supplier MEDEOR/TZ 1 PACK 0.36 0.3600 TABLETS Supplier MEDEOR/EU 30 PACK 41.43 1.3809 BLISTER PACK TABLETS Supplier IDA 30 PACK 66.43 2.2145 TABLETS Supplier MISSION 30 PACK 73.68 2.4560 Supplier Median Price/pack=1.7977 High/Low Ratio=6.82 ARTEMETHER+LUMEFANTRINE (DISPERSIBLE) 20 mg+120 mg tab-cap Price/tab-cap E P01BE52 (PO) Supplier MEDEOR/TZ 180 TAB-CAP 4.84 0.0269 30 X 6 TABLETS Supplier IDA 360 TAB-CAP 34.12 0.0948 TABLETS Supplier IDA 180 TAB-CAP 17.73 0.0985 TABLETS Supplier Median Price/tab-cap=0.0948 High/Low Ratio=3.66 ARTESUNATE 100 mg tab-cap (PO) Price/tab-cap 0.28 g P P01BE03 Supplier UNFPA 6 TAB-CAP 2.00 0.3333 TABLETS ARTESUNATE 200 mg suppos (RECT) Price/supp P P01BE03 Supplier MISSION 6 SUPP 5.28 0.8799 RECTOCAPS Supplier JMS 6 SUPP 5.94 0.9900 Supplier Median Price/supp=0.9350 High/Low Ratio=1.13 ARTESUNATE 250 mg tab-cap (PO) Price/tab-cap 0.28 g EP P01BE03 Buyer PERU 100 TAB-CAP 49.58 0.4958 TABLETS, ILLUSTRATIVE PACK SIZE ARTESUNATE 50 mg suppos (RECT) Price/supp P P01BE03 Supplier MISSION 6 SUPP 2.84 0.4726 RECTOCAPS Supplier JMS 6 SUPP 3.74 0.6233 Supplier Median Price/supp=0.5480 High/Low Ratio=1.32 ARTESUNATE 50 mg tab-cap (PO) Price/tab-cap 0.28 g C P01BE03 Supplier UNFPA 12 TAB-CAP 2.00 0.1667 TABLETS Buyer PERU 1 TAB-CAP 0.62 0.6236 TABLETS ARTESUNATE+AMODIAQUINE (12 X 12 TABLETS CO-PACK) 50 mg+153 Price/pack E P01B mg tab-cap (PO) Supplier MEG 10 PACK 10.53 1.0530 BLISTER Supplier IDA 1 PACK 1.48 1.4777 TABLETS Supplier MEDEOR/EU 25 PACK 64.89 2.5957 COMBI-BLISTER TABLETS Supplier Median Price/pack=1.4777 High/Low Ratio=2.47 ARTESUNATE+AMODIAQUINE (3 FIXED DOSE COMBO TABS) Price/treatmen P P01B 100mg+270mg tab-cap (PO) Supplier IDA 25 TREATMENT 18.83 0.7530 TABLETS Supplier MISSION 25 TREATMENT 23.12 0.9247 TABLETS, STRIPS Supplier Median Price/treatmen=0.8389 High/Low Ratio=1.23 Buyer GHANA 25 TREATMENT 13.81 0.5524 ARTESUNATE+AMODIAQUINE (3 FIXED DOSE COMBO TABS) Price/treatmen P P01B 25mg+67.5mg tab-cap (PO) WHO EML = <E>ssential, <C>omplementary, <P>resentation, <T>herapeutic group alternative, <N>ot on list *The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. DDDs have not been established for pediatric use. A-10 International Drug Price Indicator Guide, 2012 List I: Products Sorted Alphabetically ITEM DESCRIPTION PACKAGE UNIT DEFINED WHO ATC SOURCE PACKAGE PRICE (US$) PRICE (US$) COMMENTS DAILY DOSE* EML CODE Supplier IDA 25 TREATMENT 6.10 0.2441 TABLETS Supplier MISSION 25 TREATMENT 10.96 0.4385 TABLETS, STRIP Supplier Median Price/treatmen=0.3413 High/Low Ratio=1.80 Buyer GHANA 25 TREATMENT 7.31 0.2924 ARTESUNATE+AMODIAQUINE (3 FIXED DOSE COMBO TABS) 50 mg+135 Price/treatmen P P01B mg tab-cap (PO) Supplier IDA 25 TREATMENT 11.69 0.4677 TABLETS Supplier MISSION 25 TREATMENT 14.61 0.5844 TABLETS, STRIP Supplier Median Price/treatmen=0.5261 High/Low Ratio=1.25 Buyer GHANA 25 TREATMENT 9.56 0.3824 ARTESUNATE+AMODIAQUINE (3 X 3 TABLETS CO-PACK) 50 mg+153 Price/pack E P01B mg tab-cap (PO) Supplier MEG 10 PACK 3.46 0.3460 BLISTER PACK TABLETS Supplier IDA 1 PACK 0.45 0.4497 TABLETS Supplier Median Price/pack=0.3979 High/Low Ratio=1.30 ARTESUNATE+AMODIAQUINE (6 FIXED-DOSE COMBO TABS) Price/treatmen P P01B 100mg+270mg tab-cap (PO) Supplier IDA 25 TREATMENT 31.03 1.2413 TABLETS Supplier MISSION 25 TREATMENT 36.52 1.4610 TABLETS, STRIPS Supplier Median Price/treatmen=1.3512 High/Low Ratio=1.18 Buyer GHANA 25 TREATMENT 23.06 0.9224 ARTESUNATE+AMODIAQUINE (6 X 6 TABLETS CO-PACK) 50 mg+153 Price/pack E P01B mg tab-cap (PO) Supplier MEG 10 PACK 5.50 0.5500 BLISTER PACK TABLETS Supplier IDA 1 PACK 0.77 0.7710 TABLETS Supplier Median Price/pack=0.6605 High/Low Ratio=1.40 ARTESUNATE+AMODIAQUINE (FDC) 50 mg+153 mg tab-cap (PO) Price/tab-cap P P01B Supplier JMS 24 TAB-CAP 0.53 0.0220 ARTESUNATE+SULFADOXINE/PYRIMETHAMINE (6 TAB ARTES.+2 TAB Price/pack E P01BD51 SP CO-PACK) 50+500/25mg tab-cap (PO) Supplier MEG 10 PACK 6.00 0.6000 BLISTER PACK TABLETS Supplier IDA 1 PACK 0.84 0.8352 TABLETS Supplier Median Price/pack=0.7176 High/Low Ratio=1.39 ARTESUNATE+SULFADOXINE/PYRIMETHAMINE (6 TAB ARTES.+3 TAB Price/pack E P01BD51 SP CO-PACK) 100+500/25mg tab-cap (PO) Supplier MEG 25 PACK 48.51 1.9404 BLISTER PACK TABLETS ASPARAGINASE 10,000 IU/ml vial (INJ) Price/ml C L01XX02 Buyer NAMIBIA 1 VIAL (1 ml) 39.33 39.3322 ATAZANAVIR 150 mg tab-cap (PO) Price/tab-cap 0.3 g E J05AE08 Buyer SAFRICA 60 TAB-CAP 18.72 0.3120 CAPSULES ATAZANAVIR+RITONAVIR 300+100 mg tab-cap (PO) Price/tab-cap N J05AR Buyer GHANA 30 TAB-CAP 26.00 0.8667 TABLETS ATENOLOL 100 mg tab-cap (PO) Price/tab-cap 75 mg E C07AB03 Supplier IDA 1000 TAB-CAP 10.99 0.0110 TABLETS Supplier JMS 100 TAB-CAP 1.67 0.0167 TABLETS Supplier MEG 1000 TAB-CAP 20.26 0.0203 TABLETS Supplier MEDEOR/TZ 1000 TAB-CAP 25.92 0.0259 TABLETS Supplier MISSION 1000 TAB-CAP 28.61 0.0286 TABLETS Supplier Median Price/tab-cap=0.0203 High/Low Ratio=2.60 Buyer DOMREPUB 1 TAB-CAP 0.00 0.0048 BLISTER PACK TABLETS Buyer PERU 100 TAB-CAP 0.94 0.0094 TABLETS, ILLUSTRATIVE PACK SIZE Buyer GHANA 100 TAB-CAP 0.96 0.0096 10 X 10 BLISTER PACK TABLETS Buyer SAFRICA 28 TAB-CAP 0.30 0.0107 TABLETS IN A PATIENT-READY PACK Buyer MEMS 28 TAB-CAP 1.01 0.0360 TABLETS Buyer SUDANNHIF 100 TAB-CAP 4.30 0.0430 TABLETS, ILLUSTRATIVE PACK SIZE Buyer Median Price/tab-cap=0.0102 High/Low Ratio=8.96 ATENOLOL 50 mg tab-cap (PO) Price/tab-cap 75 mg E C07AB03 Supplier MEG 1000 TAB-CAP 4.40 0.0044 TABLETS Supplier IDA 1000 TAB-CAP 8.29 0.0083 TABLETS WHO EML = <E>ssential, <C>omplementary, <P>resentation, <T>herapeutic group alternative, <N>ot on list *The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. DDDs have not been established for pediatric use. A-11 International Drug Price Indicator Guide, 2012 List I: Products Sorted Alphabetically ITEM DESCRIPTION PACKAGE UNIT DEFINED WHO ATC SOURCE PACKAGE PRICE (US$) PRICE (US$) COMMENTS DAILY DOSE* EML CODE ATENOLOL 50 mg tab-cap (PO) Price/tab-cap 75 mg E C07AB03 Supplier DURBIN 1000 TAB-CAP 8.63 0.0086 TABLETS Supplier MEDEOR/EU 3000 TAB-CAP 31.77 0.0106 TABLETS Supplier JMS 100 TAB-CAP 1.23 0.0123 TABLETS Supplier MEDS 28 TAB-CAP 0.35 0.0125 TABLETS Supplier MEDEOR/TZ 1000 TAB-CAP 25.60 0.0256 TABLETS Supplier Median Price/tab-cap=0.0106 High/Low Ratio=5.82 Buyer GHANA 100 TAB-CAP 0.34 0.0034 10 X 10 BLISTER PACK TABLETS Buyer DOMREPUB 1 TAB-CAP 0.00 0.0035 BLISTER PACK TABLETS Buyer OECS/PPS 140 TAB-CAP 0.52 0.0037 TABLETS, 10 X 14 Buyer SAFRICA 28 TAB-CAP 0.20 0.0071 TABLETS IN A PATIENT-READY PACK Buyer SUDANNHIF 100 TAB-CAP 2.48 0.0248 TABLETS, ILLUSTRATIVE PACK SIZE Buyer MEMS 28 TAB-CAP 1.72 0.0613 TABLETS Buyer Median Price/tab-cap=0.0054 High/Low Ratio=18.03 ATORVASTATIN 10 mg tab-cap (PO) Price/tab-cap 20 mg N C10AA05 Supplier MEDS 28 TAB-CAP 0.98 0.0351 TABLETS Supplier MEDEOR/TZ 28 TAB-CAP 3.36 0.1200 TABLETS Supplier Median Price/tab-cap=0.0776 High/Low Ratio=3.42 Buyer GHANA 100 TAB-CAP 1.30 0.0130 10 X 10 BLISTER PACK TABLETS Buyer OECS/PPS 90 TAB-CAP 2.55 0.0283 TABLETS Buyer SAFRICA 28 TAB-CAP 1.79 0.0639 CALCIUM TRIHYDRATE TABLETS Buyer Median Price/tab-cap=0.0283 High/Low Ratio=4.92 ATORVASTATIN 20 mg tab-cap (PO) Price/tab-cap 20 mg T C10AA05 Supplier MEDS 28 TAB-CAP 1.52 0.0543 TABLETS Supplier MEDEOR/TZ 30 TAB-CAP 1.92 0.0640 TABLETS Supplier JMS 100 TAB-CAP 26.33 0.2633 TABLETS Supplier Median Price/tab-cap=0.0640 High/Low Ratio=4.85 Buyer OECS/PPS 90 TAB-CAP 4.20 0.0467 TABLETS Buyer SAFRICA 30 TAB-CAP 2.50 0.0833 TABLETS IN A PATIENT-READY PACK Buyer GHANA 100 TAB-CAP 40.80 0.4080 10 X 10 BLISTER PACK TABLETS Buyer Median Price/tab-cap=0.0833 High/Low Ratio=8.74 ATOVAQUONE+PROGUANIL 250mg+100mg tab-cap (PO) Price/tab-cap 4 tab N P01BB51 Supplier MEDEOR/TZ 12 TAB-CAP 21.38 1.7815 TABLETS Supplier DURBIN 12 TAB-CAP 50.24 4.1867 TABLETS Supplier Median Price/tab-cap=2.9841 High/Low Ratio=2.35 ATRACURIUM 10 mg/ml ampoule (INJ) Price/ml N M03AC04 Supplier JMS 5 AMP (2.50 ml) 23.40 1.8723 Buyer DOMREPUB 1 AMP (2.50 ml) 2.48 0.9918 Buyer NAMIBIA 10 VIAL (2.50 ml) 31.75 1.2698 BESYLATE Buyer SAFRICA 1 AMP (5 ml) 7.14 1.4280 Buyer Median Price/ml=1.2698 High/Low Ratio=1.44 ATROPINE SULFATE 0.5 mg/ml ampoule (INJ) Price/ml 1.5 mg P A03BA01 Supplier MISSION 100 AMP (1 ml) 23.04 0.2304 Buyer SAFRICA 1 AMP (1 ml) 0.19 0.1900 Buyer OECS/PPS 100 AMP (1 ml) 24.18 0.2418 IM/IV/SC Buyer NAMIBIA 10 AMP (1 ml) 2.73 0.2734 Buyer Median Price/ml=0.2418 High/Low Ratio=1.44 ATROPINE SULFATE 1 mg/ml ampoule (INJ) Price/ml 1.5 mg E A03BA01 Supplier DURBIN 1000 AMP (1 ml) 13.58 0.0136 Supplier JMS 10 AMP (1 ml) 0.40 0.0402 Supplier IDA 100 AMP (1 ml) 8.67 0.0867 Supplier MISSION 100 AMP (1 ml) 9.62 0.0962 Supplier UNFPA 100 AMP (1 ml) 10.00 0.1000 Supplier MEDEOR/TZ 100 AMP (1 ml) 14.29 0.1429 Supplier MEDEOR/EU 50 AMP (1 ml) 9.33 0.1867 Supplier MEG 100 AMP (1 ml) 27.00 0.2700 Supplier Median Price/ml=0.0981 High/Low Ratio=19.85 Buyer GHANA 10 AMP (1 ml) 0.45 0.0450 Buyer PERU 100 AMP (1 ml) 8.46 0.0847 ILLUSTRATIVE NUMBER OF AMPS Buyer SAFRICA 1 AMP (1 ml) 0.21 0.2100 Buyer Median Price/ml=0.0847 High/Low Ratio=4.67 ATROPINE SULFATE 1% opht drop (OPHT) Price/ml E S01FA01 Supplier DURBIN 1 BOTT (10 ml) 1.73 0.1727 Supplier MISSION 1 BOTT (5 ml) 1.39 0.2785 WHO EML = <E>ssential, <C>omplementary, <P>resentation, <T>herapeutic group alternative, <N>ot on list *The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. DDDs have not been established for pediatric use. A-12 International Drug Price Indicator Guide, 2012 List I: Products Sorted Alphabetically ITEM DESCRIPTION PACKAGE UNIT DEFINED WHO ATC SOURCE PACKAGE PRICE (US$) PRICE (US$) COMMENTS DAILY DOSE* EML CODE ATROPINE SULFATE 1% opht drop (OPHT) Price/ml E S01FA01 Supplier MEDEOR/TZ 1 BOTT (10 ml) 3.12 0.3120 Supplier JMS 1 BOTT (10 ml) 3.51 0.3510 Supplier MEDS 1 BOTT (5 ml) 2.80 0.5593 Supplier Median Price/ml=0.3120 High/Low Ratio=3.24 Buyer OECS/PPS 1 BOTT (10 ml) 4.50 0.4500 Buyer NAMIBIA 1 BOTT (5 ml) 2.45 0.4907 Buyer SAFRICA 1 BOTT (5 ml) 2.86 0.5720 DROPPER Buyer Median Price/ml=0.4907 High/Low Ratio=1.27 AZATHIOPRINE 50 mg tab-cap (PO) Price/tab-cap 0.15 g C L04AX01 Supplier DURBIN 100 TAB-CAP 21.20 0.2120 TABLETS Buyer SAFRICA 100 TAB-CAP 12.35 0.1235 TABLETS Buyer PERU 1 TAB-CAP 0.18 0.1845 TABLET Buyer NAMIBIA 100 TAB-CAP 23.00 0.2300 TABLETS Buyer Median Price/tab-cap=0.1845 High/Low Ratio=1.86 AZITHROMYCIN 200 mg/5 ml suspen (PO) Price/ml 0.3 g E J01FA10 Supplier UNFPA 1 BOTT (15 ml) 0.80 0.0533 Supplier MEDS 1 BOTT (15 ml) 0.89 0.0593 Supplier IDA 120 BOTT (15 ml) 107.87 0.0599 Supplier MISSION 1 BOTT (15 ml) 1.14 0.0760 SYRUP AS DIHYDRATE Supplier Median Price/ml=0.0596 High/Low Ratio=1.43 Buyer GHANA 1 BOTT (30 ml) 0.62 0.0207 Buyer DOMREPUB 1 BOTT (30 ml) 0.65 0.0218 Buyer PERU 1 BOTT (60 ml) 1.95 0.0325 Buyer OECS/PPS 1 BOTT (15 ml) 1.37 0.0913 Buyer SAFRICA 1 BOTT (15 ml) 4.16 0.2773 GRANULES Buyer Median Price/ml=0.0325 High/Low Ratio=13.40 AZITHROMYCIN 250 mg tab-cap (PO) Price/tab-cap 0.3 g E J01FA10 Supplier MEDS 6 TAB-CAP 0.89 0.1482 TABLETS Supplier MEG 100 TAB-CAP 17.12 0.1712 TABLETS Supplier IDA 6 TAB-CAP 1.03 0.1713 BLISTER PACK CAPSULES Supplier UNFPA 4 TAB-CAP 0.75 0.1875 FILM-COATED, BLISTER-PACK TABLETS Supplier MEDEOR/TZ 60 TAB-CAP 20.09 0.3348 TABLETS Supplier MISSION 6 TAB-CAP 2.79 0.4642 BLISTER PACK TABLETS Supplier Median Price/tab-cap=0.1794 High/Low Ratio=3.13 Buyer MEMS 6 TAB-CAP 1.03 0.1720 TABLETS Buyer GHANA 1 TAB-CAP 0.21 0.2100 BLISTER PACK TABLET Buyer SAFRICA 6 TAB-CAP 1.81 0.3017 CAPSULES Buyer Median Price/tab-cap=0.2100 High/Low Ratio=1.75 AZITHROMYCIN 500 mg tab-cap (PO) Price/tab-cap 0.3 g E J01FA10 Supplier MEDS 3 TAB-CAP 0.69 0.2301 TABLETS Supplier IDA 3 TAB-CAP 1.03 0.3427 BLISTER PACK CAPSULES Supplier UNFPA 500 TAB-CAP 266.63 0.5333 TABLETS Supplier MEDEOR/TZ 3 TAB-CAP 1.66 0.5540 TABLETS Supplier Median Price/tab-cap=0.4380 High/Low Ratio=2.41 Buyer PERU 100 TAB-CAP 13.18 0.1318 TABLETS, ILLUSTRATIVE PACK SIZE Buyer DOMREPUB 1 TAB-CAP 0.13 0.1323 CAPSULES Buyer OECS/PPS 3 TAB-CAP 1.38 0.4600 TABLETS Buyer SAFRICA 2 TAB-CAP 2.13 1.0650 TABLETS Buyer NAMIBIA 3 TAB-CAP 5.30 1.7666 TABLETS Buyer CRSS 100 TAB-CAP 203.87 2.0387 Buyer Median Price/tab-cap=0.7625 High/Low Ratio=15.47 BACLOFEN 10 mg tab-cap (PO) Price/tab-cap 50 mg N M03BX01 Buyer NAMIBIA 30 TAB-CAP 2.74 0.0914 TABLETS BALANCED SALT SOLUTION opht (OPHT) Price/ml N S01XA Buyer OECS/PPS 1 BOTT (18 ml) 4.35 0.2417 BARIUM SULFATE powder (PO) Price/kg P V08BA02 Supplier IDA 1 DRUM (10 kg) 55.00 5.4998 Supplier MISSION 1 DRUM (25 kg) 154.45 6.1781 Supplier Median Price/kg=5.8389 High/Low Ratio=1.12 Buyer OECS/PPS 24 CUP (0.34 kg) 221.97 27.2022 12 OZ. CUP, 340 GM BECLOMETASONE 100 mcg/dose inhaler (INH) Price/dose 0.8 mg P R03BA01 Supplier MEDS 1 INHALER (200 DOSE) 3.39 0.0170 WHO EML = <E>ssential, <C>omplementary, <P>resentation, <T>herapeutic group alternative, <N>ot on list *The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. DDDs have not been established for pediatric use. A-13 International Drug Price Indicator Guide, 2012 List I: Products Sorted Alphabetically ITEM DESCRIPTION PACKAGE UNIT DEFINED WHO ATC SOURCE PACKAGE PRICE (US$) PRICE (US$) COMMENTS DAILY DOSE* EML CODE BECLOMETASONE 100 mcg/dose inhaler (INH) Price/dose 0.8 mg P R03BA01 Supplier DURBIN 1 INHALER (200 DOSE) 14.37 0.0718 Supplier Median Price/dose=0.0444 High/Low Ratio=4.22 Buyer GHANA 1 INHALER (200 DOSE) 4.95 0.0248 Buyer SAFRICA 200 DOSE 5.04 0.0252 CFC-FREE Buyer Median Price/dose=0.0250 High/Low Ratio=1.02 BECLOMETASONE 250 mcg/dose inhaler (INH) Price/dose 0.8 mg E R03BA01 Buyer OECS/PPS 1 INHALER (200 DOSE) 4.95 0.0248 BECLOMETASONE 50 mcg nasal (N/T) Price/dose 0.4 mg E R01AD01 Buyer OECS/PPS 1 BOTT (200 DOSE) 2.60 0.0130 Buyer NAMIBIA 1 BOTT (150 DOSE) 6.03 0.0402 DIPROPIONATE, AQUEOUS Buyer Median Price/dose=0.0266 High/Low Ratio=3.09 BECLOMETASONE 50 mcg/dose inhaler (INH) Price/dose 0.8 mg E R03BA01 Supplier DURBIN 1 INHALER (200 DOSE) 2.59 0.0130 Supplier MEG 1 INHALER (200 DOSE) 2.75 0.0138 Supplier IDA 1 INHALER (200 DOSE) 2.89 0.0145 Supplier MISSION 1 INHALER (200 DOSE) 3.29 0.0165 CFC-FREE Supplier MEDEOR/EU 1 INHALER (200 DOSE) 3.84 0.0192 Supplier Median Price/dose=0.0145 High/Low Ratio=1.48 Buyer OECS/PPS 1 INHALER (200 DOSE) 2.93 0.0147 CFC-FREE Buyer SAFRICA 1 INHALER (200 DOSE) 3.27 0.0164 WITH MOUTH ADAPTER Buyer NAMIBIA 1 INHALER (200 DOSE) 3.71 0.0185 Buyer Median Price/dose=0.0164 High/Low Ratio=1.26 BENDROFLUMETHIAZIDE 2.5 mg tab-cap (PO) Price/tab-cap 2.5 mg T C03AA01 Buyer OECS/PPS 500 TAB-CAP 0.18 0.0004 TABLETS Buyer GHANA 1000 TAB-CAP 2.75 0.0028 10 X 100 TABLETS Buyer Median Price/tab-cap=0.0016 High/Low Ratio=7.00 BENDROFLUMETHIAZIDE 5 mg tab-cap (PO) Price/tab-cap 2.5 mg T C03AA01 Supplier MEDEOR/TZ 1000 TAB-CAP 4.68 0.0047 TABLETS Supplier DURBIN 1000 TAB-CAP 7.22 0.0072 TABLETS Supplier JMS 100 TAB-CAP 1.98 0.0198 TABLETS Supplier Median Price/tab-cap=0.0072 High/Low Ratio=4.21 Buyer GHANA 1000 TAB-CAP 5.20 0.0052 10 X 100 TABLETS Buyer MEMS 100 TAB-CAP 0.97 0.0097 TABLETS Buyer Median Price/tab-cap=0.0075 High/Low Ratio=1.87 BENZATROPINE MESILATE 1 mg/ml ampoule (INJ) Price/ml 2 mg N N04AC01 Buyer OECS/PPS 5 AMP (2 ml) 3.90 0.3900 BENZATROPINE MESILATE 2 mg tab-cap (PO) Price/tab-cap 2 mg N N04AC01 Buyer OECS/PPS 100 TAB-CAP 3.70 0.0370 TABLETS BENZOIC & SALICYLIC ACID (WHITFIELD'S) 6% + 3% ointment Price/g N D01AE20 (TOP) Supplier MEDS 1 JAR (400 g) 1.74 0.0044 Supplier JMS 1 JAR (200 g) 1.52 0.0076 Supplier IDA 1 JAR (800 g) 7.52 0.0094 Supplier MEG 1 JAR (500 g) 5.45 0.0109 Supplier DURBIN 1 JAR (500 g) 5.89 0.0118 Supplier MEG 1 TUBE (40 g) 0.52 0.0130 Supplier MEDEOR/TZ 1 TUBE (25 g) 0.40 0.0158 Supplier Median Price/g=0.0109 High/Low Ratio=3.59 Buyer MEMS 1 TUBE (40 g) 0.37 0.0092 Buyer GHANA 1 TUBE (25 g) 0.66 0.0264 Buyer Median Price/g=0.0178 High/Low Ratio=2.87 BENZOYL PEROXIDE 5% gel (TOP) Price/g P D10AE01 Buyer NAMIBIA 1 TUBE (40 g) 0.57 0.0143 Buyer SAFRICA 1 TUBE (40 g) 2.91 0.0727 Buyer Median Price/g=0.0435 High/Low Ratio=5.09 BENZYL BENZOATE 25% lotion (TOP) Price/ml E P03AX01 Supplier MEDS 1 BOTT (5000 ml) 11.23 0.0022 EMULSION Supplier MEG 1 BOTT (1000 ml) 3.45 0.0035 Supplier IDA 1 BOTT (1000 ml) 4.63 0.0046 Supplier DURBIN 1 BOTT (1000 ml) 4.63 0.0046 Supplier MEDEOR/TZ 1 BOTT (100 ml) 0.50 0.0050 EMULSION Supplier MISSION 1 BOTT (1000 ml) 5.44 0.0054 Supplier MEDEOR/EU 1 BOTT (1000 ml) 5.63 0.0056 WHO EML = <E>ssential, <C>omplementary, <P>resentation, <T>herapeutic group alternative, <N>ot on list *The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. DDDs have not been established for pediatric use. A-14 International Drug Price Indicator Guide, 2012 List I: Products Sorted Alphabetically ITEM DESCRIPTION PACKAGE UNIT DEFINED WHO ATC SOURCE PACKAGE PRICE (US$) PRICE (US$) COMMENTS DAILY DOSE* EML CODE BENZYL BENZOATE 25% lotion (TOP) Price/ml E P03AX01 Supplier JMS 1 BOTT (100 ml) 0.56 0.0056 Supplier Median Price/ml=0.0048 High/Low Ratio=2.55 Buyer SAFRICA 1 BOTT (100 ml) 0.29 0.0029 BENZYL BENZOATE (CONCENTRATED) 90% solution (TOP) Price/ml P P03AX01 Supplier MEDEOR/EU 12 BOTT (550 ml) 79.92 0.0121 BETAMETHASONE (OPHT/OTIC) 0.1% opht drop (OPHT) Price/ml P S03BA03 Buyer OECS/PPS 1 BOTT (10 ml) 2.45 0.2450 BETAMETHASONE VALERATE 0.1% cream (TOP) Price/g E D07AC01 Supplier MEDS 1 TUBE (15 g) 0.21 0.0140 Supplier JMS 1 TUBE (15 g) 0.28 0.0185 Supplier IDA 10 TUBE (15 g) 3.79 0.0253 Supplier MEG 50 TUBE (15 g) 29.22 0.0390 Supplier MEDEOR/TZ 1 TUBE (15 g) 0.59 0.0396 Supplier DURBIN 10 TUBE (15 g) 6.83 0.0455 Supplier MEDEOR/EU 50 TUBE (15 g) 36.95 0.0493 Supplier MISSION 1 TUBE (15 g) 0.95 0.0633 Supplier Median Price/g=0.0393 High/Low Ratio=4.52 Buyer SAFRICA 1 JAR (500 g) 4.59 0.0092 Buyer MEMS 1 TUBE (15 g) 0.45 0.0300 Buyer NAMIBIA 1 TUBE (15 g) 0.46 0.0304 Buyer OECS/PPS 1 TUBE (15 g) 0.80 0.0533 Buyer Median Price/g=0.0302 High/Low Ratio=5.81 BETAMETHASONE VALERATE 0.1% ointment (TOP) Price/g E D07AC01 Supplier MEDS 1 TUBE (15 g) 0.25 0.0164 Supplier JMS 1 TUBE (15 g) 0.28 0.0185 Supplier Median Price/g=0.0175 High/Low Ratio=1.13 Buyer NAMIBIA 1 TUBE (15 g) 0.50 0.0334 Buyer SAFRICA 1 JAR (500 g) 34.43 0.0689 Buyer Median Price/g=0.0511 High/Low Ratio=2.06 BICALUTAMIDE 50 mg tab-cap (PO) Price/tab-cap 50 mg N L02BB03 Buyer SAFRICA 30 TAB-CAP 14.77 0.4923 TABLETS Buyer JMS 28 TAB-CAP 17.61 0.6290 TABLETS Buyer Median Price/tab-cap=0.5607 High/Low Ratio=1.28 BIPERIDEN 2 mg tab-cap (PO) Price/tab-cap 10 mg E N04AA02 Supplier IDA 50 TAB-CAP 3.98 0.0797 TABLETS Buyer PERU 100 TAB-CAP 0.92 0.0092 TABLETS, ILLUSTRATIVE PACK SIZE Buyer NAMIBIA 500 TAB-CAP 32.77 0.0655 TABLETS Buyer SAFRICA 500 TAB-CAP 33.19 0.0664 TABLETS Buyer Median Price/tab-cap=0.0655 High/Low Ratio=7.22 BISACODYL 10 mg suppos (RECT) Price/supp 10 mg N A06AB02 Buyer OECS/PPS 12 SUPP 1.40 0.1167 Buyer CRSS 100 SUPP 11.81 0.1181 Buyer NAMIBIA 10 SUPP 3.50 0.3505 Buyer SAFRICA 10 SUPP 3.57 0.3570 Buyer Median Price/supp=0.2343 High/Low Ratio=3.06 BISACODYL 5 mg tab-cap (PO) Price/tab-cap 10 mg N A06AB02 Supplier MEDS 100 TAB-CAP 0.42 0.0042 ENTERIC-COATED TABLETS Supplier IDA 1000 TAB-CAP 4.69 0.0047 ENTERIC COATED TABLETS Supplier JMS 100 TAB-CAP 0.48 0.0048 TABLETS Supplier MISSION 1000 TAB-CAP 6.11 0.0061 ENTERIC-COATED TABLETS Supplier DURBIN 1000 TAB-CAP 7.07 0.0071 TABLETS Supplier MEDEOR/EU 3500 TAB-CAP 35.80 0.0102 DRAGEES Supplier MEG 1000 TAB-CAP 15.50 0.0155 TABLETS Supplier MEDEOR/TZ 1000 TAB-CAP 18.00 0.0180 TABLETS Supplier Median Price/tab-cap=0.0066 High/Low Ratio=4.29 Buyer GHANA 100 TAB-CAP 0.60 0.0060 10 X 10 BLISTER PACK TABLETS Buyer OECS/PPS 1000 TAB-CAP 8.41 0.0084 TABLETS Buyer MEMS 1000 TAB-CAP 14.04 0.0140 TABLETS Buyer SAFRICA 200 TAB-CAP 3.22 0.0161 ENTERIC-COATED TABLETS Buyer Median Price/tab-cap=0.0112 High/Low Ratio=2.68 WHO EML = <E>ssential, <C>omplementary, <P>resentation, <T>herapeutic group alternative, <N>ot on list *The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. DDDs have not been established for pediatric use. A-15 International Drug Price Indicator Guide, 2012 List I: Products Sorted Alphabetically ITEM DESCRIPTION PACKAGE UNIT DEFINED WHO ATC SOURCE PACKAGE PRICE (US$) PRICE (US$) COMMENTS DAILY DOSE* EML CODE BISMUTH SUBGALLATE suppos (RECT) Price/supp N C05AX02 Buyer SAFRICA 10 SUPP 3.33 0.3330 WITH BISMUTH OXIDE AND ZINC OXIDE BLEOMYCIN 15 mg vial (INJ) Price/vial C L01DC01 Supplier MEDS 1 VIAL 16.44 16.4385 Supplier IDA 1 VIAL 20.30 20.3028 Supplier Median Price/vial=18.3707 High/Low Ratio=1.24 Buyer NAMIBIA 1 VIAL 14.02 14.0174 Buyer CRSS 1 VIAL 22.00 22.0000 Buyer SAFRICA 1 AMP (1 VIAL) 27.19 27.1900 Buyer Median Price/vial=22.0000 High/Low Ratio=1.94 BROMOCRIPTINE MESILATE 2.5 mg tab-cap (PO) Price/tab-cap 40 mg N G02CB01 Supplier MEDS 30 TAB-CAP 8.42 0.2808 TABLETS Supplier UNFPA 30 TAB-CAP 18.00 0.6000 TABLETS Supplier Median Price/tab-cap=0.4404 High/Low Ratio=2.14 Buyer PERU 100 TAB-CAP 12.77 0.1277 TABLETS, ILLUSTRATIVE PACK SIZE Buyer MEMS 30 TAB-CAP 5.46 0.1820 TABLETS Buyer NAMIBIA 30 TAB-CAP 5.51 0.1837 TABLETS Buyer SAFRICA 30 TAB-CAP 9.26 0.3087 TABLETS Buyer Median Price/tab-cap=0.1829 High/Low Ratio=2.42 BUDESONIDE 100 mcg/dose inhaler (PO) Price/dose 0.8 mg E R03BA02 Buyer SAFRICA 1 INHALER (300 DOSE) 8.09 0.0270 BUDESONIDE 200 mcg/dose inhaler (PO) Price/dose 0.8 mg E R03BA02 Buyer SAFRICA 1 INHALER (300 DOSE) 9.16 0.0305 BUPIVACAINE HCL 0.25% ampoule (INJ) Price/ml E N01BB01 Buyer OECS/PPS 1 AMP (20 ml) 67.50 3.3750 PRESERVATIVE-FREE BUPIVACAINE HCL 0.5% ampoule (INJ) Price/ml E N01BB01 Supplier MEG 10 VIAL (20 ml) 13.72 0.0686 Supplier IDA 10 VIAL (20 ml) 15.36 0.0768 Supplier UNFPA 10 VIAL (20 ml) 15.50 0.0775 Supplier MISSION 10 VIAL (20 ml) 20.07 0.1003 Supplier IDA 20 AMP (4 ml) 18.18 0.2273 Supplier MEDEOR/TZ 1 VIAL (20 ml) 4.64 0.2322 Supplier MEDS 1 AMP (4 ml) 1.61 0.4037 HEAVY, SPINAL Supplier Median Price/ml=0.1003 High/Low Ratio=5.88 Buyer PERU 1 AMP (20 ml) 0.62 0.0310 Buyer SAFRICA 1 AMP (10 ml) 0.39 0.0390 Buyer NAMIBIA 10 AMP (10 ml) 5.01 0.0501 Buyer GHANA 10 AMP (10 ml) 14.77 0.1477 Buyer OECS/PPS 25 VIAL (10 ml) 38.75 0.1550 PRESERVATIVE-FREE Buyer Median Price/ml=0.0501 High/Low Ratio=5.00 BUPIVACAINE HCL + DEXTROSE 0.5% + 8% ampoule (INJ) Price/ml E N01BB51 Supplier MISSION 20 AMP (4 ml) 60.77 0.7596 HEAVY Supplier JMS 25 AMP (4 ml) 121.00 1.2100 Supplier Median Price/ml=0.9848 High/Low Ratio=1.59 Buyer DOMREPUB 1 VIAL (4 ml) 0.42 0.1063 BUPIVACAINE HCL + EPINEPHRINE (0.5% + 1:200,000) vial Price/ml N N01BB51 (INJ) Supplier UNFPA 10 VIAL (20 ml) 21.00 0.1050 Buyer SAFRICA 1 AMP (20 ml) 2.05 0.1025 BUSULFAN 2 mg tab-cap (PO) Price/tab-cap N L01AB01 Buyer CRSS 100 TAB-CAP 42.27 0.4227 TABLETS Buyer NAMIBIA 100 TAB-CAP 67.77 0.6777 TABLETS Buyer Median Price/tab-cap=0.5502 High/Low Ratio=1.60 CALAMINE lotion (TOP) Price/ml E D02AB Supplier MEDS 1 BOTT (1000 ml) 3.02 0.0030 15% Supplier DURBIN 1 BOTT (200 ml) 1.02 0.0051 Supplier MEDEOR/TZ 1 BOTT (100 ml) 0.53 0.0053 Supplier IDA 1 BOTT (500 ml) 2.70 0.0054 Supplier UNFPA 1 BOTT (100 ml) 0.65 0.0065 Supplier MEG 1 BOTT (100 ml) 0.69 0.0069 5% Supplier JMS 1 BOTT (100 ml) 0.73 0.0073 WHO EML = <E>ssential, <C>omplementary, <P>resentation, <T>herapeutic group alternative, <N>ot on list *The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. DDDs have not been established for pediatric use. A-16 International Drug Price Indicator Guide, 2012 List I: Products Sorted Alphabetically ITEM DESCRIPTION PACKAGE UNIT DEFINED WHO ATC SOURCE PACKAGE PRICE (US$) PRICE (US$) COMMENTS DAILY DOSE* EML CODE CALAMINE lotion (TOP) Price/ml E D02AB Supplier MISSION 1 BOTT (100 ml) 1.15 0.0115 15% Supplier Median Price/ml=0.0060 High/Low Ratio=3.83 Buyer SAFRICA 1 BOTT (100 ml) 0.28 0.0028 Buyer NAMIBIA 1 BOTT (100 ml) 0.31 0.0031 Buyer MEMS 1 BOTT (100 ml) 0.40 0.0040 Buyer Median Price/ml=0.0031 High/Low Ratio=1.43 CALCITONIN (SEMI-SYNTHETIC SALMON) 100 IU/ml ampoule (INJ) Price/ml 100 U N H05BA01 Supplier UNFPA 10 AMP (1 ml) 17.00 1.7000 CALCIUM CHLORIDE 10% vial (INJ) Price/ml 0.2 g N A12AA07 Buyer NAMIBIA 10 VIAL (10 ml) 2.75 0.0275 Buyer SAFRICA 1 AMP (10 ml) 0.28 0.0280 Buyer Median Price/ml=0.0278 High/Low Ratio=1.02 CALCIUM FOLINATE 15 mg tab-cap (PO) Price/tab-cap 60 mg C V03AF03 Buyer NAMIBIA 100 TAB-CAP 19.44 0.1944 TABLETS Buyer SAFRICA 10 TAB-CAP 18.15 1.8150 TABLETS Buyer Median Price/tab-cap=1.0047 High/Low Ratio=9.34 CALCIUM FOLINATE 50 mg vial (INJ) Price/vial 60 mg P V03AF03 Buyer SAFRICA 1 VIAL 3.71 3.7100 POWDER CALCIUM GLUCONATE 100 mg/ml ampoule (INJ) Price/ml 3 g E A12AA03 Supplier UNFPA 20 AMP (10 ml) 3.56 0.0178 Supplier IDA 20 AMP (10 ml) 4.05 0.0202 Supplier DURBIN 100 AMP (10 ml) 21.90 0.0219 Supplier JMS 100 AMP (10 ml) 32.53 0.0325 Supplier MEDS 1 AMP (10 ml) 1.19 0.1193 10% Supplier Median Price/ml=0.0219 High/Low Ratio=6.70 Buyer GHANA 100 AMP (10 ml) 10.28 0.0103 10 X 10 Buyer OECS/PPS 20 VIAL (20 ml) 5.00 0.0125 Buyer PERU 1 AMP (10 ml) 0.22 0.0218 Buyer SAFRICA 1 AMP (10 ml) 0.53 0.0530 Buyer NAMIBIA 10 AMP (10 ml) 6.42 0.0642 Buyer MEMS 1 AMP (10 ml) 0.96 0.0960 Buyer Median Price/ml=0.0374 High/Low Ratio=9.34 CALCIUM LACTATE 250-300 mg tab-cap (PO) Price/tab-cap 2 g P A12AA05 Supplier JMS 1000 TAB-CAP 2.25 0.0023 300 MG TABLETS Supplier MEG 1000 TAB-CAP 2.79 0.0028 300 MG TABLETS Supplier MISSION 1000 TAB-CAP 5.74 0.0057 300 MG TABLETS Supplier DURBIN 1000 TAB-CAP 7.54 0.0075 300 MG TABLETS Supplier MEDEOR/EU 1000 TAB-CAP 9.27 0.0093 300 MG TABLETS Supplier UNFPA 1000 TAB-CAP 20.00 0.0200 300 MG TABLETS Supplier MEDEOR/TZ 1000 TAB-CAP 21.78 0.0218 300 MG TABLETS Supplier IDA 1000 TAB-CAP 21.97 0.0220 300 MG TABLET Supplier Median Price/tab-cap=0.0084 High/Low Ratio=9.57 Buyer NAMIBIA 500 TAB-CAP 2.31 0.0046 300 MG GLUCONATE TABLETS Buyer MEMS 1000 TAB-CAP 12.00 0.0120 300 MG TABLET Buyer Median Price/tab-cap=0.0083 High/Low Ratio=2.61 CALCIUM LACTATE 650 mg tab-cap (PO) Price/tab-cap 2 g P A12AA05 Buyer OECS/PPS 500 TAB-CAP 8.75 0.0175 600 MG TABLETS CAMPHOR 10% ointment (TOP) Price/g N M02AB Supplier MEDEOR/EU 15 TUBE (100 g) 27.11 0.0181 Supplier MEDEOR/TZ 1 TUBE (100 g) 2.36 0.0236 Supplier Median Price/g=0.0209 High/Low Ratio=1.30 CAPECITABINE 150 mg tab-cap (PO) Price/tab-cap N L01BC06 Buyer SAFRICA 60 TAB-CAP 51.09 0.8515 TABLETS CAPECITABINE 500 mg tab-cap (PO) Price/tab-cap N L01BC06 Buyer SAFRICA 120 TAB-CAP 343.73 2.8644 TABLETS Buyer NAMIBIA 120 TAB-CAP 354.34 2.9528 TABLETS Buyer SICA 100 TAB-CAP 383.30 3.8330 BLISTER PACK COATED TABLETS, ILLUSTRATIVE PACK SIZE Buyer Median Price/tab-cap=2.9528 High/Low Ratio=1.34 CAPREOMYCIN 1 g vial (INJ) Price/vial 1 g C J04AB30 Supplier GDF 1 VIAL 8.00 8.0000 POWDER FOR INJECTION WHO EML = <E>ssential, <C>omplementary, <P>resentation, <T>herapeutic group alternative, <N>ot on list *The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. DDDs have not been established for pediatric use. A-17 International Drug Price Indicator Guide, 2012 List I: Products Sorted Alphabetically ITEM DESCRIPTION PACKAGE UNIT DEFINED WHO ATC SOURCE PACKAGE PRICE (US$) PRICE (US$) COMMENTS DAILY DOSE* EML CODE CAPREOMYCIN 1 g vial (INJ) Price/vial 1 g C J04AB30 Buyer SAFRICA 1 VIAL 11.84 11.8400 10 ML CAPTOPRIL 12.5 mg tab-cap (PO) Price/tab-cap 50 mg T C09AA01 Buyer OECS/PPS 100 TAB-CAP 1.65 0.0165 TABLETS CAPTOPRIL 25 mg tab-cap (PO) Price/tab-cap 50 mg T C09AA01 Supplier MEDEOR/EU 4000 TAB-CAP 36.06 0.0090 SCORED TABLETS Supplier MEG 1000 TAB-CAP 12.45 0.0125 TABLETS Supplier IDA 100 TAB-CAP 1.28 0.0128 Supplier JMS 100 TAB-CAP 2.16 0.0216 TABLETS Supplier MISSION 100 TAB-CAP 2.28 0.0228 BLISTER PACK TABLETS, 10 X 10 Supplier DURBIN 56 TAB-CAP 2.04 0.0364 TABLETS Supplier MEDEOR/TZ 100 TAB-CAP 3.96 0.0396 TABLETS Supplier Median Price/tab-cap=0.0216 High/Low Ratio=4.40 Buyer PERU 100 TAB-CAP 0.57 0.0057 TABLETS, ILLUSTRATIVE PACK SIZE Buyer OECS/PPS 1000 TAB-CAP 8.70 0.0087 TABLETS Buyer SAFRICA 56 TAB-CAP 0.78 0.0139 TABLETS Buyer MEMS 100 TAB-CAP 3.21 0.0321 TABLET Buyer Median Price/tab-cap=0.0113 High/Low Ratio=5.63 CAPTOPRIL 50 mg tab-cap (PO) Price/tab-cap 50 mg T C09AA01 Supplier IDA 100 TAB-CAP 2.25 0.0225 Buyer DOMREPUB 1 TAB-CAP 0.01 0.0083 BLISTER PACK TABLETS CARBAMAZEPINE 100 mg/5 ml suspen (PO) Price/ml 1 g E N03AF01 Buyer OECS/PPS 1 BOTT (450 ml) 3.73 0.0083 Buyer NAMIBIA 1 BOTT (250 ml) 11.94 0.0478 Buyer Median Price/ml=0.0281 High/Low Ratio=5.76 CARBAMAZEPINE 200 mg tab-cap (PO) Price/tab-cap 1 g E N03AF01 Supplier MEG 1000 TAB-CAP 14.76 0.0148 TABLETS Supplier JMS 100 TAB-CAP 1.67 0.0167 TABLETS Supplier MEDS 1000 TAB-CAP 17.08 0.0171 TABLETS Supplier IDA 1000 TAB-CAP 17.28 0.0173 Supplier MEDEOR/EU 2500 TAB-CAP 45.78 0.0183 SCORED TABLETS Supplier DURBIN 1000 TAB-CAP 21.98 0.0220 TABLETS Supplier MISSION 1000 TAB-CAP 22.09 0.0221 TABLETS Supplier MEDEOR/TZ 1000 TAB-CAP 40.72 0.0407 TABLETS Supplier Median Price/tab-cap=0.0178 High/Low Ratio=2.75 Buyer DOMREPUB 1 TAB-CAP 0.01 0.0147 BLISTER PACK TABLETS Buyer PERU 100 TAB-CAP 1.75 0.0175 TABLET, ILLUSTRATIVE PACK SIZE Buyer SAFRICA 100 TAB-CAP 2.57 0.0257 TABLETS Buyer NAMIBIA 500 TAB-CAP 17.00 0.0340 TABLETS Buyer SICA 100 TAB-CAP 4.80 0.0480 TABLETS, ILLUSTRATIVE PACK SIZE Buyer MEMS 100 TAB-CAP 4.84 0.0484 TABLETS Buyer Median Price/tab-cap=0.0299 High/Low Ratio=3.29 CARBAMAZEPINE (SUSTAINED-RELEASE) 200 mg tab-cap (PO) Price/tab-cap 1 g E N03AF01 Buyer SAFRICA 28 TAB-CAP 2.52 0.0900 TABLETS Buyer OECS/PPS 20 TAB-CAP 3.39 0.1695 TABLETS Buyer Median Price/tab-cap=0.1298 High/Low Ratio=1.88 CARBAMAZEPINE (SUSTAINED-RELEASE) 400 mg tab-cap (PO) Price/tab-cap 1 g P N03AF01 Buyer SAFRICA 28 TAB-CAP 4.06 0.1450 TABLETS CARBIMAZOLE 5 mg tab-cap (PO) Price/tab-cap 15 mg N H03BB01 Supplier MEDS 100 TAB-CAP 2.11 0.0211 BLISTER PACK TABLETS Supplier IDA 1000 TAB-CAP 21.84 0.0218 Supplier JMS 100 TAB-CAP 7.91 0.0791 TABLETS Supplier DURBIN 100 TAB-CAP 9.26 0.0926 TABLETS Supplier Median Price/tab-cap=0.0505 High/Low Ratio=4.39 Buyer MEMS 100 TAB-CAP 5.35 0.0535 TABLETS Buyer NAMIBIA 100 TAB-CAP 7.36 0.0736 TABLETS Buyer OECS/PPS 100 TAB-CAP 7.80 0.0780 TABLETS Buyer Median Price/tab-cap=0.0736 High/Low Ratio=1.46 CARBOPLATIN 150 mg vial (INJ) Price/vial C L01XA02 Buyer SAFRICA 1 VIAL 10.10 10.1000 Buyer NAMIBIA 1 VIAL 16.45 16.4468 Buyer Median Price/vial=13.2734 High/Low Ratio=1.63 WHO EML = <E>ssential, <C>omplementary, <P>resentation, <T>herapeutic group alternative, <N>ot on list *The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. DDDs have not been established for pediatric use. A-18 International Drug Price Indicator Guide, 2012 List I: Products Sorted Alphabetically ITEM DESCRIPTION PACKAGE UNIT DEFINED WHO ATC SOURCE PACKAGE PRICE (US$) PRICE (US$) COMMENTS DAILY DOSE* EML CODE CARBOPLATIN 450 mg vial (INJ) Price/vial C L01XA02 Buyer SAFRICA 1 VIAL 29.71 29.7100 Buyer NAMIBIA 1 VIAL 39.72 39.7158 Buyer Median Price/vial=34.7129 High/Low Ratio=1.34 CARVEDILOL 12.5 mg tab-cap (PO) Price/tab-cap 37.5 mg T C07AG02 Buyer OECS/PPS 100 TAB-CAP 2.95 0.0295 TABLETS Buyer DOMREPUB 1 TAB-CAP 0.05 0.0491 BLISTER PACK TABLET Buyer SAFRICA 30 TAB-CAP 3.08 0.1027 TABLETS, SCORED IN QUARTERS Buyer Median Price/tab-cap=0.0491 High/Low Ratio=3.48 CARVEDILOL 25 mg tab-cap (PO) Price/tab-cap 37.5 mg T C07AG02 Buyer OECS/PPS 100 TAB-CAP 4.20 0.0420 TABLETS Buyer DOMREPUB 1 TAB-CAP 0.05 0.0539 BLISTER PACK TABLET Buyer SAFRICA 30 TAB-CAP 2.82 0.0940 TABLETS Buyer Median Price/tab-cap=0.0539 High/Low Ratio=2.24 CARVEDILOL 6.25 mg tab-cap (PO) Price/tab-cap 37.5 mg N C07AG02 Supplier MEDS 30 TAB-CAP 1.33 0.0445 TABLETS Buyer OECS/PPS 100 TAB-CAP 2.30 0.0230 TABLETS Buyer SAFRICA 30 TAB-CAP 1.95 0.0650 TABLETS Buyer SICA 100 TAB-CAP 11.90 0.1190 TABLETS, ILLUSTRATIVE PACK SIZE Buyer CRSS 100 TAB-CAP 17.85 0.1785 COATED TABLETS Buyer Median Price/tab-cap=0.0920 High/Low Ratio=7.76 CEFADROXIL MONOHYDRATE 500 mg tab-cap (PO) Price/tab-cap 2 g N J01DA09 Buyer DOMREPUB 1 TAB-CAP 0.06 0.0552 BLISTER PACK CAPSULES Buyer OECS/PPS 100 TAB-CAP 14.00 0.1400 CAPSULES Buyer Median Price/tab-cap=0.0976 High/Low Ratio=2.54 CEFALEXIN 125 mg/5 ml suspen (PO) Price/ml 2 g E J01DA01 Supplier UNFPA 1 BOTT (100 ml) 2.15 0.0215 POWDER Supplier DURBIN 1 BOTT (100 ml) 3.53 0.0353 SYRUP Supplier Median Price/ml=0.0284 High/Low Ratio=1.64 Buyer SAFRICA 1 BOTT (100 ml) 0.87 0.0087 GRANULES Buyer MEMS 1 BOTT (100 ml) 0.95 0.0095 Buyer Median Price/ml=0.0091 High/Low Ratio=1.09 CEFALEXIN 125 mg/ml suspen (PO) Price/ml 2 g P J01DA01 Supplier MEDS 1 BOTT (100 ml) 0.63 0.0063 CEFALEXIN 250 mg tab-cap (PO) Price/tab-cap 2 g E J01DA01 Supplier MEDS 100 TAB-CAP 3.35 0.0335 CAPSULES Supplier UNFPA 1000 TAB-CAP 40.00 0.0400 CAPSULES Supplier MEDEOR/EU 1000 TAB-CAP 46.61 0.0466 CAPSULES Supplier DURBIN 100 TAB-CAP 5.65 0.0565 CAPSULES Supplier MEDEOR/TZ 100 TAB-CAP 6.84 0.0684 CAPSULES Supplier Median Price/tab-cap=0.0466 High/Low Ratio=2.04 Buyer MEMS 100 TAB-CAP 4.32 0.0432 TABLETS Buyer SAFRICA 20 TAB-CAP 0.91 0.0455 Buyer Median Price/tab-cap=0.0444 High/Low Ratio=1.05 CEFALEXIN 250 mg/5 ml suspen (PO) Price/ml 2 g E J01DA01 Buyer DOMREPUB 1 BOTT (120 ml) 0.73 0.0061 Buyer SAFRICA 1 BOTT (100 ml) 1.08 0.0108 GRANULES Buyer Median Price/ml=0.0085 High/Low Ratio=1.77 CEFALEXIN 500 mg tab-cap (PO) Price/tab-cap 2 g P J01DA01 Supplier IDA 100 TAB-CAP 5.91 0.0591 Supplier MEDS 100 TAB-CAP 6.90 0.0690 CAPSULES Supplier MISSION 100 TAB-CAP 7.61 0.0761 CAPSULES Supplier UNFPA 500 TAB-CAP 40.00 0.0800 CAPSULES Supplier DURBIN 100 TAB-CAP 10.36 0.1036 CAPSULES Supplier Median Price/tab-cap=0.0761 High/Low Ratio=1.75 Buyer DOMREPUB 1 TAB-CAP 0.04 0.0352 BLISTER PACK CAPSULES Buyer PERU 100 TAB-CAP 5.13 0.0513 TABLETS, ILLUSTRATIVE PACK SIZE Buyer SAFRICA 100 TAB-CAP 9.22 0.0922 Buyer Median Price/tab-cap=0.0513 High/Low Ratio=2.62 CEFAZOLIN 1 g vial (INJ) Price/vial 3 g E J01DA04 Supplier UNFPA 1 VIAL 1.60 1.6000 WHO EML = <E>ssential, <C>omplementary, <P>resentation, <T>herapeutic group alternative, <N>ot on list *The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. DDDs have not been established for pediatric use. A-19 International Drug Price Indicator Guide, 2012 List I: Products Sorted Alphabetically ITEM DESCRIPTION PACKAGE UNIT DEFINED WHO ATC SOURCE PACKAGE PRICE (US$) PRICE (US$) COMMENTS DAILY DOSE* EML CODE CEFAZOLIN 1 g vial (INJ) Price/vial 3 g E J01DA04 Buyer SAFRICA 1 VIAL 0.57 0.5700 POWDER CEFAZOLIN 500 mg ampoule (INJ) Price/vial 3 g P J01DA04 Buyer SAFRICA 1 VIAL 0.37 0.3700 POWDER Buyer OECS/PPS 1 VIAL 0.56 0.5600 Buyer Median Price/vial=0.4650 High/Low Ratio=1.51 CEFEPIME 1 g vial (INJ) Price/vial 2 g T J01DA24 Buyer DOMREPUB 1 VIAL 1.10 1.0988 Buyer SAFRICA 1 VIAL 2.92 2.9200 Buyer Median Price/vial=2.0094 High/Low Ratio=2.66 CEFIXIME 200 mg tab-cap (PO) Price/tab-cap 0.4 g P J01DA23 Supplier MEG 100 TAB-CAP 15.11 0.1511 25 X 4 BLISTER PACK TABLETS Supplier IDA 100 TAB-CAP 19.21 0.1921 Supplier MISSION 10 TAB-CAP 3.17 0.3165 TABLETS Supplier Median Price/tab-cap=0.1921 High/Low Ratio=2.09 Buyer SUDANNHIF 1 TAB-CAP 0.29 0.2929 CAPSULES CEFIXIME 400 mg tab-cap (PO) Price/tab-cap 0.4 g E J01DA23 Supplier IDA 100 TAB-CAP 26.66 0.2666 Supplier UNFPA 10 TAB-CAP 4.00 0.4000 FILM-COATED, BLISTER-PACK TABLETS Supplier Median Price/tab-cap=0.3333 High/Low Ratio=1.50 Buyer SAFRICA 100 TAB-CAP 248.69 2.4869 TABLET, PATIENT-READY PACK CEFOTAXIME 1 g vial (INJ) Price/vial 4 g CP J01DA10 Supplier IDA 1 VIAL 4.56 4.5617 Buyer DOMREPUB 1 VIAL 0.24 0.2391 Buyer SAFRICA 1 VIAL 0.45 0.4500 POWDER Buyer OECS/PPS 1 VIAL 0.85 0.8500 Buyer MEMS 1 VIAL 1.02 1.0200 Buyer Median Price/vial=0.6500 High/Low Ratio=4.27 CEFOTAXIME 500 mg vial (INJ) Price/vial 4 g CP J01DA10 Buyer SAFRICA 1 VIAL 0.33 0.3300 POWDER Buyer GHANA 10 VIAL 4.08 0.4080 POWDER Buyer Median Price/vial=0.3690 High/Low Ratio=1.24 CEFOXITIN 1 g vial (INJ) Price/vial 6 g N J01DC01 Buyer SAFRICA 1 VIAL 2.93 2.9300 POWDER CEFTAZIDIME 1 g vial (INJ) Price/vial 4 g P J01DA11 Supplier MEDS 1 VIAL 4.00 4.0014 Buyer OECS/PPS 1 VIAL 1.20 1.2000 Buyer CRSS 1 VIAL 1.28 1.2800 Buyer SAFRICA 1 VIAL 4.68 4.6800 POWDER Buyer Median Price/vial=1.2800 High/Low Ratio=3.90 CEFTAZIDIME 250 mg vial (INJ) Price/vial 4 g C J01DD02 Supplier MEDS 1 VIAL 2.28 2.2815 CEFTAZIDIME 30 mcg disc (DIAG) Price/each N V07AR Supplier UNFPA 250 DISC (1 EACH) 12.50 0.0500 5 X 50 DISCS CEFTRIAXONE 1 g vial (INJ) Price/vial 2 g E J01DA13 Supplier UNFPA 1 VIAL 0.38 0.3800 Supplier MEG 50 VIAL 20.20 0.4040 POWDER Supplier IDA 10 VIAL 4.88 0.4883 Supplier MEDS 1 VIAL 0.54 0.5382 IV/IM Supplier MEDEOR/TZ 1 VIAL 0.87 0.8700 POWDER Supplier MISSION 1 VIAL 0.87 0.8735 WITH SOLVENT Supplier DURBIN 10 VIAL 14.05 1.4052 POWDER, SODIUM SALT Supplier MEDEOR/EU 10 VIAL 15.34 1.5344 POWDER Supplier Median Price/vial=0.7041 High/Low Ratio=4.04 Buyer DOMREPUB 1 VIAL 0.22 0.2247 Buyer SAFRICA 1 VIAL 0.48 0.4800 POWDER Buyer MEMS 1 VIAL 0.57 0.5700 WHO EML = <E>ssential, <C>omplementary, <P>resentation, <T>herapeutic group alternative, <N>ot on list *The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. DDDs have not been established for pediatric use. A-20 International Drug Price Indicator Guide, 2012 List I: Products Sorted Alphabetically ITEM DESCRIPTION PACKAGE UNIT DEFINED WHO ATC SOURCE PACKAGE PRICE (US$) PRICE (US$) COMMENTS DAILY DOSE* EML CODE CEFTRIAXONE 1 g vial (INJ) Price/vial 2 g E J01DA13 Buyer NAMIBIA 1 VIAL 0.67 0.6668 Buyer OECS/PPS 1 VIAL 0.73 0.7300 Buyer GHANA 1 VIAL 4.85 4.8500 POWDER Buyer Median Price/vial=0.6184 High/Low Ratio=21.58 CEFTRIAXONE 250 mg vial (INJ) Price/vial 2 g E J01DA13 Supplier UNFPA 1 VIAL 0.17 0.1700 Supplier MEG 50 VIAL 10.44 0.2088 POWDER Supplier MISSION 1 VIAL 0.47 0.4684 WITH SOLVENT Supplier IDA 10 VIAL 5.33 0.5333 Supplier MEDS 1 VIAL 0.68 0.6786 IV/IM Supplier MEDEOR/TZ 1 VIAL 0.68 0.6810 Supplier Median Price/vial=0.5009 High/Low Ratio=4.01 Buyer SAFRICA 1 VIAL 0.29 0.2900 POWDER Buyer GHANA 10 VIAL 3.43 0.3430 POWDER Buyer NAMIBIA 1 VIAL 0.40 0.3967 Buyer MEMS 1 VIAL 0.42 0.4200 Buyer OECS/PPS 1 AMP (1 VIAL) 1.13 1.1300 Buyer Median Price/vial=0.3967 High/Low Ratio=3.90 CEFTRIAXONE 30 mcg disc (DIAG) Price/each N V07AR Supplier UNFPA 250 DISC (1 EACH) 12.50 0.0500 5 X 50 DISCS CEFTRIAXONE 500 mg vial (INJ) Price/vial 2 g P J01DA13 Supplier IDA 10 VIAL 6.04 0.6039 Supplier MISSION 1 VIAL 0.67 0.6710 W/ SOLVENT Supplier DURBIN 10 VIAL 14.05 1.4052 Supplier MEDS 1 VIAL 1.56 1.5561 IV Supplier Median Price/vial=1.0381 High/Low Ratio=2.58 Buyer SAFRICA 1 VIAL 0.42 0.4200 POWDER Buyer GHANA 1 VIAL 0.52 0.5200 POWDER Buyer Median Price/vial=0.4700 High/Low Ratio=1.24 CEFUROXIME 1.5 g vial (INJ) Price/vial 3 g N J01DA06 Buyer GHANA 10 VIAL 9.31 0.9310 POWDER Buyer OECS/PPS 1 VIAL 2.41 2.4100 Buyer Median Price/vial=1.6705 High/Low Ratio=2.59 CEFUROXIME 125 mg/5 ml suspen (PO) Price/ml 0.5 g N J01DA06 Supplier MEDS 1 BOTT (50 ml) 1.51 0.0302 Buyer GHANA 1 BOTT (100 ml) 1.38 0.0138 Buyer SAFRICA 1 BOTT (100 ml) 7.22 0.0722 GRANULES Buyer NAMIBIA 1 BOTT (100 ml) 9.26 0.0926 Buyer OECS/PPS 1 BOTT (70 ml) 7.09 0.1013 Buyer Median Price/ml=0.0824 High/Low Ratio=7.34 CEFUROXIME 250 mg tab-cap (PO) Price/tab-cap 0.5 g N J01DA06 Supplier MEDS 10 TAB-CAP 1.79 0.1790 TABLETS Buyer GHANA 10 TAB-CAP 1.15 0.1150 1 X 10 BLISTER PACK TABLETS Buyer OECS/PPS 100 TAB-CAP 18.00 0.1800 TABLETS Buyer NAMIBIA 10 TAB-CAP 1.81 0.1814 TABLETS Buyer SAFRICA 10 TAB-CAP 1.95 0.1950 TABLETS Buyer Median Price/tab-cap=0.1807 High/Low Ratio=1.70 CEFUROXIME 250 mg vial (INJ) Price/vial 3 g N J01DA06 Buyer SAFRICA 1 VIAL 0.63 0.6300 POWDER CEFUROXIME 500 mg tab-cap (PO) Price/tab-cap 0.5 g N J01DC02 Supplier MEDS 10 TAB-CAP 3.07 0.3065 TABLETS Supplier UNFPA 10 TAB-CAP 4.50 0.4500 AXETIL, TABLETS Supplier Median Price/tab-cap=0.3783 High/Low Ratio=1.47 Buyer SAFRICA 10 TAB-CAP 3.62 0.3620 TABLETS Buyer GHANA 10 TAB-CAP 4.50 0.4500 1 X 10 BLISTER PACK TABLETS Buyer PERU 1 TAB-CAP 0.46 0.4613 TABLET Buyer Median Price/tab-cap=0.4500 High/Low Ratio=1.27 CEFUROXIME 750 mg vial (INJ) Price/vial 3 g N J01DA06 Supplier MEDS 1 VIAL 0.80 0.7956 WHO EML = <E>ssential, <C>omplementary, <P>resentation, <T>herapeutic group alternative, <N>ot on list *The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. DDDs have not been established for pediatric use. A-21 International Drug Price Indicator Guide, 2012 List I: Products Sorted Alphabetically ITEM DESCRIPTION PACKAGE UNIT DEFINED WHO ATC SOURCE PACKAGE PRICE (US$) PRICE (US$) COMMENTS DAILY DOSE* EML CODE CEFUROXIME 750 mg vial (INJ) Price/vial 3 g N J01DA06 Supplier DURBIN 10 VIAL 16.09 1.6093 POWDER Supplier Median Price/vial=1.2025 High/Low Ratio=2.02 Buyer NAMIBIA 10 VIAL 6.23 0.6226 Buyer GHANA 10 VIAL 6.50 0.6500 POWDER Buyer OECS/PPS 1 VIAL 1.08 1.0800 Buyer SAFRICA 1 VIAL 1.12 1.1200 POWDER Buyer SUDANNHIF 1 VIAL 2.22 2.2248 Buyer Median Price/vial=1.0800 High/Low Ratio=3.57 CETIRIZINE 10 mg tab-cap (PO) Price/tab-cap 10 mg N R06AE07 Supplier MEDS 100 TAB-CAP 0.78 0.0078 TABLETS Supplier JMS 100 TAB-CAP 1.10 0.0110 TABLETS Supplier MEDEOR/TZ 100 TAB-CAP 1.19 0.0119 TABLETS Supplier IDA 30 TAB-CAP 0.77 0.0257 Supplier Median Price/tab-cap=0.0115 High/Low Ratio=3.29 Buyer GHANA 100 TAB-CAP 0.39 0.0039 10 X 10 BLISTER PACK TABLETS Buyer DOMREPUB 1 TAB-CAP 0.00 0.0043 TABLET Buyer SAFRICA 30 TAB-CAP 0.52 0.0173 TABLETS Buyer Median Price/tab-cap=0.0043 High/Low Ratio=4.44 CETIRIZINE 5 mg/5 ml syrup (PO) Price/ml 10 mg N R06AE07 Supplier MEDEOR/TZ 1 BOTT (100 ml) 0.55 0.0055 Supplier MEDS 1 BOTT (60 ml) 0.35 0.0059 Supplier Median Price/ml=0.0057 High/Low Ratio=1.07 Buyer GHANA 1 BOTT (200 ml) 0.16 0.0008 Buyer SAFRICA 1 BOTT (150 ml) 1.19 0.0079 Buyer Median Price/ml=0.0044 High/Low Ratio=9.91 CETRIMIDE+CHLORHEXIDINE GLUCONATE 15%+1.5% solution (TOP) Price/ml P D08AC52 Supplier MEDS 1 BOTT (5000 ml) 14.39 0.0029 Supplier MEDEOR/TZ 1 BOTT (5000 ml) 18.00 0.0036 1 JERRYCAN Supplier MISSION 1 BOTT (5000 ml) 20.89 0.0042 Supplier MEG 1 BOTT (1000 ml) 4.27 0.0043 DI-GLUCONATE Supplier IDA 10 BOTT (1000 ml) 46.77 0.0047 Supplier DURBIN 1 BOTT (1000 ml) 4.95 0.0049 CONCENTRATE Supplier JMS 1 BOTT (1000 ml) 4.95 0.0050 Supplier MISSION 1 BOTT (1000 ml) 6.17 0.0062 Supplier MEDEOR/EU 1 BOTT (1000 ml) 7.42 0.0074 Supplier Median Price/ml=0.0047 High/Low Ratio=2.55 Buyer SAFRICA 1 BOTT (5000 ml) 24.12 0.0048 Buyer OECS/PPS 1 BOTT (5000 ml) 33.15 0.0066 Buyer Median Price/ml=0.0057 High/Low Ratio=1.37 CHARCOAL, ACTIVATED 125 mg tab-cap (PO) Price/tab-cap 5 g P A07BA01 Supplier MISSION 1000 TAB-CAP 8.74 0.0087 TABLETS Supplier MEG 1000 TAB-CAP 13.50 0.0135 TABLETS Supplier IDA 1000 TAB-CAP 13.75 0.0137 Supplier Median Price/tab-cap=0.0135 High/Low Ratio=1.57 CHARCOAL, ACTIVATED 250 mg tab-cap (PO) Price/tab-cap 5 g P A07BA01 Supplier JMS 100 TAB-CAP 2.48 0.0248 TABLETS CHLORAMBUCIL 2 mg tab-cap (PO) Price/tab-cap C L01AA02 Buyer CRSS 100 TAB-CAP 64.50 0.6450 COATED TABLETS Buyer NAMIBIA 25 TAB-CAP 20.81 0.8325 TABLETS Buyer SAFRICA 25 TAB-CAP 29.18 1.1672 TABLETS Buyer Median Price/tab-cap=0.8325 High/Low Ratio=1.81 CHLORAMINE 500 mg tab-cap (TOP) Price/tab-cap N Supplier IDA 1000 TAB-CAP 14.58 0.0146 Supplier MISSION 1000 TAB-CAP 18.84 0.0188 TABLETS Supplier Median Price/tab-cap=0.0167 High/Low Ratio=1.29 CHLORAMPHENICOL 0.5% opht drop (OPHT) Price/ml P S01AA01 Supplier MEDS 1 BOTT (10 ml) 0.20 0.0199 Supplier MEDEOR/TZ 1 BOTT (5 ml) 0.22 0.0444 Supplier MEG 25 BOTT (10 ml) 14.61 0.0584 Supplier DURBIN 1 BOTT (10 ml) 0.86 0.0864 Supplier IDA 1 BOTT (10 ml) 2.51 0.2506 Supplier Median Price/ml=0.0584 High/Low Ratio=12.59 Buyer MEMS 1 BOTT (10 ml) 0.19 0.0186 WHO EML = <E>ssential, <C>omplementary, <P>resentation, <T>herapeutic group alternative, <N>ot on list *The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. DDDs have not been established for pediatric use. A-22 International Drug Price Indicator Guide, 2012 List I: Products Sorted Alphabetically ITEM DESCRIPTION PACKAGE UNIT DEFINED WHO ATC SOURCE PACKAGE PRICE (US$) PRICE (US$) COMMENTS DAILY DOSE* EML CODE CHLORAMPHENICOL 0.5% opht drop (OPHT) Price/ml P S01AA01 Buyer GHANA 10 BOTT (5 ml) 1.40 0.0280 Buyer OECS/PPS 1 BOTT (10 ml) 0.95 0.0950 Buyer NAMIBIA 1 BOTT (10 ml) 1.76 0.1757 Buyer SAFRICA 1 BOTT (10 ml) 2.33 0.2330 Buyer Median Price/ml=0.0950 High/Low Ratio=12.53 CHLORAMPHENICOL 1% opht oint (OPHT) Price/g P S01AA01 Supplier MEG 50 TUBE (5 g) 9.55 0.0382 Supplier DURBIN 50 TUBE (5 g) 11.38 0.0455 Supplier MEDEOR/TZ 1 TUBE (3.50 g) 0.18 0.0514 Supplier MISSION 50 TUBE (5 g) 15.51 0.0620 Supplier MEDEOR/EU 50 TUBE (5 g) 47.31 0.1892 Supplier Median Price/g=0.0514 High/Low Ratio=4.95 Buyer GHANA 10 TUBE (5 g) 2.00 0.0400 Buyer MEMS 1 TUBE (3.50 g) 0.20 0.0583 Buyer SAFRICA 1 TUBE (3.50 g) 0.90 0.2571 Buyer NAMIBIA 1 TUBE (3.50 g) 1.19 0.3397 Buyer OECS/PPS 1 TUBE (4 g) 1.95 0.4875 Buyer Median Price/g=0.2571 High/Low Ratio=12.19 CHLORAMPHENICOL 10 mcg disc (DIAG) Price/each N V07AR Supplier JMS 100 DISC (1 EACH) 5.87 0.0587 CHLORAMPHENICOL 125 mg/5 ml suspen (PO) Price/ml 3 g P J01BA01 Supplier UNFPA 25 BOTT (100 ml) 7.00 0.0028 POWDER Supplier MEDS 1 BOTT (100 ml) 0.49 0.0049 Supplier JMS 1 BOTT (100 ml) 0.56 0.0056 Supplier MEDEOR/TZ 1 BOTT (100 ml) 0.79 0.0079 Supplier DURBIN 1 BOTT (100 ml) 0.88 0.0088 PALMITATE Supplier IDA 1 BOTT (100 ml) 1.35 0.0135 Supplier MEG 1 BOTT (100 ml) 1.58 0.0158 POWDER Supplier MISSION 1 BOTT (100 ml) 1.71 0.0171 Supplier MEDEOR/EU 10 BOTT (60 ml) 11.96 0.0199 PALMITATE Supplier Median Price/ml=0.0088 High/Low Ratio=7.11 Buyer MEMS 1 BOTT (100 ml) 0.60 0.0060 Buyer GHANA 10 BOTT (100 ml) 6.70 0.0067 PALMITATE Buyer NAMIBIA 1 BOTT (100 ml) 1.75 0.0175 PALMITATE Buyer Median Price/ml=0.0067 High/Low Ratio=2.92 CHLORAMPHENICOL 250 mg tab-cap (PO) Price/tab-cap 3 g E J01BA01 Supplier UNFPA 1000 TAB-CAP 12.00 0.0120 CAPSULES Supplier MEG 1000 TAB-CAP 17.50 0.0175 CAPSULES Supplier DURBIN 1000 TAB-CAP 18.53 0.0185 CAPSULES Supplier JMS 1000 TAB-CAP 19.04 0.0190 CAPSULES Supplier MEDEOR/TZ 1000 TAB-CAP 22.20 0.0222 CAPSULES Supplier IDA 1000 TAB-CAP 29.55 0.0296 CAPSULES Supplier MISSION 1000 TAB-CAP 29.75 0.0298 CAPSULES Supplier Median Price/tab-cap=0.0190 High/Low Ratio=2.48 Buyer MEMS 1000 TAB-CAP 16.50 0.0165 CAPSULES Buyer GHANA 100 TAB-CAP 2.55 0.0255 10 X 10 BLISTER PACK TABLETS Buyer NAMIBIA 1000 TAB-CAP 46.41 0.0464 CAPSULES Buyer Median Price/tab-cap=0.0255 High/Low Ratio=2.81 CHLORAMPHENICOL 30 mcg disc (DIAG) Price/each N V07AR Supplier UNFPA 250 DISC (1 EACH) 12.50 0.0500 5 X 50 DISCS CHLORAMPHENICOL 5% otic drop (OTIC) Price/ml P S02AA01 Buyer MEMS 1 BOTT (10 ml) 0.32 0.0324 Buyer OECS/PPS 1 BOTT (10 ml) 2.04 0.2040 Buyer Median Price/ml=0.1182 High/Low Ratio=6.30 CHLORAMPHENICOL 500 mg tab-cap (PO) Price/tab-cap 3 g P J01BA01 Buyer DOMREPUB 1 TAB-CAP 0.02 0.0215 BLISTER PACK CAPSULES CHLORAMPHENICOL (BASE) 1 g vial (INJ) Price/vial 3 g E J01BA01 Supplier MEG 50 VIAL 17.90 0.3580 SODIUM SUCCINATE Supplier UNFPA 50 VIAL 18.00 0.3600 Supplier DURBIN 50 VIAL 22.92 0.4584 POWDER, SODIUM SUCCINATE Supplier MISSION 50 VIAL 23.59 0.4717 SODIUM SUCCINATE Supplier MEDEOR/TZ 50 VIAL 23.87 0.4774 POWDER WHO EML = <E>ssential, <C>omplementary, <P>resentation, <T>herapeutic group alternative, <N>ot on list *The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. DDDs have not been established for pediatric use. A-23 International Drug Price Indicator Guide, 2012 List I: Products Sorted Alphabetically ITEM DESCRIPTION PACKAGE UNIT DEFINED WHO ATC SOURCE PACKAGE PRICE (US$) PRICE (US$) COMMENTS DAILY DOSE* EML CODE CHLORAMPHENICOL (BASE) 1 g vial (INJ) Price/vial 3 g E J01BA01 Supplier MEDS 1 VIAL 0.49 0.4914 Supplier IDA 50 VIAL 27.11 0.5423 Supplier Median Price/vial=0.4717 High/Low Ratio=1.51 Buyer GHANA 10 VIAL 2.77 0.2770 POWDER Buyer DOMREPUB 1 VIAL 0.28 0.2780 Buyer MEMS 1 VIAL 0.49 0.4860 POWDER Buyer NAMIBIA 50 VIAL 26.28 0.5257 POWDER Buyer OECS/PPS 1 VIAL 1.00 1.0000 Buyer Median Price/vial=0.4860 High/Low Ratio=3.61 CHLORAMPHENICOL IN OIL 250 mg/ml ampoule (INJ) Price/ml 3 g E J01BA01 Buyer GHANA 10 AMP (2 ml) 57.50 2.8750 CHLORAMPHENICOL+DEXAMETHASONE 0.5%+0.1% opht drop (OPHT) Price/ml N S01AA20 Supplier MEDEOR/TZ 1 BOTT (5 ml) 0.58 0.1164 Buyer SAFRICA 1 BOTT (5 ml) 1.32 0.2640 CHLORHEXIDINE 1% cream (TOP) Price/g P D08AC02 Supplier DURBIN 10 TUBE (50 g) 15.07 0.0301 Buyer SAFRICA 1 TUBE (50 g) 1.68 0.0336 CHLORHEXIDINE GLUCONATE 20% solution (TOP) Price/ml P D08AC02 Supplier MISSION 1 BOTT (5000 ml) 23.55 0.0047 Supplier IDA 1 BOTT (5000 ml) 46.32 0.0093 Supplier MEDEOR/EU 1 BOTT (5000 ml) 59.78 0.0120 Supplier Median Price/ml=0.0093 High/Low Ratio=2.55 Buyer SAFRICA 1 BOTT (500 ml) 8.41 0.0168 Buyer NAMIBIA 1 BOTT (500 ml) 8.60 0.0172 Buyer Median Price/ml=0.0170 High/Low Ratio=1.02 CHLORHEXIDINE GLUCONATE 5% solution (TOP) Price/ml E D08AC02 Supplier MEDS 1 BOTT (5000 ml) 13.81 0.0028 Supplier UNFPA 1 BOTT (1000 ml) 2.95 0.0030 DI-GLUCONATE Supplier MEG 1 BOTT (1000 ml) 3.55 0.0036 Supplier IDA 1 BOTT (1000 ml) 4.24 0.0042 Supplier MISSION 1 BOTT (1000 ml) 5.13 0.0051 Supplier DURBIN 1 BOTT (1000 ml) 5.42 0.0054 DIGLUCONATE Supplier Median Price/ml=0.0039 High/Low Ratio=1.93 Buyer NAMIBIA 1 BOTT (5000 ml) 20.61 0.0041 Buyer SAFRICA 1 BOTT (5000 ml) 21.54 0.0043 Buyer OECS/PPS 1 BOTT (5000 ml) 38.60 0.0077 4% W/V Buyer Median Price/ml=0.0043 High/Low Ratio=1.88 CHLORHEXIDINE SURGICAL SCRUB 4% liquid (TOP) Price/ml P D08AC02 Supplier UNFPA 1 BOTT (500 ml) 2.25 0.0045 Buyer SAFRICA 5 LITER (1000 ml) 17.93 0.0036 DRUM Buyer NAMIBIA 20 BOTT (1000 ml) 77.24 0.0039 Buyer Median Price/ml=0.0037 High/Low Ratio=1.09 CHLOROQUINE (BASE) 100 mg tab-cap (PO) Price/tab-cap 0.5 g E P01BA01 Supplier MEDEOR/EU 3500 TAB-CAP 27.11 0.0077 TABLETS CHLOROQUINE (BASE) 150 mg tab-cap (PO) Price/tab-cap 0.5 g E P01BA01 Supplier UNFPA 1000 TAB-CAP 8.00 0.0080 TABLETS, PHOSPHATE Supplier DURBIN 1000 TAB-CAP 10.60 0.0106 TABLETS, PHOSPHATE Supplier MEG 1000 TAB-CAP 10.80 0.0108 TABLETS Supplier IDA 1000 TAB-CAP 13.11 0.0131 TABLETS Supplier Median Price/tab-cap=0.0107 High/Low Ratio=1.64 Buyer OECS/PPS 1000 TAB-CAP 29.70 0.0297 SULFATE TABLETS Buyer SAFRICA 100 TAB-CAP 5.17 0.0517 TABLETS Buyer Median Price/tab-cap=0.0407 High/Low Ratio=1.74 CHLOROQUINE (BASE) 40 mg/ml ampoule (INJ) Price/ml 0.5 g P P01BA01 Supplier DURBIN 100 AMP (5 ml) 16.09 0.0322 WHO EML = <E>ssential, <C>omplementary, <P>resentation, <T>herapeutic group alternative, <N>ot on list *The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. DDDs have not been established for pediatric use. A-24 International Drug Price Indicator Guide, 2012 List I: Products Sorted Alphabetically ITEM DESCRIPTION PACKAGE UNIT DEFINED WHO ATC SOURCE PACKAGE PRICE (US$) PRICE (US$) COMMENTS DAILY DOSE* EML CODE CHLOROQUINE (BASE) 50 mg/5 ml syrup (PO) Price/ml 0.5 g E P01BA01 Supplier UNFPA 10 BOTT (60 ml) 4.00 0.0067 PHOSPHATE Supplier IDA 195 BOTT (60 ml) 114.24 0.0098 Supplier DURBIN 1 BOTT (100 ml) 1.41 0.0141 Supplier MEG 1 BOTT (60 ml) 0.85 0.0142 Supplier MEDEOR/EU 12 BOTT (60 ml) 13.11 0.0182 Supplier Median Price/ml=0.0141 High/Low Ratio=2.72 Buyer SAFRICA 1 BOTT (100 ml) 3.02 0.0302 CHLOROXYLENOL 4.8% solution (N/A) Price/ml E D08AE05 Supplier MEDEOR/TZ 1 BOTT (5000 ml) 10.08 0.0020 1 JERRYCAN Supplier UNFPA 1 BOTT (5000 ml) 18.00 0.0036 Supplier IDA 1 BOTT (1000 ml) 14.65 0.0146 Supplier Median Price/ml=0.0036 High/Low Ratio=7.30 Buyer MEMS 1 BOTT (5000 ml) 15.60 0.0031 5% CHLORPHENAMINE MALEATE 10 mg/ml ampoule (INJ) Price/ml 12 mg E R06AB04 Supplier IDA 100 AMP (1 ml) 7.58 0.0758 Supplier MISSION 100 AMP (1 ml) 9.13 0.0913 Supplier DURBIN 100 AMP (1 ml) 14.84 0.1484 Supplier Median Price/ml=0.0913 High/Low Ratio=1.96 Buyer DOMREPUB 1 AMP (1 ml) 0.03 0.0339 Buyer OECS/PPS 100 AMP (2 ml) 37.70 0.1885 IV/IM/SC Buyer Median Price/ml=0.1112 High/Low Ratio=5.56 CHLORPHENAMINE MALEATE 2 mg/5 ml elixir (PO) Price/ml 6 mg P R06AB02 Supplier MEDS 1 BOTT (5000 ml) 2.28 0.0005 SYRUP Buyer PERU 100 BOTT (120 ml) 26.02 0.0022 ILLUSTRATIVE NUMBER OF BOTTLES Buyer OECS/PPS 1 BOTT (2000 ml) 5.82 0.0029 Buyer MEMS 1 BOTT (100 ml) 0.33 0.0033 Buyer GHANA 1 BOTT (100 ml) 0.42 0.0042 Buyer SAFRICA 1 BOTT (50 ml) 0.21 0.0042 Buyer NAMIBIA 1 BOTT (100 ml) 0.67 0.0067 SYRUP Buyer Median Price/ml=0.0038 High/Low Ratio=3.05 CHLORPHENAMINE MALEATE 4 mg tab-cap (PO) Price/tab-cap 12 mg E R06AB04 Supplier JMS 1000 TAB-CAP 0.69 0.0007 TABLETS Supplier MEDS 1000 TAB-CAP 0.77 0.0008 TABLETS Supplier MEDEOR/TZ 1000 TAB-CAP 1.15 0.0011 TABLETS Supplier UNFPA 1000 TAB-CAP 1.41 0.0014 TABLETS Supplier IDA 1000 TAB-CAP 2.06 0.0021 TABLETS Supplier MEG 1000 TAB-CAP 2.44 0.0024 TABLETS Supplier DURBIN 1000 TAB-CAP 4.08 0.0041 HYDROGEN, TABLETS Supplier MISSION 1000 TAB-CAP 4.33 0.0043 TABLETS Supplier Median Price/tab-cap=0.0018 High/Low Ratio=6.14 Buyer MEMS 1000 TAB-CAP 0.99 0.0010 TABLETS Buyer SAFRICA 1000 TAB-CAP 3.22 0.0032 TABLETS Buyer OECS/PPS 1000 TAB-CAP 3.50 0.0035 TABLETS Buyer GHANA 1000 TAB-CAP 3.78 0.0038 10 X 100 BLISTER PACK TABLETS Buyer PERU 100 TAB-CAP 0.52 0.0052 TABLETS, ILLUSTRATIVE PACK SIZE Buyer NAMIBIA 100 TAB-CAP 0.93 0.0093 TABLETS Buyer CRSS 100 TAB-CAP 3.07 0.0307 TABLETS Buyer Median Price/tab-cap=0.0038 High/Low Ratio=30.70 CHLORPROMAZINE HCL 100 mg tab-cap (PO) Price/tab-cap 0.3 g C N05AA01 Supplier DURBIN 1000 TAB-CAP 10.99 0.0110 TABLETS Supplier MEDS 1000 TAB-CAP 11.23 0.0112 TABLETS Supplier MEDEOR/EU 2000 TAB-CAP 30.18 0.0151 TABLETS Supplier IDA 1000 TAB-CAP 15.81 0.0158 COATED TABLETS Supplier MEG 1000 TAB-CAP 18.10 0.0181 TABLETS Supplier JMS 1000 TAB-CAP 23.87 0.0239 TABLETS Supplier MISSION 1000 TAB-CAP 28.48 0.0285 COATED TABLETS Supplier MEDEOR/TZ 1000 TAB-CAP 34.02 0.0340 TABLETS Supplier Median Price/tab-cap=0.0170 High/Low Ratio=3.09 Buyer MEMS 1000 TAB-CAP 15.75 0.0158 TABLETS Buyer OECS/PPS 1000 TAB-CAP 19.00 0.0190 TABLETS Buyer CRSS 100 TAB-CAP 1.92 0.0192 Buyer PERU 100 TAB-CAP 2.25 0.0225 TABLETS, ILLUSTRATIVE PACK SIZE Buyer SAFRICA 84 TAB-CAP 5.51 0.0656 TABLETS IN A PATIENT-READY PACK Buyer Median Price/tab-cap=0.0192 High/Low Ratio=4.15 WHO EML = <E>ssential, <C>omplementary, <P>resentation, <T>herapeutic group alternative, <N>ot on list *The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. DDDs have not been established for pediatric use. A-25 International Drug Price Indicator Guide, 2012 List I: Products Sorted Alphabetically ITEM DESCRIPTION PACKAGE UNIT DEFINED WHO ATC SOURCE PACKAGE PRICE (US$) PRICE (US$) COMMENTS DAILY DOSE* EML CODE CHLORPROMAZINE HCL 25 mg tab-cap (PO) Price/tab-cap 0.3 g C N05AA01 Supplier MEDS 1000 TAB-CAP 5.02 0.0050 TABLETS Supplier DURBIN 1000 TAB-CAP 6.20 0.0062 TABLETS Supplier IDA 1000 TAB-CAP 6.36 0.0064 COATED TABLETS Supplier MEG 1000 TAB-CAP 7.50 0.0075 TABLETS Supplier JMS 1000 TAB-CAP 7.67 0.0077 TABLETS Supplier MISSION 1000 TAB-CAP 13.04 0.0130 COATED TABLETS Supplier Median Price/tab-cap=0.0070 High/Low Ratio=2.60 Buyer MEMS 100 TAB-CAP 0.92 0.0092 TABLETS Buyer OECS/PPS 1000 TAB-CAP 11.20 0.0112 TABLETS Buyer SAFRICA 84 TAB-CAP 1.98 0.0236 TABLETS IN A PATIENT-READY PACK Buyer Median Price/tab-cap=0.0112 High/Low Ratio=2.57 CHLORPROMAZINE HCL 25 mg/5 ml suspen (PO) Price/ml 0.3 g C N05AA01 Supplier IDA 1 BOTT (150 ml) 4.63 0.0308 CHLORPROMAZINE HCL 25 mg/ml ampoule (INJ) Price/ml 0.1 g C N05AA01 Supplier JMS 10 AMP (2 ml) 0.67 0.0333 Supplier IDA 100 AMP (2 ml) 8.22 0.0411 Supplier MISSION 100 AMP (2 ml) 9.37 0.0468 Supplier DURBIN 100 AMP (2 ml) 12.56 0.0628 Supplier MEG 100 AMP (2 ml) 17.50 0.0875 Supplier MEDEOR/TZ 100 AMP (2 ml) 21.95 0.1097 Supplier Median Price/ml=0.0548 High/Low Ratio=3.29 Buyer MEMS 1 AMP (2 ml) 0.29 0.1440 Buyer SAFRICA 1 AMP (2 ml) 0.29 0.1450 Buyer OECS/PPS 100 AMP (2 ml) 31.75 0.1588 Buyer NAMIBIA 10 AMP (2 ml) 4.26 0.2128 Buyer Median Price/ml=0.1519 High/Low Ratio=1.48 CHLORPROMAZINE HCL 50 mg tab-cap (PO) Price/tab-cap 0.3 g C N05AA01 Buyer SAFRICA 500 TAB-CAP 15.58 0.0312 TABLETS CHLORPROPAMIDE 250 mg tab-cap (PO) Price/tab-cap 0.375 g T A01BB02 Supplier MEDEOR/TZ 112 TAB-CAP 2.20 0.0196 TABLETS Buyer MEMS 112 TAB-CAP 2.16 0.0193 TABLETS CICLOSPORIN 100 mg tab-cap (PO) Price/tab-cap 0.25 g P S01XA18 Buyer NAMIBIA 50 TAB-CAP 87.81 1.7563 CAPSULES Buyer SAFRICA 50 TAB-CAP 88.72 1.7744 CAPSULES Buyer Median Price/tab-cap=1.7654 High/Low Ratio=1.01 CICLOSPORIN 100 mg/ml solution (PO) Price/ml 0.25 g CP S01XA18 Buyer SICA 1 BOTT (50 ml) 40.00 0.8000 WITH PIPETTE Buyer SAFRICA 1 BOTT (50 ml) 120.93 2.4186 Buyer Median Price/ml=1.6093 High/Low Ratio=3.02 CICLOSPORIN 25 mg tab-cap (PO) Price/tab-cap 0.25 g C S01XA18 Buyer NAMIBIA 50 TAB-CAP 21.95 0.4391 CAPSULES Buyer SAFRICA 50 TAB-CAP 22.18 0.4436 CAPSULES Buyer Median Price/tab-cap=0.4414 High/Low Ratio=1.01 CIMETIDINE 100 mg/ml vial (INJ) Price/ml 0.8 g T A02BA01 Supplier MISSION 100 AMP (2 ml) 42.41 0.2121 Buyer SAFRICA 1 AMP (2 ml) 0.19 0.0950 CIMETIDINE 200 mg tab-cap (PO) Price/tab-cap 0.8 g T A02BA01 Supplier MEG 1000 TAB-CAP 8.15 0.0082 TABLETS Supplier JMS 100 TAB-CAP 0.88 0.0088 TABLETS Supplier MEDEOR/EU 2500 TAB-CAP 22.89 0.0092 TABLETS Supplier IDA 500 TAB-CAP 4.82 0.0096 TABLETS Supplier DURBIN 500 TAB-CAP 6.20 0.0124 TABLETS Supplier MISSION 1000 TAB-CAP 13.04 0.0130 TABLETS Supplier Median Price/tab-cap=0.0094 High/Low Ratio=1.59 Buyer MEMS 100 TAB-CAP 1.83 0.0183 TABLETS CIMETIDINE 400 mg tab-cap (PO) Price/tab-cap 0.8 g T A02BA01 Supplier JMS 100 TAB-CAP 1.40 0.0140 TABLETS Supplier MEDEOR/TZ 100 TAB-CAP 3.40 0.0340 TABLETS WHO EML = <E>ssential, <C>omplementary, <P>resentation, <T>herapeutic group alternative, <N>ot on list *The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. DDDs have not been established for pediatric use. A-26 International Drug Price Indicator Guide, 2012 List I: Products Sorted Alphabetically ITEM DESCRIPTION PACKAGE UNIT DEFINED WHO ATC SOURCE PACKAGE PRICE (US$) PRICE (US$) COMMENTS DAILY DOSE* EML CODE CIMETIDINE 400 mg tab-cap (PO) Price/tab-cap 0.8 g T A02BA01 Supplier DURBIN 100 TAB-CAP 3.61 0.0361 TABLETS Supplier Median Price/tab-cap=0.0340 High/Low Ratio=2.58 Buyer MEMS 100 TAB-CAP 2.26 0.0226 TABLETS CIPROFLOXACIN 2 mg/ml vial (INJ) Price/ml 0.5 g P J01MA02 Supplier MEDEOR/TZ 1 VIAL (100 ml) 0.48 0.0048 INFUSION Buyer GHANA 10 BOTT (100 ml) 2.39 0.0024 Buyer DOMREPUB 1 VIAL (100 ml) 0.32 0.0032 Buyer MEMS 1 VIAL (100 ml) 0.47 0.0047 Buyer OECS/PPS 1 VIAL (100 ml) 2.28 0.0228 Buyer SAFRICA 1 BOTT (200 ml) 7.03 0.0352 LACTATE, INFUSION Buyer Median Price/ml=0.0047 High/Low Ratio=14.71 CIPROFLOXACIN 250 mg tab-cap (PO) Price/tab-cap 1 g E J01MA02 Supplier MEG 100 TAB-CAP 1.45 0.0145 TABLETS Supplier JMS 100 TAB-CAP 1.60 0.0160 TABLETS Supplier IDA 1000 TAB-CAP 20.69 0.0207 TABLETS Supplier MISSION 100 TAB-CAP 2.75 0.0275 TABLETS Supplier UNFPA 100 TAB-CAP 3.10 0.0310 FILM-COATED TABLETS Supplier MEDS 100 TAB-CAP 3.14 0.0314 TABLETS Supplier DURBIN 100 TAB-CAP 3.14 0.0314 TABLETS, HYDROCHLORIDE Supplier MEDEOR/EU 100 TAB-CAP 5.56 0.0556 TABLETS Supplier Median Price/tab-cap=0.0293 High/Low Ratio=3.83 Buyer GHANA 100 TAB-CAP 1.71 0.0171 10 X 10 BLISTER PACK TABLETS Buyer SAFRICA 10 TAB-CAP 0.41 0.0410 TABLETS Buyer OECS/PPS 30 TAB-CAP 1.24 0.0413 TABLETS Buyer Median Price/tab-cap=0.0410 High/Low Ratio=2.42 CIPROFLOXACIN 250 mg/5 ml suspen (PO) Price/ml 1 g E J01MA02 Buyer SAFRICA 1 BOTT (100 ml) 21.38 0.2138 CIPROFLOXACIN 3 mg/ml opht drop (OPHT) Price/ml P S01AX13 Supplier MEDS 1 BOTT (5 ml) 0.41 0.0819 Supplier MEDEOR/TZ 1 BOTT (5 ml) 0.56 0.1116 Supplier Median Price/ml=0.0968 High/Low Ratio=1.36 Buyer GHANA 10 BOTT (5 ml) 2.75 0.0550 Buyer OECS/PPS 1 BOTT (5 ml) 0.40 0.0800 Buyer CRSS 1 BOTT (5 ml) 1.33 0.2660 Buyer SAFRICA 1 BOTT (5 ml) 4.09 0.8180 DROPPER Buyer Median Price/ml=0.1730 High/Low Ratio=14.87 CIPROFLOXACIN 5 mcg disc (DIAG) Price/each N V07AR Supplier JMS 100 DISC (1 EACH) 5.67 0.0567 CIPROFLOXACIN 500 mg tab-cap (PO) Price/tab-cap 1 g P J01MA02 Supplier JMS 100 TAB-CAP 2.86 0.0286 TABLETS Supplier UNFPA 100 TAB-CAP 3.06 0.0306 TABLETS Supplier MEDS 10 TAB-CAP 0.35 0.0351 CAPSULES Supplier MEG 1000 TAB-CAP 37.40 0.0374 TABLETS Supplier MEDEOR/TZ 100 TAB-CAP 3.82 0.0382 TABLETS Supplier IDA 100 TAB-CAP 3.98 0.0398 TABLETS Supplier DURBIN 100 TAB-CAP 4.32 0.0432 TABLETS, HYDROCHLORIDE Supplier MISSION 100 TAB-CAP 4.37 0.0437 BLISTER PACK TABLETS Supplier Median Price/tab-cap=0.0378 High/Low Ratio=1.53 Buyer GHANA 100 TAB-CAP 2.14 0.0214 10 X 10 BLISTER PACK TABLETS Buyer DOMREPUB 1 TAB-CAP 0.02 0.0243 BLISTER PACK TABLETS Buyer PERU 100 TAB-CAP 3.25 0.0325 TABLETS, ILLUSTRATIVE PACK SIZE Buyer MEMS 100 TAB-CAP 3.60 0.0360 TABLET Buyer NAMIBIA 10 TAB-CAP 0.38 0.0380 TABLETS Buyer SAFRICA 10 TAB-CAP 0.57 0.0570 TABLETS Buyer Median Price/tab-cap=0.0343 High/Low Ratio=2.66 CISATRACURIUM 2 mg/ml ampoule (INJ) Price/ml N M03AC11 Buyer SAFRICA 1 AMPOULE (5 ml) 6.34 1.2680 Buyer OECS/PPS 5 AMP (5 ml) 48.13 1.9252 Buyer Median Price/ml=1.5966 High/Low Ratio=1.52 CISPLATIN 10 mg vial (INJ) Price/ml N L01XA01 Buyer SAFRICA 1 VIAL (10 ml) 4.39 0.4390 WHO EML = <E>ssential, <C>omplementary, <P>resentation, <T>herapeutic group alternative, <N>ot on list *The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. DDDs have not been established for pediatric use. A-27 International Drug Price Indicator Guide, 2012 List I: Products Sorted Alphabetically ITEM DESCRIPTION PACKAGE UNIT DEFINED WHO ATC SOURCE PACKAGE PRICE (US$) PRICE (US$) COMMENTS DAILY DOSE* EML CODE CISPLATIN 50 mg vial (INJ) Price/vial N L01XA01 Buyer SAFRICA 1 VIAL 7.73 7.7300 Buyer NAMIBIA 1 VIAL 8.82 8.8167 Buyer OECS/PPS 1 AMP (1 VIAL) 18.00 18.0000 Buyer Median Price/vial=8.8167 High/Low Ratio=2.33 CLARITHROMYCIN 125 mg/5 ml suspen (PO) Price/ml 0.5 g N J01FA09 Supplier MEDS 1 BOTT (70 ml) 3.93 0.0562 Buyer SAFRICA 1 BOTT (50 ml) 1.98 0.0396 GRANULES CLARITHROMYCIN 250 mg tab-cap (PO) Price/tab-cap 0.5 g N J01FA09 Buyer OECS/PPS 14 TAB-CAP 2.30 0.1643 TABLETS CLARITHROMYCIN 500 mg tab-cap (PO) Price/tab-cap 0.5 g N J01FA09 Supplier MEDS 15 TAB-CAP 5.57 0.3713 TABLETS Supplier IDA 40 TAB-CAP 17.93 0.4481 BLISTER PACK TABLETS Supplier Median Price/tab-cap=0.4097 High/Low Ratio=1.21 Buyer PERU 100 TAB-CAP 14.17 0.1417 TABLET, ILLUSTRATIVE PACK SIZE Buyer DOMREPUB 1 TAB-CAP 0.18 0.1751 BLISTER PACK Buyer GHANA 100 TAB-CAP 24.00 0.2400 10 X 10 BLISTER PACK TABLETS Buyer SAFRICA 14 TAB-CAP 3.84 0.2743 TABLETS Buyer NAMIBIA 14 TAB-CAP 5.13 0.3667 TABLETS Buyer SUDANNHIF 1 TAB-CAP 0.49 0.4895 TABLET Buyer Median Price/tab-cap=0.2571 High/Low Ratio=3.45 CLINDAMYCIN 300 mg tab-cap (PO) Price/tab-cap 1.2 g P J01FF01 Supplier UNFPA 30 TAB-CAP 5.50 0.1833 HCL, CAPSULES, BLISTER PACK Buyer PERU 100 TAB-CAP 5.60 0.0560 TABLETS, ILLUSTRATIVE PACK SIZE Buyer DOMREPUB 1 TAB-CAP 0.07 0.0734 BLISTER PACK CAPSULES Buyer OECS/PPS 100 TAB-CAP 12.50 0.1250 CAPSULES Buyer Median Price/tab-cap=0.0734 High/Low Ratio=2.23 CLINDAMYCIN (BASE) 150 mg tab-cap (PO) Price/tab-cap 0.1 g C J01FF01 Supplier JMS 100 TAB-CAP 12.32 0.1232 TABLETS Buyer GHANA 100 TAB-CAP 9.19 0.0919 10 X 10 BLISTER PACK TABLETS Buyer NAMIBIA 100 TAB-CAP 11.68 0.1168 CAPSULES Buyer SAFRICA 100 TAB-CAP 12.54 0.1254 CAPSULES Buyer Median Price/tab-cap=0.1168 High/Low Ratio=1.36 CLINDAMYCIN (BASE) 150 mg/ml vial (INJ) Price/ml 1.8 g C J01FF01 Supplier UNFPA 1 AMP (4 ml) 12.50 3.1250 PHOSPHATE Buyer DOMREPUB 1 AMP (4 ml) 0.46 0.1150 Buyer NAMIBIA 1 VIAL (4 ml) 3.34 0.8347 Buyer Median Price/ml=0.4749 High/Low Ratio=7.26 CLOBETASOL PROPRIONATE 0.05% cream (TOP) Price/g N D07AD01 Buyer PERU 1 TUBE (25 g) 0.33 0.0131 Buyer NAMIBIA 1 TUBE (25 g) 0.75 0.0299 Buyer SAFRICA 1 TUBE (25 g) 2.32 0.0928 Buyer Median Price/g=0.0299 High/Low Ratio=7.08 CLOFAZIMINE (LAMPRENE) 100 mg tab-cap (PO) Price/tab-cap 0.1 g E J04BA01 Buyer NAMIBIA 100 TAB-CAP 329.82 3.2982 TABLETS CLOMIFENE 50 mg tab-cap (PO) Price/tab-cap 9 mg C G03GB02 Supplier JMS 10 TAB-CAP 2.86 0.2860 TABLETS, CITRATE Supplier MEDS 10 TAB-CAP 4.18 0.4177 TABLETS Supplier Median Price/tab-cap=0.3519 High/Low Ratio=1.46 Buyer MEMS 10 TAB-CAP 2.28 0.2280 CAPSULES CLOMIPRAMINE 25 mg tab-cap (PO) Price/tab-cap 0.1 g E N06AA04 Buyer PERU 100 TAB-CAP 2.00 0.0200 TABLET, ILLUSTRATIVE PACK SIZE CLONAZEPAM 0.5 mg tab-cap (PO) Price/tab-cap 8 mg N N03AE01 Buyer PERU 100 TAB-CAP 0.48 0.0048 TABLETS, ILLUSTRATIVE PACK SIZE Buyer SAFRICA 90 TAB-CAP 8.63 0.0959 TABLETS WHO EML = <E>ssential, <C>omplementary, <P>resentation, <T>herapeutic group alternative, <N>ot on list *The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. DDDs have not been established for pediatric use. A-28 International Drug Price Indicator Guide, 2012 List I: Products Sorted Alphabetically ITEM DESCRIPTION PACKAGE UNIT DEFINED WHO ATC SOURCE PACKAGE PRICE (US$) PRICE (US$) COMMENTS DAILY DOSE* EML CODE CLONAZEPAM 0.5 mg tab-cap (PO) Price/tab-cap 8 mg N N03AE01 Buyer NAMIBIA 90 TAB-CAP 14.32 0.1591 TABLETS Buyer Median Price/tab-cap=0.0959 High/Low Ratio=33.15 CLONAZEPAM 2 mg tab-cap (PO) Price/tab-cap 8 mg N N03AE01 Buyer PERU 100 TAB-CAP 0.86 0.0086 TABLETS, ILLUSTRATIVE PACK SIZE Buyer OECS/PPS 100 TAB-CAP 3.26 0.0326 TABLETS Buyer CRSS 100 TAB-CAP 6.52 0.0652 TABLETS Buyer SAFRICA 90 TAB-CAP 19.81 0.2201 TABLETS Buyer NAMIBIA 90 TAB-CAP 32.89 0.3654 TABLETS Buyer Median Price/tab-cap=0.0652 High/Low Ratio=42.49 CLONAZEPAM 2.5 mg/ml drops (PO) Price/ml 8 mg N N03AE01 Buyer CRSS 1 BOTT (10 ml) 1.45 0.1450 CLOPIDOGREL BISULFATE 75 mg tab-cap (PO) Price/tab-cap 75 mg N B01AC04 Buyer DOMREPUB 1 TAB-CAP 0.03 0.0311 BLISTER PACK TABLET Buyer OECS/PPS 100 TAB-CAP 5.26 0.0526 TABLETS Buyer SAFRICA 28 TAB-CAP 2.65 0.0946 TABLETS Buyer CRSS 100 TAB-CAP 111.08 1.1108 Buyer Median Price/tab-cap=0.0736 High/Low Ratio=35.72 CLOTRIMAZOLE 1% cream (TOP) Price/g E D01AC01 Supplier MEDS 1 TUBE (20 g) 0.19 0.0094 Supplier JMS 1 TUBE (20 g) 0.20 0.0101 Supplier IDA 10 TUBE (20 g) 2.76 0.0138 Supplier MEDEOR/TZ 1 TUBE (20 g) 0.29 0.0147 Supplier MISSION 1 TUBE (20 g) 0.35 0.0177 Supplier UNFPA 50 TUBE (20 g) 27.50 0.0275 Supplier DURBIN 10 TUBE (20 g) 6.04 0.0302 Supplier MEDEOR/EU 24 TUBE (20 g) 15.86 0.0330 Supplier Median Price/g=0.0162 High/Low Ratio=3.51 Buyer DOMREPUB 1 TUBE (30 g) 0.21 0.0071 Buyer PERU 1 TUBE (20 g) 0.30 0.0148 Buyer NAMIBIA 1 TUBE (20 g) 0.30 0.0152 Buyer SAFRICA 1 TUBE (20 g) 0.31 0.0155 Buyer GHANA 10 TUBE (15 g) 3.12 0.0208 Buyer MEMS 1 TUBE (15 g) 0.47 0.0316 Buyer Median Price/g=0.0154 High/Low Ratio=4.45 CLOTRIMAZOLE 1% cream (VAG) Price/g 0.1 g E G01AF02 Buyer OECS/PPS 1 TUBE (35 g) 3.62 0.1034 CLOTRIMAZOLE 100 mg pessary (VAG) Price/pessary 0.1 g E G01AF02 Supplier MISSION 100 PESS 2.66 0.0266 Supplier JMS 6 PESS 0.23 0.0378 Supplier UNFPA 6 PESS 0.30 0.0500 Supplier MEDEOR/TZ 6 PESS 0.50 0.0840 WITH APPLICATOR Supplier IDA 6 TAB-CAP (1 PESSARY) 1.48 0.2463 Supplier MEG 1 PESS 0.95 0.9500 + APPLICATOR Supplier Median Price/pessary=0.0670 High/Low Ratio=35.71 Buyer DOMREPUB 1 PESS 0.04 0.0367 Buyer GHANA 1 PESS 0.04 0.0400 Buyer MEMS 6 PESS 0.45 0.0750 Buyer OECS/PPS 6 PESS 2.46 0.4100 WITH APPLICATOR Buyer Median Price/pessary=0.0575 High/Low Ratio=11.17 CLOTRIMAZOLE 500 mg pessary (VAG) Price/pessary 0.1 g E G01AF02 Supplier UNFPA 100 PESS 6.50 0.0650 BLISTER PACK 10 X 10, WITH APPLICATOR Supplier IDA 100 PESS 19.40 0.1940 Supplier Median Price/pessary=0.1295 High/Low Ratio=2.98 Buyer NAMIBIA 1 PESS 0.96 0.9560 SINGLE DOSE Buyer SAFRICA 1 PESS 1.12 1.1200 WITH APPLICATOR Buyer Median Price/pessary=1.0380 High/Low Ratio=1.17 CLOXACILLIN 5 mcg disc (DIAG) Price/each N V07AR Supplier JMS 100 DISC (1 EACH) 6.35 0.0635 CLOXACILLIN SODIUM 125 mg/5 ml suspen (PO) Price/ml 2 g T J01CF02 Supplier MEDS 1 BOTT (100 ml) 0.35 0.0035 POWDER FOR SYRUP Supplier MEG 1 BOTT (100 ml) 0.65 0.0065 POWDER Supplier MEDEOR/TZ 1 BOTT (100 ml) 0.68 0.0068 POWDER WHO EML = <E>ssential, <C>omplementary, <P>resentation, <T>herapeutic group alternative, <N>ot on list *The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. DDDs have not been established for pediatric use. A-29 International Drug Price Indicator Guide, 2012 List I: Products Sorted Alphabetically ITEM DESCRIPTION PACKAGE UNIT DEFINED WHO ATC SOURCE PACKAGE PRICE (US$) PRICE (US$) COMMENTS DAILY DOSE* EML CODE CLOXACILLIN SODIUM 125 mg/5 ml suspen (PO) Price/ml 2 g T J01CF02 Supplier MISSION 1 BOTT (100 ml) 0.70 0.0070 Supplier UNFPA 1 BOTT (100 ml) 0.75 0.0075 POWDER Supplier IDA 40 BOTT (100 ml) 32.57 0.0081 Supplier DURBIN 1 BOTT (100 ml) 1.10 0.0110 POWDER FOR SYRUP, SODIUM SALT Supplier Median Price/ml=0.0070 High/Low Ratio=3.14 Buyer MEMS 1 BOTT (100 ml) 0.66 0.0066 Buyer OECS/PPS 1 BOTT (100 ml) 0.89 0.0089 Buyer NAMIBIA 1 BOTT (100 ml) 1.98 0.0198 Buyer Median Price/ml=0.0089 High/Low Ratio=3.00 CLOXACILLIN SODIUM 250 mg tab-cap (PO) Price/tab-cap 2 g T J01CF02 Supplier MEDS 1000 TAB-CAP 16.44 0.0164 CAPSULES Supplier MEG 1000 TAB-CAP 17.90 0.0179 CAPSULES Supplier JMS 100 TAB-CAP 1.80 0.0180 CAPSULES Supplier MEDEOR/TZ 1000 TAB-CAP 18.00 0.0180 CAPSULES Supplier IDA 1000 TAB-CAP 21.65 0.0217 CAPSULES Supplier MISSION 1000 TAB-CAP 23.29 0.0233 CAPSULES Supplier DURBIN 1000 TAB-CAP 25.91 0.0259 CAPSULES Supplier Median Price/tab-cap=0.0180 High/Low Ratio=1.58 Buyer MEMS 100 TAB-CAP 1.80 0.0180 CAPSULES Buyer NAMIBIA 100 TAB-CAP 2.58 0.0258 CAPSULES Buyer Median Price/tab-cap=0.0219 High/Low Ratio=1.43 CLOXACILLIN SODIUM 250 mg vial (INJ) Price/vial 2 g T J01CF02 Buyer NAMIBIA 10 VIAL 4.86 0.4859 Buyer SAFRICA 1 VIAL 0.68 0.6800 POWDER Buyer Median Price/vial=0.5830 High/Low Ratio=1.40 CLOXACILLIN SODIUM 500 mg tab-cap (PO) Price/tab-cap 2 g T J01CF02 Supplier IDA 1000 TAB-CAP 34.44 0.0344 CAPSULES Supplier MEG 500 TAB-CAP 17.78 0.0356 CAPSULES Supplier UNFPA 500 TAB-CAP 18.44 0.0369 CAPSULES Supplier MISSION 1000 TAB-CAP 40.06 0.0401 CAPSULES Supplier MEDEOR/EU 1000 TAB-CAP 74.23 0.0742 CAPSULES Supplier Median Price/tab-cap=0.0369 High/Low Ratio=2.16 Buyer OECS/PPS 1000 TAB-CAP 34.30 0.0343 CAPSULES CLOXACILLIN SODIUM 500 mg vial (INJ) Price/vial 2 g T J01CF02 Supplier UNFPA 50 VIAL 5.66 0.1132 POWDER Supplier IDA 50 VIAL 6.42 0.1285 Supplier MISSION 50 VIAL 8.48 0.1696 Supplier DURBIN 50 VIAL 10.99 0.2198 POWDER, SODIUM SALT Supplier MEDEOR/EU 50 VIAL 27.94 0.5588 POWDER Supplier MEDEOR/TZ 50 VIAL 30.72 0.6144 POWDER Supplier Median Price/vial=0.1947 High/Low Ratio=5.43 Buyer OECS/PPS 1 VIAL 0.26 0.2600 Buyer MEMS 1 VIAL 0.29 0.2880 POWDER Buyer NAMIBIA 10 VIAL 5.84 0.5841 Buyer SAFRICA 1 VIAL 0.75 0.7500 POWDER Buyer Median Price/vial=0.4361 High/Low Ratio=2.88 CLOZAPINE 100 mg tab-cap (PO) Price/tab-cap 0.3 g N N05AH02 Buyer PERU 100 TAB-CAP 1.95 0.0195 TABLETS, ILLUSTRATIVE PACK SIZE Buyer SAFRICA 100 TAB-CAP 13.61 0.1361 TABLETS Buyer NAMIBIA 100 TAB-CAP 21.83 0.2183 TABLETS Buyer OECS/PPS 50 TAB-CAP 21.59 0.4318 TABLETS Buyer CRSS 100 TAB-CAP 67.00 0.6700 Buyer Median Price/tab-cap=0.2183 High/Low Ratio=34.36 CLOZAPINE 25 mg tab-cap (PO) Price/tab-cap 0.3 g N N05AH02 Buyer SAFRICA 100 TAB-CAP 4.39 0.0439 TABLETS Buyer NAMIBIA 100 TAB-CAP 8.43 0.0843 TABLETS Buyer OECS/PPS 50 TAB-CAP 9.00 0.1800 TABLETS Buyer Median Price/tab-cap=0.0843 High/Low Ratio=4.10 CODEINE (IC) 30 mg tab-cap (PO) Price/tab-cap 0.1 g E R05DA04 Supplier DURBIN 1000 TAB-CAP 31.40 0.0314 TABLETS, PHOSPHATE Supplier MEDS 100 TAB-CAP 8.35 0.0835 TABLETS, PHOSPHATE Supplier IDA 100 TAB-CAP 10.41 0.1041 TABLETS Supplier JMS 100 TAB-CAP 13.07 0.1307 TABLETS, PHOSPHATE Supplier Median Price/tab-cap=0.0938 High/Low Ratio=4.16 Buyer NAMIBIA 100 TAB-CAP 15.11 0.1511 TABLETS, PHOSPHATE WHO EML = <E>ssential, <C>omplementary, <P>resentation, <T>herapeutic group alternative, <N>ot on list *The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. DDDs have not been established for pediatric use. A-30 International Drug Price Indicator Guide, 2012 List I: Products Sorted Alphabetically ITEM DESCRIPTION PACKAGE UNIT DEFINED WHO ATC SOURCE PACKAGE PRICE (US$) PRICE (US$) COMMENTS DAILY DOSE* EML CODE CODEINE (IC) 30 mg tab-cap (PO) Price/tab-cap 0.1 g E R05DA04 Buyer SAFRICA 100 TAB-CAP 38.80 0.3880 TABLETS Buyer Median Price/tab-cap=0.2696 High/Low Ratio=2.57 COLCHICINE 0.5-0.6 mg tab-cap (PO) Price/tab-cap 1 mg N M04AC01 Buyer NAMIBIA 50 TAB-CAP 1.67 0.0335 0.5 MG TABLETS Buyer OECS/PPS 100 TAB-CAP 7.00 0.0700 0.5 MG TABLETS Buyer SAFRICA 50 TAB-CAP 5.26 0.1052 0.5 MG TABLETS Buyer Median Price/tab-cap=0.0700 High/Low Ratio=3.14 CONDOM, FEMALE condom (N/A) Price/condom P V07AY Supplier UNFPA 1 CONDOM 0.56 0.5600 NATURAL RUBBER LATEX Supplier UNFPA 1 CONDOM 0.57 0.5700 NITRILE Supplier USAID/DEL 1 CONDOM 0.58 0.5803 Supplier IDA 1000 CONDOM 859.40 0.8594 Supplier MISSION 1 CONDOM 1.27 1.2660 Supplier Median Price/condom=0.5803 High/Low Ratio=2.26 CONDOMS (LUBRICATED) condom (N/A) Price/condom E V07AY Supplier UNFPA 144 CONDOM 3.53 0.0245 49 MM Supplier UNFPA 144 CONDOM 3.58 0.0249 53 MM Supplier UNFPA 144 CONDOM 3.85 0.0267 55-58 MM Supplier USAID/DEL 1000 CONDOM 32.70 0.0327 VARIOUS BRANDS, ILLUSTRATIVE PACK SIZE Supplier MEG 144 CONDOM 6.87 0.0477 Supplier IDA 144 CONDOM 7.32 0.0509 Supplier MISSION 144 CONDOM 8.04 0.0558 Supplier MEDEOR/EU 144 CONDOM 9.53 0.0662 Supplier Median Price/condom=0.0402 High/Low Ratio=2.70 COUGH PREPARATION syrup (PO) Price/ml N R05D Supplier MEDS 1 BOTT (5000 ml) 6.13 0.0012 GUAIPHENESIN Supplier MEDS 1 BOTT (5000 ml) 7.66 0.0015 DEXTROMETHORPHAN HBR 7.5 MG/5 ML Supplier JMS 1 BOTT (100 ml) 0.66 0.0066 EXPECTORANT WITH ANTIHISTAMINE Supplier MEDEOR/TZ 1 BOTT (100 ml) 0.72 0.0072 ANTI-TUSSIVE Supplier MEDEOR/TZ 1 BOTT (100 ml) 0.72 0.0072 EXPECTORANT Supplier Median Price/ml=0.0066 High/Low Ratio=6.00 Buyer DOMREPUB 1 BOTT (120 ml) 0.33 0.0027 SUPPRESSANT Buyer OECS/PPS 1 BOTT (2000 ml) 8.65 0.0043 EXPECTORANT Buyer MEMS 1 BOTT (100 ml) 0.45 0.0045 EXPECTORANT, ADULT Buyer Median Price/ml=0.0043 High/Low Ratio=1.67 CROMOGLICIC ACID (SODIUM CROMOGLICATE) 2% opht drop (OPHT) Price/ml N S01GX01 Supplier MEDEOR/TZ 1 BOTT (10 ml) 1.48 0.1476 Supplier MEDS 1 BOTT (10 ml) 1.81 0.1814 Supplier Median Price/ml=0.1645 High/Low Ratio=1.23 Buyer SAFRICA 1 BOTT (10 ml) 1.04 0.1040 Buyer NAMIBIA 1 BOTT (13.50 ml) 2.24 0.1662 Buyer Median Price/ml=0.1351 High/Low Ratio=1.60 CYCLEBEADS (TM) (32 BEADS W/ RUBBER MARKER) each (N/A) Price/each N Supplier USAID/DEL 1 EACH 1.41 1.4137 CYCLIZINE 50 mg tab-cap (PO) Price/tab-cap 0.1 g E R06AE03 Buyer SAFRICA 10 TAB-CAP 0.36 0.0360 TABLETS CYCLOPENTOLATE 1% opht drop (OPHT) Price/ml N S01FA04 Supplier DURBIN 1 BOTT (5 ml) 13.19 2.6376 Buyer SAFRICA 1 BOTT (15 ml) 6.32 0.4213 DROPPER CYCLOPHOSPHAMIDE 1 g vial (INJ) Price/vial P L01AA01 Buyer OECS/PPS 1 AMP (1 VIAL) 3.81 3.8100 Buyer NAMIBIA 5 VIAL 53.26 10.6518 Buyer SAFRICA 1 VIAL 13.03 13.0300 Buyer Median Price/vial=10.6518 High/Low Ratio=3.42 CYCLOPHOSPHAMIDE 200 mg vial (INJ) Price/vial P L01AA01 Buyer NAMIBIA 10 VIAL 41.85 4.1847 CYCLOPHOSPHAMIDE 50 mg tab-cap (PO) Price/tab-cap P L01AA01 Supplier IDA 1000 TAB-CAP 178.29 0.1783 TABLETS WHO EML = <E>ssential, <C>omplementary, <P>resentation, <T>herapeutic group alternative, <N>ot on list *The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. DDDs have not been established for pediatric use. A-31 International Drug Price Indicator Guide, 2012 List I: Products Sorted Alphabetically ITEM DESCRIPTION PACKAGE UNIT DEFINED WHO ATC SOURCE PACKAGE PRICE (US$) PRICE (US$) COMMENTS DAILY DOSE* EML CODE CYCLOPHOSPHAMIDE 50 mg tab-cap (PO) Price/tab-cap P L01AA01 Buyer NAMIBIA 50 TAB-CAP 12.47 0.2493 TABLETS Buyer OECS/PPS 50 TAB-CAP 13.00 0.2600 TABLETS Buyer SAFRICA 50 TAB-CAP 21.30 0.4260 TABLETS Buyer Median Price/tab-cap=0.2600 High/Low Ratio=1.71 CYCLOPHOSPHAMIDE 500 mg vial (INJ) Price/vial C L01AA01 Buyer SAFRICA 1 VIAL 8.77 8.7700 Buyer NAMIBIA 5 VIAL 45.11 9.0215 Buyer Median Price/vial=8.8958 High/Low Ratio=1.03 CYCLOSERINE 250 mg tab-cap (PO) Price/tab-cap 0.75 g C J04AB01 Supplier GDF 100 TAB-CAP 59.09 0.5909 10 X 10 BLISTER PACK CAPSULES Buyer PERU 100 TAB-CAP 40.84 0.4084 TABLETS, ILLUSTRATIVE PACK SIZE CYPROTERONE ACETATE 50 mg tab-cap (PO) Price/tab-cap 0.1 g N G03HA01 Buyer OECS/PPS 100 TAB-CAP 20.00 0.2000 TABLETS Buyer SAFRICA 20 TAB-CAP 11.61 0.5805 TABLETS Buyer Median Price/tab-cap=0.3903 High/Low Ratio=2.90 CYTARABINE 100 mg vial (INJ) Price/vial C L01BC01 Buyer SAFRICA 1 VIAL 3.49 3.4900 WITH DILUENT CYTARABINE 500 mg vial (INJ) Price/vial C L01BC01 Buyer SAFRICA 1 VIAL 7.44 7.4400 DACARBAZINE 10 mg/ml vial (INJ) Price/ml P L01AX04 Buyer CRSS 1 VIAL (20 ml) 11.70 0.5850 DACARBAZINE 200 mg vial (INJ) Price/vial P L01AX04 Buyer NAMIBIA 1 VIAL 9.11 9.1119 DACTINOMYCIN 500 mcg vial (INJ) Price/vial C L01DA01 Buyer NAMIBIA 1 VIAL 25.23 25.2312 DAPSONE 100 mg tab-cap (PO) Price/tab-cap 50 mg E J04BA02 Supplier MEDEOR/TZ 100 TAB-CAP 1.26 0.0126 TABLETS Supplier MEDS 100 TAB-CAP 1.67 0.0167 TABLETS Supplier IDA 28 TAB-CAP 0.58 0.0207 TABLETS Supplier JMS 1000 TAB-CAP 21.32 0.0213 TABLETS Supplier Median Price/tab-cap=0.0187 High/Low Ratio=1.69 Buyer NAMIBIA 100 TAB-CAP 7.28 0.0728 TABLETS Buyer OECS/PPS 1000 TAB-CAP 120.00 0.1200 TABLETS Buyer SAFRICA 100 TAB-CAP 22.17 0.2217 TABLETS Buyer CRSS 100 TAB-CAP 43.20 0.4320 TABLETS Buyer Median Price/tab-cap=0.1709 High/Low Ratio=5.93 DARUNAVIR 300 mg tab-cap (PO) Price/tab-cap 1.2 g N J05AE10 Buyer SAFRICA 120 TAB-CAP 76.54 0.6378 TABLETS Buyer CRSS 100 TAB-CAP 471.77 4.7177 Buyer Median Price/tab-cap=2.6778 High/Low Ratio=7.40 DAUNORUBICIN 20 mg vial (INJ) Price/vial CP L01DB02 Buyer SAFRICA 1 VIAL 6.08 6.0800 DEFEROXAMINE MESILATE 500 mg ampoule (INJ) Price/ampoule E V03AC01 Buyer SAFRICA 1 VIAL (1 AMPOULE) 8.36 8.3600 POWDER Buyer NAMIBIA 10 AMP 86.16 8.6158 Buyer Median Price/ampoule=8.4879 High/Low Ratio=1.03 DESMOPRESSIN ACETATE 100 mcg/ml nasal (N/T) Price/ml 0.4 mg N H01BA02 Buyer SAFRICA 1 BOTT (5 ml) 73.12 14.6240 DESMOPRESSIN ACETATE 4 mcg/ml vial (INJ) Price/ml 0.4 mg N H01BA02 Buyer SAFRICA 1 AMP (1 ml) 8.83 8.8300 DETERMINE CHASE BUFFER vial (N/A) Price/ml N V07AZ Supplier IDA 1 BOTT (2.50 ml) 9.64 3.8550 DEXAMETHASONE 0.1% opht drop (OPHT) Price/ml P S01BA01 Supplier MEDEOR/TZ 1 BOTT (5 ml) 0.49 0.0984 WHO EML = <E>ssential, <C>omplementary, <P>resentation, <T>herapeutic group alternative, <N>ot on list *The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. DDDs have not been established for pediatric use. A-32 International Drug Price Indicator Guide, 2012 List I: Products Sorted Alphabetically ITEM DESCRIPTION PACKAGE UNIT DEFINED WHO ATC SOURCE PACKAGE PRICE (US$) PRICE (US$) COMMENTS DAILY DOSE* EML CODE DEXAMETHASONE 0.1% opht drop (OPHT) Price/ml P S01BA01 Supplier JMS 1 BOTT (5 ml) 0.60 0.1206 Supplier MISSION 1 BOTT (10 ml) 1.39 0.1393 Supplier Median Price/ml=0.1206 High/Low Ratio=1.42 Buyer SAFRICA 1 BOTT (5 ml) 1.25 0.2500 PHOSPHATE SOLUTION, DROPPER Buyer NAMIBIA 1 BOTT (5 ml) 1.27 0.2543 Buyer GHANA 10 BOTT (5 ml) 15.99 0.3198 Buyer Median Price/ml=0.2543 High/Low Ratio=1.28 DEXAMETHASONE 0.5 mg tab-cap (PO) Price/tab-cap 1.5 mg E H02AB02 Supplier JMS 1000 TAB-CAP 2.89 0.0029 TABLETS Supplier IDA 1000 TAB-CAP 4.24 0.0042 TABLETS Supplier MISSION 1000 TAB-CAP 5.24 0.0052 TABLETS Supplier MEDEOR/EU 7000 TAB-CAP 57.80 0.0083 TABLETS Supplier MEDEOR/TZ 1000 TAB-CAP 26.04 0.0260 TABLETS Supplier Median Price/tab-cap=0.0052 High/Low Ratio=8.97 Buyer PERU 100 TAB-CAP 0.76 0.0076 TABLETS, ILLUSTRATIVE PACK SIZE Buyer MEMS 100 TAB-CAP 1.80 0.0180 TABLETS Buyer NAMIBIA 100 TAB-CAP 7.25 0.0725 TABLETS Buyer Median Price/tab-cap=0.0180 High/Low Ratio=9.54 DEXAMETHASONE 4 mg/ml ampoule (INJ) Price/ml 1.5 mg E H02AB02 Supplier MISSION 100 AMP (1 ml) 9.49 0.0949 SODIUM PHOSPHATE Supplier JMS 6 AMP (2 ml) 1.19 0.0990 Supplier MEDEOR/TZ 100 AMP (2 ml) 22.32 0.1116 Supplier MEG 100 AMP (1 ml) 19.90 0.1990 SODIUM PHOSPHATE Supplier DURBIN 100 AMP (1 ml) 22.37 0.2237 Supplier UNFPA 100 AMP (1 ml) 23.00 0.2300 SODIUM PHOSPHATE Supplier Median Price/ml=0.1553 High/Low Ratio=2.42 Buyer DOMREPUB 1 AMP (2 ml) 0.06 0.0276 Buyer GHANA 10 AMP (1 ml) 0.55 0.0550 Buyer MEMS 1 AMP (2 ml) 0.14 0.0720 Buyer OECS/PPS 100 VIAL (1 ml) 22.15 0.2215 SODIUM PHOSPHATE Buyer NAMIBIA 10 AMP (2 ml) 7.01 0.3504 Buyer SAFRICA 1 AMP (1 ml) 0.37 0.3700 Buyer Median Price/ml=0.1468 High/Low Ratio=13.41 DEXAMETHASONE 5 mg/ml ampoule (INJ) Price/ml 1.5 mg P H02AB02 Supplier IDA 100 AMP (1 ml) 9.83 0.0983 DEXTRAN 70 6% IN SOD. CHLORIDE 0.9% solution (IV) Price/ml E B05AA05 Supplier UNFPA 1 BOTT (500 ml) 5.00 0.0100 Supplier DURBIN 20 BAG (500 ml) 114.61 0.0115 Supplier Median Price/ml=0.0108 High/Low Ratio=1.15 DEXTROSE 10% IN WATER solution (IV) Price/ml E B05BA03 Supplier MEDS 1 BOTT (500 ml) 0.48 0.0010 Supplier UNFPA 1 BOTT (500 ml) 0.65 0.0013 Supplier MEDEOR/TZ 1 BOTT (500 ml) 0.74 0.0015 Supplier MISSION 1 BOTT (500 ml) 0.82 0.0016 Supplier IDA 20 BAG (500 ml) 19.66 0.0020 Supplier Median Price/ml=0.0015 High/Low Ratio=2.00 Buyer PERU 1 BOTT (1000 ml) 1.09 0.0011 Buyer SAFRICA 1 BAG (1000 ml) 1.42 0.0014 Buyer OECS/PPS 1 BOTT (500 ml) 0.83 0.0017 Buyer Median Price/ml=0.0014 High/Low Ratio=1.51 DEXTROSE 2.5% IN SOD. CHLORIDE 0.45% solution (IV) Price/ml P B05BB02 Supplier IDA 12 BAG (1000 ml) 14.91 0.0012 Supplier IDA 20 BAG (500 ml) 18.31 0.0018 Supplier Median Price/ml=0.0015 High/Low Ratio=1.50 Buyer SAFRICA 1 BAG (1000 ml) 1.65 0.0017 DEXTROSE 5% IN SODIUM CHLORIDE 0.45% solution (IV) Price/ml P B05BB02 Buyer OECS/PPS 1 BOTT (1000 ml) 0.85 0.0008 Buyer SAFRICA 1 BAG (1000 ml) 1.16 0.0012 Buyer NAMIBIA 1 BOTT (1000 ml) 1.46 0.0015 Buyer Median Price/ml=0.0012 High/Low Ratio=1.76 DEXTROSE 5% IN SODIUM CHLORIDE 0.9% solution (IV) Price/ml P B05BB02 Supplier MEDS 1 BOTT (1000 ml) 0.89 0.0009 Supplier MEG 1 BOTT (1000 ml) 0.90 0.0009 WHO EML = <E>ssential, <C>omplementary, <P>resentation, <T>herapeutic group alternative, <N>ot on list *The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. DDDs have not been established for pediatric use. A-33 International Drug Price Indicator Guide, 2012 List I: Products Sorted Alphabetically ITEM DESCRIPTION PACKAGE UNIT DEFINED WHO ATC SOURCE PACKAGE PRICE (US$) PRICE (US$) COMMENTS DAILY DOSE* EML CODE DEXTROSE 5% IN SODIUM CHLORIDE 0.9% solution (IV) Price/ml P B05BB02 Supplier MEDS 1 BOTT (500 ml) 0.50 0.0010 Supplier MISSION 1 BOTT (1000 ml) 1.15 0.0012 NIPPLEHEAD Supplier MEG 1 BOTT (500 ml) 0.65 0.0013 Supplier MEDEOR/TZ 1 BOTT (500 ml) 0.66 0.0013 Supplier DURBIN 10 BOTT (1000 ml) 13.35 0.0013 Supplier MISSION 1 BOTT (500 ml) 0.75 0.0015 NIPPLEHEAD Supplier DURBIN 20 BOTT (500 ml) 15.62 0.0016 Supplier MEDEOR/EU 10 BOTT (500 ml) 11.19 0.0022 Supplier Median Price/ml=0.0013 High/Low Ratio=2.44 Buyer DOMREPUB 1 BOTT (1000 ml) 0.48 0.0005 Buyer OECS/PPS 1 BOTT (1000 ml) 0.91 0.0009 Buyer MEMS 1 BOTT (500 ml) 0.60 0.0012 Buyer SAFRICA 1 BAG (1000 ml) 1.21 0.0012 Buyer GHANA 20 BAG (500 ml) 19.50 0.0019 Buyer Median Price/ml=0.0012 High/Low Ratio=3.90 DEXTROSE 5% IN WATER solution (IV) Price/ml E B05BA03 Supplier UNFPA 1 BOTT (1000 ml) 0.61 0.0006 Supplier UNFPA 1 BOTT (500 ml) 0.35 0.0007 Supplier JMS 1 BOTT (500 ml) 0.42 0.0008 Supplier MEDS 1 BOTT (1000 ml) 0.89 0.0009 Supplier MEDS 1 BOTT (500 ml) 0.44 0.0009 Supplier IDA 12 BAG (1000 ml) 11.18 0.0009 Supplier MEG 1 BOTT (1000 ml) 1.10 0.0011 Supplier DURBIN 12 BOTT (1000 ml) 13.35 0.0011 Supplier MISSION 1 BOTT (1000 ml) 1.15 0.0012 NIPPLEHEAD Supplier IDA 20 BAG (500 ml) 11.76 0.0012 Supplier MEDEOR/TZ 1 BOTT (500 ml) 0.66 0.0013 Supplier DURBIN 20 BOTT (500 ml) 14.52 0.0015 Supplier MISSION 1 BOTT (500 ml) 0.75 0.0015 NIPPLEHEAD Supplier MEG 1 BOTT (500 ml) 0.75 0.0015 Supplier MEDEOR/EU 10 BOTT (500 ml) 11.06 0.0022 Supplier Median Price/ml=0.0011 High/Low Ratio=3.67 Buyer DOMREPUB 1 BOTT (1000 ml) 0.48 0.0005 Buyer OECS/PPS 1 BOTT (1000 ml) 0.85 0.0008 Buyer SAFRICA 1 BAG (1000 ml) 1.00 0.0010 Buyer PERU 1 BOTT (1000 ml) 1.10 0.0011 Buyer NAMIBIA 1 BOTT (1000 ml) 1.14 0.0011 Buyer MEMS 1 BOTT (500 ml) 0.60 0.0012 Buyer GHANA 20 BAG (500 ml) 19.00 0.0019 Buyer PERU 1 BOTT (500 ml) 1.02 0.0020 Buyer Median Price/ml=0.0011 High/Low Ratio=4.08 DEXTROSE 50% IN WATER (HYPERTONIC) solution (IV) Price/ml E B05BA03 Supplier JMS 1 BOTT (100 ml) 0.69 0.0069 Supplier MEDEOR/TZ 1 VIAL (500 ml) 5.21 0.0104 Supplier UNFPA 25 VIAL (50 ml) 15.00 0.0120 Supplier MEDS 1 VIAL (50 ml) 0.69 0.0138 Supplier IDA 20 VIAL (50 ml) 16.70 0.0167 Supplier MISSION 20 VIAL (50 ml) 21.24 0.0212 Supplier DURBIN 25 VIAL (50 ml) 46.31 0.0371 Supplier MEDEOR/EU 25 VIAL (50 ml) 52.17 0.0417 Supplier Median Price/ml=0.0153 High/Low Ratio=6.04 Buyer SAFRICA 1 BAG (500 ml) 3.37 0.0067 Buyer NAMIBIA 1 BOTT (500 ml) 3.76 0.0075 VACUUM-PACKED Buyer DOMREPUB 1 AMP (20 ml) 0.16 0.0081 Buyer OECS/PPS 1 VIAL (50 ml) 0.69 0.0138 Buyer NAMIBIA 10 VIAL (20 ml) 12.89 0.0645 Buyer MEMS 1 VIAL (50 ml) 5.40 0.1080 Buyer Median Price/ml=0.0110 High/Low Ratio=16.02 DIAZEPAM (IC) 10 mg tab-cap (PO) Price/tab-cap 10 mg P N05BA01 Buyer PERU 100 TAB-CAP 0.85 0.0085 TABLETS, ILLUSTRATIVE PACK SIZE DIAZEPAM (IC) 5 mg tab-cap (PO) Price/tab-cap 10 mg E N05BA01 Supplier JMS 1000 TAB-CAP 3.25 0.0032 TABLETS Supplier MISSION 1000 TAB-CAP 6.18 0.0062 TABLETS Supplier IDA 1000 TAB-CAP 6.23 0.0062 TABLETS Supplier MEDS 1000 TAB-CAP 6.27 0.0063 TABLETS Supplier DURBIN 1000 TAB-CAP 7.07 0.0071 TABLETS Supplier MEG 1000 TAB-CAP 8.10 0.0081 TABLETS WHO EML = <E>ssential, <C>omplementary, <P>resentation, <T>herapeutic group alternative, <N>ot on list *The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. DDDs have not been established for pediatric use. A-34 International Drug Price Indicator Guide, 2012 List I: Products Sorted Alphabetically ITEM DESCRIPTION PACKAGE UNIT DEFINED WHO ATC SOURCE PACKAGE PRICE (US$) PRICE (US$) COMMENTS DAILY DOSE* EML CODE DIAZEPAM (IC) 5 mg tab-cap (PO) Price/tab-cap 10 mg E N05BA01 Supplier MEDEOR/TZ 100 TAB-CAP 0.86 0.0086 TABLETS Supplier Median Price/tab-cap=0.0063 High/Low Ratio=2.69 Buyer OECS/PPS 1000 TAB-CAP 0.46 0.0005 SCORED TABLETS Buyer GHANA 100 TAB-CAP 0.26 0.0026 10 X 10 BLISTER PACK TABLETS Buyer SAFRICA 500 TAB-CAP 1.78 0.0036 SCORED TABLETS Buyer MEMS 1000 TAB-CAP 3.96 0.0040 TABLETS Buyer Median Price/tab-cap=0.0031 High/Low Ratio=8.00 DIAZEPAM (IC) 5 mg/ml ampoule (INJ) Price/ml 10 mg P N05BA01 Supplier JMS 10 AMP (2 ml) 0.76 0.0382 Supplier DURBIN 100 AMP (2 ml) 10.60 0.0530 Supplier IDA 100 AMP (2 ml) 10.86 0.0543 Supplier MISSION 100 AMP (2 ml) 10.95 0.0548 Supplier MEG 100 AMP (2 ml) 14.50 0.0725 Supplier UNFPA 100 AMP (2 ml) 20.00 0.1000 Supplier MEDEOR/TZ 100 AMP (2 ml) 23.40 0.1170 Supplier MEDS 1 AMP (2 ml) 0.51 0.2574 IM/IV Supplier Median Price/ml=0.0637 High/Low Ratio=6.74 Buyer MEMS 1 AMP (2 ml) 0.15 0.0750 Buyer GHANA 10 AMP (2 ml) 1.60 0.0800 Buyer DOMREPUB 1 AMP (2 ml) 0.18 0.0917 Buyer SAFRICA 1 AMP (2 ml) 0.19 0.0950 Buyer OECS/PPS 100 AMP (2 ml) 25.50 0.1275 IM/IV Buyer NAMIBIA 10 AMP (2 ml) 4.63 0.2315 Buyer Median Price/ml=0.0934 High/Low Ratio=3.09 DICLOFENAC 1% ointment (TOP) Price/g N D11AX18 Supplier MEDEOR/TZ 1 TUBE (30 g) 0.40 0.0132 Supplier MEDS 1 TUBE (15 g) 0.23 0.0156 Supplier MEDEOR/EU 20 TUBE (50 g) 23.04 0.0230 Supplier Median Price/g=0.0156 High/Low Ratio=1.75 Buyer DOMREPUB 1 TUBE (20 g) 0.16 0.0082 Buyer GHANA 1 TUBE (20 g) 0.37 0.0185 Buyer Median Price/g=0.0134 High/Low Ratio=2.25 DICLOFENAC 100 mg suppos (RECT) Price/supp 0.1 g N M01AB05 Supplier MEDS 10 SUPP 1.61 0.1615 Buyer GHANA 10 SUPP 0.69 0.0690 Buyer SAFRICA 5 SUPP 1.67 0.3340 Buyer Median Price/supp=0.2015 High/Low Ratio=4.84 DICLOFENAC SODIUM 25 mg tab-cap (PO) Price/tab-cap 0.1 g N M01AB05 Supplier IDA 1000 TAB-CAP 4.95 0.0049 ENTERIC COATED TABLETS Supplier MEDEOR/EU 3500 TAB-CAP 18.99 0.0054 TABLETS Supplier DURBIN 1000 TAB-CAP 5.50 0.0055 TABLETS Supplier MISSION 1000 TAB-CAP 5.90 0.0059 ENTERIC-COATED TABLETS Supplier MEG 100 TAB-CAP 0.81 0.0081 10 X 10 BLISTER PACK ENTERIC-COATED TABLETS Supplier Median Price/tab-cap=0.0055 High/Low Ratio=1.65 Buyer SAFRICA 500 TAB-CAP 3.16 0.0063 TABLETS DICLOFENAC SODIUM 25 mg/ml ampoule (INJ) Price/ml 0.1 g N M01AB05 Supplier JMS 10 AMP (3 ml) 0.62 0.0205 Supplier MEDEOR/TZ 100 AMP (3 ml) 9.72 0.0324 Supplier IDA 100 AMP (3 ml) 10.67 0.0356 Supplier MISSION 100 AMP (3 ml) 11.69 0.0390 Supplier MEG 100 AMP (3 ml) 11.90 0.0397 Supplier MEDS 1 AMP (3 ml) 0.15 0.0507 IM Supplier UNFPA 100 AMP (3 ml) 19.00 0.0633 Supplier DURBIN 100 AMP (3 ml) 24.34 0.0811 Supplier MEDEOR/EU 50 AMP (3 ml) 14.83 0.0989 Supplier Median Price/ml=0.0397 High/Low Ratio=4.82 Buyer DOMREPUB 1 AMP (3 ml) 0.03 0.0091 Buyer GHANA 10 AMP (3 ml) 0.35 0.0117 Buyer MEMS 1 AMP (3 ml) 0.06 0.0190 Buyer SAFRICA 1 AMP (3 ml) 0.09 0.0300 Buyer OECS/PPS 100 AMP (3 ml) 22.75 0.0758 Buyer Median Price/ml=0.0190 High/Low Ratio=8.33 DICLOFENAC SODIUM 50 mg tab-cap (PO) Price/tab-cap 0.1 g N M01AB05 Supplier MEDS 1000 TAB-CAP 2.92 0.0029 ENTERIC-COATED TABLETS Supplier MEDEOR/TZ 100 TAB-CAP 0.50 0.0050 TABLETS WHO EML = <E>ssential, <C>omplementary, <P>resentation, <T>herapeutic group alternative, <N>ot on list *The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. DDDs have not been established for pediatric use. A-35 International Drug Price Indicator Guide, 2012 List I: Products Sorted Alphabetically ITEM DESCRIPTION PACKAGE UNIT DEFINED WHO ATC SOURCE PACKAGE PRICE (US$) PRICE (US$) COMMENTS DAILY DOSE* EML CODE DICLOFENAC SODIUM 50 mg tab-cap (PO) Price/tab-cap 0.1 g N M01AB05 Supplier MEG 1000 TAB-CAP 5.70 0.0057 ENTERIC-COATED TABLETS Supplier IDA 1000 TAB-CAP 7.32 0.0073 ENTERIC COATED TABLETS Supplier MISSION 1000 TAB-CAP 7.93 0.0079 TABLETS Supplier JMS 100 TAB-CAP 0.90 0.0090 TABLETS Supplier Median Price/tab-cap=0.0065 High/Low Ratio=3.10 Buyer DOMREPUB 1 TAB-CAP 0.00 0.0028 BLISTER PACK TABLETS Buyer MEMS 100 TAB-CAP 0.42 0.0042 TABLETS Buyer SAFRICA 21 TAB-CAP 0.28 0.0133 ENTERIC-COATED TABLETS Buyer Median Price/tab-cap=0.0042 High/Low Ratio=4.76 DICLOFENAC SODIUM (SUSTAINED-RELEASE) 75 mg tab-cap (PO) Price/tab-cap 0.1 g N M01AB05 Buyer OECS/PPS 500 TAB-CAP 8.88 0.0178 TABLETS Buyer GHANA 100 TAB-CAP 16.70 0.1670 10 X 10 BLISTER PACK CAPSULES Buyer Median Price/tab-cap=0.0924 High/Low Ratio=9.38 DICLOXACILLIN 250 mg tab-cap (PO) Price/tab-cap 2 g E J01CF01 Buyer PERU 100 TAB-CAP 6.57 0.0657 TABLETS, ILLUSTRATIVE PACK SIZE DICLOXACILLIN 500 mg tab-cap (PO) Price/tab-cap 2 g N J01CF01 Buyer PERU 100 TAB-CAP 4.63 0.0463 TABLETS, ILLUSTRATIVE PACK SIZE DIDANOSINE (CHEWABLE, DISPERSIBLE) 200 mg tab-cap (PO) Price/tab-cap 0.4 g E J05AF02 Supplier SCMS 60 TAB-CAP 14.82 0.2470 TABLETS DIDANOSINE (DDI) 10 mg/ml powder (PO) Price/g 0.4 g E J05AF02 Supplier SCMS 1 PACKET (2 g) 13.22 6.6098 RECONSTITUTE TO 200 ML DIDANOSINE (DDI) 200 mg tab-cap (PO) Price/tab-cap 0.4 g E J05AF02 Supplier IDA 30 TAB-CAP 13.04 0.4348 ENTERIC-COATED CAPSULES Supplier SCMS 60 TAB-CAP 26.77 0.4463 TABLETS Supplier Median Price/tab-cap=0.4406 High/Low Ratio=1.03 DIDANOSINE (DDI) 250 mg tab-cap (PO) Price/tab-cap 0.4 g P J05AF02 Buyer SAFRICA 30 TAB-CAP 7.95 0.2650 CAPSULES DIDANOSINE (DDI) 400 mg tab-cap (PO) Price/tab-cap 0.4 g E J05AF02 Supplier IDA 30 TAB-CAP 22.33 0.7443 ENTERIC-COATED TABLETS Buyer SAFRICA 30 TAB-CAP 12.78 0.4260 ENTERIC-COATED TABLETS Buyer PERU 100 TAB-CAP 62.24 0.6224 TABLET, ILLUSTRATIVE PACK SIZE Buyer Median Price/tab-cap=0.5242 High/Low Ratio=

View the publication

You are currently offline. Some pages or content may fail to load.